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The mouse major urinary proteins (MUPs) are encoded of by 
a family of about 35 genes. The expression of the genes is 
under complex tissue-specific, developmental and hormonal 
control. Four groups of Mup genes have been identified, 
the largest of which are the group 1 genes and the inert 
group 2 pseudogenes. Most group 1 genes are expressed 
exclusively in the liver, while a small subset are also 
expressed in the mammary glands of females. In an attempt 
to identify the regions in Mup genes which lead to their 
tissue specificity and hormone responses, transgenic mice 
were generated containing the 2.2 kb 5' promoter region of 
a mouse Mmup group 1 gene (BS6) linked to the coding region 
of the herpes simplex virus type 1 thymidine kinase gene 
(HSV1-tk). HSV1 thymidine kinase (HSV1-TK) assays revealed 
that the hybrid gene was expressed in the liver of 4 of 
the 5 transgenic lines examined, with expression first 
being detected at just over 2 weeks of age. In 3 of the 4 
expressing lines examined expression was lower in female 
than male livers and when females of one of the sexually 
dimorphic lines were treated with testosterone, levels of 
HSV1-TK activity were elevated, although not to male 
levels. In these aspects of liver expression, the 
transgene exhibited many of the characteristics of the 
endogenous group 1 Mup genes. However, the transgene was 
also consistently expressed at high levels in the 
preputial gland and testis. This is unexpected since Mup 
genes are not expressed in either tissue. Evidence is 
presented here which suggests that the causes of 
misexpression in the preputial gland and testis are 
different. 
Testicular misexpression is independent of the 
attached tissue-specific promoter, and is observed in 
transgenic lines containing a promoterless HSV1-tk gene. 
In all cases the testis transcripts originated at 
positions in the E-ISV1-tk reporter gene downstream of the 
normal translation initiation codon. In agreement with 
this, the TK protein synthesized in the testis was shorter 
than the full-length protein, of a size consistent with 
initiation at Met46 and Met60, the second and third 
internal ATG codons. Thus the transcription of E-ISV1-tk in 
the testis is directed by sequences present in the HSV1-tk 
reporter gene itself, acting as a testis tissue-specific 
promoter. In most cases the TK activity in the testis 
rendered the transgeriic male mice sterile. In lines with 
high levels of expression, sperm counts were low, 
malformed sperm were present and males were sterile. In 
lines with lower expression levels sperm counts were 
normal but sperm motility was reduced and males were again 
sterile. Low levels of HSV1-TK were detected before the 
first meioses occurred. However expression increased 
greatly thereafter and most HSV1-TK is found in 
spermatids. In an attempt to restore fertility in 
transgenic male mice, synthesis of 5'-ethynyl-thymidine, a 
non-toxic competitive inhibitor of [-LSV1-TK, was 
undertaken. Preliminary results indicated that 5'-ethynyl-
thymidine causes a decrease in HSV1-TK activity. 
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Chapter 1: GENE EXPRESSION IN TRANSGENIC ANIMALS. 
"Transgenic animals", a term introduced by Gordon and 
Ruddle in 1981, may be defined as those that have foreign 
DNA integrated into the chromosomes present in their 
somatic cells, and usually also their germ line, as a 
consequence of the experimental introduction of DNA 
(Palmiter and Brinster, 1985). Many cloned genes that have 
been introduced into the mouse germ line have shown 
appropriate tissue-specific and stage specific patterns of 
expression, despite their integration into apparently 
random sites in the host genome. Therefore, gene transfer 
into mouse embryos, combined with in vitro mutagenesis, 
can serve as an experimental assay for the cis-acting DNA 
sequences that dictate specific patterns of transcription 
in the developing animal. Furthermore, the ability to 
introduce and express cloned genes allows one to 
investigate the phenotypic effects of altered gene 
expression. One can cause the over-production of a normal 
gene product or direct its synthesis to an unusual cell 
type, or inhibit the expression of an endogenous gene in a 
developing mouse by introducing a gene encoding antisense 
RNA (Munir et al., 1990; Han et al., 1991; Pepin et al., 
1992). These approaches can be used either with a gene 
whose normal function is already known, or with newly 
identified genes whose functions are being investigated. 
In addition, novel genes not normally expressed in the 
mouse, or mutant forms of normal mouse genes, can be 
introduced. These approaches provide new experimental 
strategies for answering basic questions in many areas of 
mammalian biology, and in some cases make possible the 
production of animal models of human diseases. 
Although most publications on transgenic animals have 
dealt with mice, DNA integration has also been achieved in 
pigs, sheep and rabbits (Hammer et al., 1985c; Hammer et 
al., 1986b). In addition, transgenic techniques have 
proved useful in plant breeding and one application is to 
confer plants with resistance to certain diseases (Loesch-
Fries et al., 1987). 
Transgenic mice may be derived in three different 
ways (1) direct injection of DNA into one of the pronuclei 
of the fertilized eggs; (2) infection of embryos with a 
retrovirus; (3) the use of embryonic stem cells previously 
transfected with the DNA of interest to produce chimaeras 
either via aggregation or blastocyst injection. To date 
method 1 is the most widely used and all of the results 
presented in this thesis were obtained from transgenic 
mice derived by this method. However, methods 2 and 3 have 
some special and interesting features that I will discuss. 
Methods Used To Generate Transgenic Animals. 
Gordon et al (1980) were the first to report the 
successful integration of foreign DNA into mice by 
microinjection. Since then many investigators have had 
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success with 	this method (Brinster et al., 	1981; 
Costantinj and Lacey, 1981; Wagner E.F. et al., 1981; 
Wagner T.E. et al., 1981). The method of microinjection is 
described in detail elsewhere (Brinster et al., 1985; 
Gordon and Ruddle, 1983; Hogan et al., 1986). Briefly, 
superovulated females are mated and single-cell embryos 
are harvested from the oviducts. After the removal of the 
cells that surround the embryo, 1 to 2 picolitres of the 
appropriate foreign DNA (containing about 1 ug/ml of 
linear DNA) is injected into one of the pronuclei. This is 
followed by implanting the microinjected eggs into the 
oviduct of a pseudopregnant mother and allowing gestation 
to proceed normally. 
When foreign DNA molecules are injected into 
pronuclei, about 25% of the mice that are born carry one 
or more copies of the injected gene (Brinster et al., 
1985). Because integration usually occurs prior to DNA 
replication, about 70% of the transgenic mice carry the 
transgenes in all of their cells, including the germ line 
cells (Costantini et al., 1985; Gordon and Ruddle, 1981; 
Palmiter et al., 1982; Stewart et al., 1982). In the 
remaining 30% of the transgenic mice, integration 
apparently occurs after one or more rounds of replication; 
hence, the transgenes are present in only a fraction of 
the cells (Costantini and Lacey, 1981). These mice usually 
show mosaicism in both somatic and germ cells, but in some 
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mice the germ line is deficient. The original transgenic 
mice are designated "founder" mice and, when it is 
present in germ line cells, the foreign gene is usually 
inherited as a Mendelian trait. 
Integration within the host genome appears to be at 
random (Lacey et al., 1983). The number of copies of the 
foreign DNA sequence that are integrated ranges from one 
to several hundred. When multiple copies are present, they 
are usually found at a single chromosomal locus (Lacey et 
al., 1983). However, insertion at more than one site 
sometimes occurs and is detected by the segregation of 
sites in the Gi and subsequent generations. The copies of 
the foreign DNA at each integration site are arranged 
primarily in a head to tail tandem array (Brinster et al., 
1981; Costantini and Lacey, 1981; Palmiter et al., 1982), 
although other arrangements have been documented. The 
efficiency of introducing foreign DNA into the eggs of 
mice has been studied by Brinster et al, (1985) who found 
that the optimal conditions for integration involve the 
injection of several hundred molecules into the male 
pronucleus of fertilized one-cell embryos. They also noted 
that linear DNA is integrated more efficiently than 
circular DNA. Furthermore, the efficiency of transgenic 
mouse production is influenced by the strain of mouse 
used. 
The mechanism of integration of microinjected DNA is 
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unknown, although it is thought that the injected DNA 
molecules associated by homologous recombination before 
integration and in most cases insert subsequently at a 
single chromosome site (Brinster et al., 1985). 
Frequently, rearrangements, deletions, duplications (Mark 
et al., 1985; Covarrubjas et al., 1987), or translocations 
(Mahon et al., 1988) of the host sequences occur at the 
insertion sites. 
An alternative method for introducing genes into the 
mouse germ line is the infection of mouse embryos with 
retrovira]. vectors. Pre- or postimplantation embryos can 
be infected by either wild-type or genetically engineered 
retroviruses, leading to the stable integration of viral 
genomes into the host chromosomes (Jaenisch, 1976; 
Jaenisch et al., 1981; Stuhlmann et al., 1984; Jahner et 
al., 1985; van der Putten et a].., 1985). In contrast to 
microinjected DNA, retroviruses integrate by a precisely 
defined mechanism into the genorne of the infected cell. 
Only one proviral copy is inserted at a given chromosomal 
site and no rearrangements of the host genome are induced 
apart from a short duplication of host sequence at the 
site of integration (Varrnus, 1982). Preimplantation mouse 
embryos can be exposed to concentrated virus stocks 
(Jaenisch, 1977) or co-cultivated on monolayers of virus-
producing cells (Jahner and Jaenisch, 1980). Methods have 
also been devised to introduce virus into postimplantation 
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embryos between days 8 and 12 of gestation (Jaenisch, 
1980). While this allows infection of somatic cells, germ 
cells are infected with a low frequency (Jaenisch et al., 
1981). 
The use of retroviral vectors as a means of obtaining 
transgenic animals that correctly express a gene that has 
been introduced into the vector, has several 
disadvantages. Firstly, there is a size limit of the 
foreign DNA inserted into the vector, although to a 
certain extent the use of cDNA-based genes circumvent this 
problem. Secondly, there is interference with expression 
of the inserted DNA due to methylation, which occurs when 
retroviral vector is passed through the germline. However, 
retroviral vectors have proven useful as an approach for 
expressing genes in a subset of cells in the adult animal. 
This work is motivated by an interest in delivering genes 
to specific cells in humans for gene therapy. For example 
gene therapy is being considered as a treatment for 
several diseases of the hematopoietic system, including 
sickle cell disease and beta-thalassaernja. 
The integration of retroviruses into the genome may 
disrupt an endogenous gene and therefore serve as an 
insertional mutagen. This offers a way for obtaining 
mutants with the altered developmental processes. The 
virtue of such a strategy is that it not only produces 
mutations, but at the same time, tags a gene and therefore 
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offers a way of cloning the mutated gene. Several types of 
insertional mutations, after retrovirus insertion, have 
been obtained in transgenic mice (Schnieke et al., 1983; 
Soriano et al., 1987; Weiher et al., 1990). 
A more recently developed technique involves the use 
of embryonic stem cell lines (ES cells), which are derived 
in vitro from explanted blastocysts and retain their 
normal karyotype in culture (Doetschman et al., 1985). 
When injected into host blastocysts, ES cells can colonise 
the embryo and contribute to the germ line of the 
resulting chimeric animal (Bradley et al., 1984; Gossler 
et al., 1986). Genes can be efficiently introduced into ES 
cells by DNA transfection or by retrovirus-mediated 
transduction, and cell clones selected for the presence of 
foreign DNA often retain their pluripotent character. By 
means of this approach, mice have been generated from 
clones that were selected in vitro for a specific 
phenotype. For example, hypoxanthine-guanine 
phosphoribosyl transferase (HPRT-)-deficient ES cells were 
introduced into the developing mouse and subsequently 
contributed to the germ line to produce animals totally 
deficient in HPRT (Kuehn et al., 1987). 
A very promising use of ES lines is made possible by 
recombination between exogenous DNA sequences transferred 
into these cells and homologous endogenous sequences 
(Doetschman et al., 1987; Thomas and Capecchi, 1987). 
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Several reports have shown that the selectable Hprt locus 
could be targeted by homologous recombination in ES cells 
at frequencies around 1 in 1000 cells that integrated DNA 
(Doetschman et al., 1987; Thomas and Capecchi, 1987). More 
recently, clever selection schemes for the selection or 
detection of these rare homologous events has been 
developed. These include the use of the polymerase chain 
reaction to identify target clones (Joyner et al., 1989; 
Zimmer and Gruss, 1989; Koller and Smithies, 1989), use of 
promoterless or enhancerless neo constructs to enrich for 
gene targeted events in genes expressed in ES cells (Jasin 
and Berg, 1988; Doetschman et al., 1988; Schwartzberg et 
al., 1989; Sedivy and Sharp, 1989), and application of a 
positive-negative selection system to enrich for targeted 
events in expressed or nonexpressed genes (Mansour et al., 
1988). Successful transmission into the mouse germ line 
has now been published for HPRT+ targeted cell lines 
(Thompson et al., 1989; Koller et al., 1989). Other 
targeted genes have now been transmitted through the mouse 
germline, these include lines carrying targeted 
alterations in c-abl (Schwartzberg et al., 1990, 1991), 
Hox-2,6 homeobox (Hasty et al., 1991), N-myc (Charron et 
al., 1990), c-src (Soriano et al., 1991) and c-engrailed-2 
homeobox genes (Joyner et al., 1991). A way is now open to 
site-directed mutagenesis of any gene and subsequent 
transfer of the genetic modification in the mouse germ 
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line, thus allowing the investigation of the functional 
role of developmentally important genes, for example. 
Gene Expression In Transgenic Animals. 
The expression of genes that are transcribed in a tissue-
specific manner is controlled by cis-acting regulatory 
sequences. Such sequences can be identified by introducing 
suitably manipulated genes into the mouse genome. 
The usual strategy is to harvest various tissues from 
the transgenic mice and assay for specific mRNA or 
protein. In order to distinguish the products of the 
injected gene from the endogenous counterpart, it must be 
marked in some way. For example, it may be from a 
different species, it may be a minigene with some exons 
deleted, or it may be modified by altering, inserting or 
deleting a few nucleotides. Alternatively, hybrid genes 
can be constructed in which the regulatory region 
(promoter) of the gene of interest is used to direct the 
expression of the protein coding region (reporter gene) of 
another gene. Reporter genes might code for an easily 
assayable enzyme that is not normally found in the mouse, 
a polypeptide that is easily identified immunologically, 
or an oncogene that could lead to unrestrained growth of 
the cell type in which it is expressed (Brinster and 
Palmiter, 1985; Overbeek et al., 1985; Hammer et al., 
1985a 1 b; Readhead et al., 1987). 
Specific transgene expression, which is also stably 
transmitted, has been found for many genes either active 
in only one cell type, in a few cell types, or in many 
cell types. Among the great number of studies utilizing 
transgenic mice, I have chosen to discuss the analysis of 
two different genes for which the results obtained are the 
most complete: the elastase I and alpha-fetoprotein genes. 
The elastase I gene. Elastase I is a digestive enzyme 
synthesized and secreted by the acinar cells of the 
exocrine pancreas. Initially, a 27 kb genomic fragment 
containing 7 kb of upstream flanking sequence, 11 kb of 
exon and intron sequences, and 5 kb of downstream flanking 
sequence was used to generate transgenic mice (Swift et 
al., 1984). The integrated gene exhibited the 
physiological pattern of tissue-specific expression. 
Analysis of a series of deletions showed that 205 bp of 5' 
flanking sequence were sufficient to selectively direct 
the expression of an heterologous structural gene (the 
human growth hormone gene) to the pancreas of transgenic 
mice (Ornitz et al., 1985a). More recently, Hammer et al 
(1987a) showed that an even shorter sequence of 134 bp, 5' 
of the gene, containing an enhancer like sequence, is both 
necessary and sufficient for the specific expression of 
the reporter gene. Furthermore, this sequence was able to 
confer the correct timing in developmental expression on 
the fusion gene. Thus in the case of the elastase I gene, 
a small genomic region contains the information required 
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for tissue-specific regulation of gene expression. Similar 
results have been obtained in the case of other genes, 
including the gamma-crystallin (Goring et al., 1987; 
Kondohn et al., 1987), and the protamine genes (Peschon et 
al., 1987). 
The alpha-fetoprotein gene (AFP). Although many genes 
analysed in transgenic mice thus far have contained only 
one defined tissue-specific enhancer, some genes expressed 
in several tissues may contain multiple enhancers. 
Expression of the alpha-fetoprotein gene is directed by no 
less than three enhancers with over-lapping tissue 
specificities. AFF is expressed during development in 
three different tissues, namely the visceral endoderm of 
the embryonic yolk sac, and the foetal liver and 
intestine. Its expression is very different from one organ 
to another. To discriminate both at the rnRNA and DNA 
levels between transgene and endogenous gene expression, 
an AFP minigene was constructed. This consisted of 7 kb of 
5'flanking sequence, together with the first 3 and last 2 
exons (out of the 15 normal exons) and 0.4 kb of 
3'flanking sequences (Krumlauf et al., 1985). This AFP 
minigene directed expression to all three tissues that 
normally express the endogenous AFP gene, but the liver 
overexpressed the transgene several-fold over endogenous 
expression, while in the intestinal tract expression was 
often greater than 5000-fold higher than normal. This 
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expression was seen even when more 5'flanking sequence 
sequence was introduced, suggesting that any repressing 
elements are not within the 14 kb upstream region of the 
AFP gene. In a subsequent analysis of the 5'Elanking 
sequences, three enhancer domains spanning several 
kilobases could be defined. At least one of these was 
necessary for the transcription of AFP gene in one of the 
three embryonic tissues. Moreover, the analysis of the 
mice transgenic for constructs that included the different 
enhancers suggest that these enhancers act in combination 
to determine the level of expression in the different 
organs (Hammer et al., 1987b). 
Modulation of transgene expression by environmental 
stimuli. Promoters of genes subject to modulation by 
hormonal or other environmental stimuli have also been 
shown in several instances to properly control expression 
of transgenes, as long as the cis-acting elements are 
included in the construct. The metallothionein promoter, 
for example, has been used to direct expression of many 
different reporter genes, and in some cases expression 
could be stimulated by feeding the animals with heavy 
metals (Palmiter, 1987). Hormone-inducible promoters that 
function in transgenic mice include the mouse mammary 
tumour virus (MMTV) long terminal repeat (LTR) (Stewart et 
al., 1988; Leder et al., 1986) 9 the transferrin gene 
(Hammer et al., 1986a), and the H-2 Ealpha gene (Pinkert 
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et al., 1985). These results indicate that transgene 
expression can be modulated in vivo by external signals. 
Variable gene expression in transgenic animals. As a rule, 
tissue-specific genes are expressed appropriately, despite 
being integrated at an abnormal chromosomal location 
(Palmiter and Brinster, 1985; Shani, 1986; Sifers et al., 
1987). This phenomenon is particularly common with 
unaltered genes and genes that have been only slightly 
modified. A difference in gene expression between a 
founder animal and its offspring is frequently due to 
mosaicism of the founder animal (McKnight et al., 1983). 
Mosaicism occurs when integration of the foreign DNA 
follows one or more cycles of DNA replication in the 
embryo. On average about 30% of the transgenic mice 
generated exhibit mosaicism. One expects to observe higher 
levels of expression in the offspring relative to the 
founder, and this increase usually corresponds to that 
expected based upon the germline transmission frequency 
(Ornitz et al., 1985a). In subsequent generations gene 
expression becomes stable. 
Different lines of transgeriic mice, generated by 
microinjecting the same DNA construct, exhibit varying 
levels of transgene expression (Chada et al., 1985; Ornitz 
et al., 1985a,b; Palmiter et al., 1982; Townes et al., 
1985) and correlation between copy number and expression 
is generally poor. This effect is assumed to be due to the 
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exact position of the transgene in the chromosome. 
Transgenes are thought to integrate relatively randomly in 
the genome, placing the injected gene in different regions 
of the chromosome in different founder mice. The site of 
integration affects the level of transcription of a 
transgene in different mice. In some cases a mouse will 
have the transgene integrated but not expressed; the same 
transgene in a different founder may express to very high 
levels. Therefore, it is possible to study the effects of 
varying level of transgene expression by studying 
different lines of transgenic mice. 
Variability in gene expression between individuals 
within a given trarisgenic line may be due to variable DNA 
methylation (Palmiter et al., 1982) and/or may include 
effects of modifier genes that could be segregating as a 
result of using a cross of two inbred strains of mice 
(e.g. C57 X CBA) to establish and propagate the transgenic 
lines. Alternatively, some genes may be very sensitive to 
nucleosome phasing and during development of the somatic 
cells the chromatin configuration might be "reset". 
Developmental Specificity. 
Fusion genes transferred into the germ line by pronuclear 
injection may also be used to study specific developmental 
lineages. For example Alpert et al., 1988, created 
transgenic mice carrying a fusion gene comprising the 
regulatory sequences of the insulin promoter linked to the 
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coding sequences of the SV40 T antigen (Tag). This can be 
used as a cell marker because it is a nonsecreted nuclear 
antigen. 	They 	examined 	the 	appearance 	of 	Tag 
immunoreactivity at different times of embryonic 
development and could deduce the existence of a common 
precursor for the various endocrine cells of the pancreas. 
Furthermore, the results support the idea of a common 
precursor for neuronal and pancreatic tissue, an idea that 
has long been debated (Le Douarin, 1988). 
It has been shown that subpopulations of cells can be 
ablated by targeting to them the expression of a cell 
toxin (e.g. diphtheria toxin A chain) (Palmiter et al., 
1987; Breitman et al., 1987; Behringer et al., 1988). Mice 
carrying an elastase promoter/toxin construct lacked a 
normal pancreas as a result of expression in pancreatic 
acinar cells, whereas expression of the diphtheria toxin 
gene under the control of the gamma-2 crystallin promoter 
resulted in mice with lens defects (Palmiter et al., 
1987). This strategy should allow the elimination of any 
cell type to which expression of the toxin can be directed 
by a specific promoter. Live animals can be obtained in 
which targeted lineages, such as lens or pancreatic 
exocrine cells, are ablated. More recently, drug-inducible 
ablation of specific lymphoid cells was reported in mice 
expressing the herpes thymidine kinase gene under Ig gene 
promoter control (Heyman et al., 1989). Because dose and 
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time of drug delivery can be experimentally controlled, 
this approach can permit the ablation of any lineage, 
including those that are essential for survival of the 
animal. 
Unusual Aspects Of Gene Expression In Transgenic Animals. 
While many genes can be expressed in transgenic mice in an 
appropriate manner, there are some examples of genes that 
have not been expressed at all or with very low frequency. 
Prokaryotic vector sequences prevent the appropriate 
expression of some genes. The presence of plasmid or 
lambda phage vector sequences severely inhibited both the 
level and frequency of expression of beta-globin genes 
(Townes et al., 1985). Plasmid sequences also inhibited 
MT-hGE-1, alpha-actin and alpha-fetoprotein gene expression 
(Hammer et al., 1985a; Krurnlauf et al., 1985; Shani, 
1986). Furthermore, intronless cDNA genes are less 
efficiently expressed than complete genes (Brinster et 
al., 1988). The lack of expression of other constructs may 
be due to the exclusion of certain sequences that are 
required for expression. Alternatively, the hybrid gene 
could contain a new combination of cis-acting sequences 
which has an inhibitory influence on expression. 
Occasionally, hybrid gene expression may occur 
consistently in inappropriate tissues, in addition to or 
instead of normal expression. Possibly the native gene is 
transcribed but the mRNA is not stable, whereas the hybrid 
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gene transcript may be sufficiently stable to allow 
detection. Alternatively, the hybrid gene could contain 
new regulatory specificities which activate its 
transcription in novel tissues (Swanson et al., 1985), or 
lacks cis-acting "silencer" sequences which are required 
for repression of the endogenous gene and which are 
located outside the hybrid construct. Silencers might be 
sites for covalent modifications (e.g. methylation), they 
might initiate condensation into an inactive chromatin 
conformation or they might phase nucleosomes in an 
inappropriate manner. 
Synthesis Of Important Proteins. 
Genes have also been microinjected into rabbit, sheep and 
pig embryos (Hammer et al., 1985c, 1986b). The success 
rate of generating transgenic domestic farm animals is 
lower than that obtained with mice. Hammer et al (1985a) 
demonstrated the technical feasibility of gene insertion 
into rabbits, sheep, and pigs by transferring growth 
hormone (GH) genes. While it is not clear that such 
experiments will lead to more rapid growth of economically 
important livestock, it is likely that transgenic farm 
animals may become a source of economically valuable 
proteins. Efforts have been made to direct the synthesis 
of human secretory proteins to the milk of mice (Gordon et 
al., 1987) and sheep (Simons et al., 1988). To this 
effect, the promoter of a milk protein gene is coupled to 
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the coding region of a gene which specifies a plasma 
protein (tissue plasminogen activator, blood clotting 
Factor IX) and the hybrid gene is introduced into the 
germ-line. Expression has been correctly directed to the 
lactating mammary gland. In the first instance protein 
concentrations were low, but recent observations, 
consisting of a fusion between the 5'sequence of the beta-
lactoglobulin gene and a genomic fragment of aiphal-
antitrypsin, revealed the production of concentrations of 
protein that are suitable for commercial exploitation 
(Archibald et al., 1990). These and other experiments 
indicate that large animals can be used as "factories" for 
the production of complex proteins that, because of 
extensive post-translational modifications, are difficult 
to synthesis in bacteria. These proteins would be free of 
a variety of human diseases that could be acquired by 
harvesting such compounds from human serum. 
Future Prospects. 
The transgenic animals analysed thus far represent first 
steps in working out the technical and practical 
approaches to addressing questions in such fields as 
developmental biology, endocrinology, oncogenesis, and 
neurobiology, and it seems inevitable that there will be a 
tremendous increase in the generation of transgenic 
animals to study these questions further. 
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Chapter 2: CONTROL OF EUKARYOTE GENE EXPRESSION. 
A central problem in molecular biology is to understand the 
mechanisms by which specific genes are expressed in a temporal 
tissue-specific manner or are activated in response to 
extracellular inducers. The regulation of gene expression can 
occur at various stages from transcription initiation to post-
translational modification and protein transfer. It appears, 
however, that transcriptional control is the most common 
(reviewed by Darnell, 1982). In contrast to prokaryotes where 
one type of RNA polyrnerase catalyses the synthesis of all three 
types of RNA (messenger RNA, mRNA; transfer RNA, tRNA; and 
ribosomal RNA, rRNA), in eukaryotes a separate polymerase 
species is responsible for the synthesis of each type. That 
catalysing the synthesis of mRNA is called RNA polymerase II 
(p0111; Sentenac and Hall, 1982). 
DNA Sequences And Protein Factors. 
Two different classes of promoter structure and function have 
been described for RNA p0111 transcription in eukaryotes. The 
first class includes the majority of genes and is characterized 
by the presence of a TATA element which specifies the site of 
transcription initiation, and is located about 30 bp upstream 
of it. Extensive genetic and biochemical evidence has shown 
that the TATA element plays a significant role in start site 
selection and in specifying the frequency of transcriptional 
initiation (Benoist and Chambon, 1981; Breathnach and Chambon, 
1981; Dierks et al., 1983; Eisenmann et al., 1989; Ghosh et 
al., 1981; Hahn et al., 1989; Horikoshni et al., 1989; Nakajima 
et al., 1988). By itself, a TATA element is sufficient to 
stimulate specific transcription in vitro, though it does so 
with low efficiency in vivo in the absence of auxiliary 
elements (McKnight et al., 1981; Sassone-Corsi et al., 1981). 
Based on these properties, the TATA element can reasonably 
be considered to constitute a type of core promoter. In vivo 
reconstituted basal level transcription from poill promoters 
requires at least five distinct general factor activities. 
TFIIA, TFIIB, TFIID, TFIIE, and TFIIF, in addition to polil, 
all of which have been partially purified (Buratowski et al., 
1989; Reinberg et al., 1987; Reinberg and Roeder, 1989). The 
TFIID fraction contains an activity that binds specifically to 
the TATA box (Buratowski et al., 1989; Van Dyke et al., 1988). 
This TATA binding factor is thought to play a pivotal role in 
orchestrating transcription initiation from poiii promoters. In 
vitro, the binding of TFIID to the TATA box is a prerequisite 
for the subsequent binding of other factors and poill to form 
an active transcription complex (3,6). In addition to factors 
needed for basal levels of transcription initiation, some 
factors stimulate and/or repress transcription initiation. Such 
factors may bind to transcriptional enhancers, as well as more 
proximal upstream promoter elements (UPEs). In the current 
view, enhancers and UPEs mediate environmental and 
developmental regulation of transcription initiation by 
positively or negatively modulating the activity of the core 
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promoter complex (Horikoshni et al., 1989; Mitchell and Tjian, 
1989). 
A second class of core promoters lacks a detectable TATA 
element but in some cases these promoters have a discrete 
element overlying the start site itself which helps to fix the 
place of initiation (Smale and Baltimore, 1989; Ayer and Dynan, 
1988). The promoters for these genes are found primarily in 
housekeeping genes (for review see Sehgal et al., 1988). They 
are usually GC-rich, contain several transcription initiation 
sites spread over a fairly large region and possess several 
potential binding sites for the transcription factor SP1 (Dynan 
and Tjian, 1983). The nature and extent of mechanistic 
differences between TATA-dependent and TATA-independent modes 
of transcription initiation are not presently known. 
UPEs are a group of transcriptional control elements that 
are clustered in the region 30-110 bp upstream of the start 
site, although a number of promoters have recently been shown 
to contain functional elements downstream of the start site as 
well (Stenlund et al., 1987; Ayer and Dynan, 1988). These 
elements consist of short consensus sequences that bind to 
regulatory proteins. Many viral promoters contain multiple 
copies of a particular upstream element, the 'GC box'. Examples 
are the viral promoters of the SV40 early (Benoist and Chambon, 
1981), and the HSV1-tk promoters (McKnight and Kingsbury, 
1982). cc boxes are also found upstream of a number of cellular 
genes, especially in many housekeeping genes. These include the 
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mouse hypoxanthjne phosphoribosyl transferase gene (Melton et 
al., 1984), the mouse adenine phosphoribosyl transferase gene 
(Dush et al., 1985),the human adenosine deaminase gene (Valerio 
et al., 1985), and the rat type II procollagen gene (Kohno et 
al., 1985). 
DNase 1 footprinting and protection studies on mature and 
mutant versions of the SV40 early promoter have shown that the 
transcription factor Spi binds in a sequence-specific manner to 
the GC rich hexanucleotides that occur twice in each of the 
three 21 bp repeats of the SV40 early promoter (Dynan and 
Tjian, 1983; Gidonj et al., 1985). Steric constraints and 
differences in binding affinities at each site limit Spl-DNA 
interactions to five out of six sites at any one time. Not all 
GC boxes bind Spi equally well and sequences outside the core 
hexanucleotide seem to modulate the efficiency of binding 
(Kadonaga et al., 1986; Jones et al., 1986). Spi appears to act 
in conjunction with cellular factors such as CTF'/NF-1 (Jones et 
al., 1985), which suggests that these factors may act in 
conjunction with each other to modulate the level of 
transcription. 
A region of about 24 bp containing a binding site for a 
protein factor distinct from Spi is positioned between the two 
Spi binding  sites of the HSV1-tk promoter. The pentanucleotide 
sequence CCAAT is found within this binding domain and is known 
:o be a crucial component of several eukaryotic promoters 
McKnight and Tjian, 1986). Two cellular factors that interact 
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with CCAAT sequence have been described. These include C/EBP, 
isolated from rat liver cells (Graves et al., 1986) and the 
CTF/NF-1, isolated from HeLa cells (Jones et al., 1987). The 
first interacts not only with several CCAAT sequences but also 
with the core enhancer of SV40 and polyomavirus (Johnson et 
al., 1987). The second is identical to NF-1, a protein required 
for adenovirus DNA replication (Nagata et al., 1983) and 
interacts with the promoters of alpha and beta-globin genes 
(Efstradiadis et al., 1980) and HSV and chicken tk genes 
(McKnight and Kingsbury, 1982; Merrill et al., 1984). Although 
these various CCAAT-containing elements appear grossly similar 
in sequence, evidence suggests that different DNA binding 
factors are capable of distinguishing between them (Dorn et 
al., 1987; Oikarinen et al., 1987). Other IJPEs such as the 
metal regulatory element (Karin et al., 1984; Stuart et al., 
1984; Carter et al., 1984) or the heat shock regulatory element 
(Pelham, 1982) have a more specialized role. 
The activity of many viral and cellular promoters is also 
modulated by an enhancer. Like an UPE, an enhancer is composed 
of a group of transcriptional control elements. An enhancer 
must be on the same molecule of DNA, but can be 1,000 bp or 
more from the promoter. The most extensively studied of these 
elements are the two 72 bp repeats present between the early 
and late transcription units of the SV40 virus. Although most 
enhancers are found between 100-500 bp upstream from the TATA 
box, some are located within the transcription unit itself. For 
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example, the mouse immunoglobulin heavy chain enhancer is 
situated in the intron between the J and C segments of the gene 
(Gillies et al., 1983; Banerji et al., 1983). Other enhancers 
may be located great distances from the TATA box, e.g. that of 
the mouse albumin gene is 10 kb upstream of the TATA box 
(Pinkert et al., 1987). 
As more enhancers and UPEs were analysed it became clear 
that they resemble each other. Certain short consensus 
sequences typical of enhancers are also found as UPEs in 
certain other genes. An example is the octamer element which is 
found within immunoglobulin upstream promoter and enhancer 
regions (Falkner and Zachau, 1984). The operational distinction 
between enhancers and UPEs is action at a distance from the 
TATA box. For example, the SV40 enhancer can functionally 
replace the beta-globin UPEs when placed in a position normally 
occupied by the UPEs (Treisman and Maniatis, 1985). Similarly 
particular sequence motifs originally classified as UPEs, for 
example the hsp70 gene heat shock regulatory elements of 
Drosophila melanogaster, are able to act as inducible enhancers 
when present in more than one copy (Bienz and Pelham, 1986). 
Elements within UPEs and enhancers can be classified as 
basically two types: constitutive elements and regulatory 
elements. Constitutive elements are often well conserved 
between different genes which are functionally unrelated, and 
are found in many diverse organisms. Examples include the GC 
box, the CAAT box, the core enhancer element, the octamer and 
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the APi binding site (Lee et al., 1987). These elements are 
involved in controlling the basal rate of transcription. 
Regulatory elements are capable of activating or 
repressing the level of transcription. Examples of regulatory 
elements include those present within enhancers responsible for 
induction of certain genes by the action of specific agents 
including heat shock, viral infection, exposure to heavy metals 
and response to steroid hormones. Inducible enhancers are found 
in the heat shock inducible genes originally studied in detail 
with the hsp70 gene of Drosophila inelanogaster (Pelham, 1982) 
and since analysed in the hsp70 genes of other organisms 
including Xenopus laevis (Bienz and Pelham, 1986), the heavy 
metal inducible metallothionein genes of mice and man (Serfling 
et al., 1985; Carter et al., 1984), the steroid hormone 
responsive LTRs of MMTV (Chandler et al., 1983) and a number of 
other cellular genes including the chicken lysozyme gene 
(Renkawitz et al., 1984). The cis-acting elements within 
enhancers and UPEs are generally short. They are well conserved 
between different genes responding to the same stimuli, and are 
often present in multiple copies. The number of copies often 
dictates the strength of response (Topol et al., 1985; Searle 
et al., 1985). Examples include the metal response element 
(Stuart et al., 1984) of the heavy metal inducible genes, the 
heat shock response element (Pelham and Bienz, 1982) of heat 
shock inducible genes, and the glucocorticoid response element 
of glucocorticoid inducible genes (Jantzen et al., 1987). 
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Other regulatory elements may be conditional in that they 
are only active in particular cell lines or at specific stages 
of development. These are present in tissue- and developmental 
stage-specific enhancers, and bring about specific expression. 
Two of the best characterised examples are the immunoglobulin 
light and heavy chain enhancers which are active in B mature 
cells (Gillies et al., 1983; Banerji et al., 1983). 
Finally, certain promoter elements are able to mediate 
negative regulation. One such element was identified in the 
upstream region of the inducible beta-interferon gene on the 
basis that its deletion resulted in high levels of gene 
expression in the absence of the inducer (Goodbourn et al., 
1986). Other such elements have been found in the retinol-
binding protein, insulin, alpha-fetoprotein, c-myc, and 
immunoglobulin heavy chain genes among others (Camper and 
Tilghman, 1989; Hay et al., 1989; Imler et al., 1987; Nir et 
al., 1986). 
Transcriptional control in hepatocytes. The liver plays many 
crucial roles in body function, balancing carbohydrate and 
lipid metabolism, providing the great majority of serum 
proteins, detoxifying exogenous chemicals and removing 
internally produced products that can be toxic in excess. 
Special proteins are required to carry out these functions and 
a large number that are made in hepatocytes are unique to this 
cell type. 
Analysis of liver-specific gene regulation has led to the 
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identification 	of 	two 	classes 	of 	required 	cellular 
transcription factors, some that are widely distributed and 
others that display a more limited cellular distribution 
(Babiss et al., 1987; Cereghini et al., 1988; Costa et al., 
1988; Costa et al., 1989; Courtois et al., 1988; Grayson et 
al., 1988a,b; Herbst et al., 1989; Lichsteiner et al., 1987; 
Liu et al., 1988). These factors interact with multiple DNA 
sequence-specific motifs present in the promoter and enhancer 
elements of hepatocyte-expressed genes so that a single gene 
(for example, transthyretin) can employ as many as five 
different proteins acting on as many as 10 independent sites 
(Costa et al., 1989). These factors may dictate liver 
specificity by either acting directly to positively stimulate 
transcription complex formation or, alternatively, by 
functioning to suppress the activity of negative-acting 
ubiquitous factors, thereby allowing expression in hepatocytes 
while preventing transcription in inappropriate cell types. 
Albumin is a prototypical tissue-specific gene product 
whose gene contains a highly liver-specific promoter segment 
(from -175 to -.30bp) regulated by the ubiquitous proteins NFl 
and CAAT together with the liver enriched C/EBP and hepatocyte 
nuclear factor-1 (E-LNF-1) proteins (Babiss et al., 1987; 
Cereghini et al., 1988; Cereghini et al., 1987; Lichsteiner et 
al., 1987). The nuclear protein HNF-1 (also named LFB1) was 
detected as a protein that bound to sites required for cell-
specific expression of fibrinogen and aiphal-antitrypsin genes. 
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Its binding site is also present in the promoter and/or 
enhancer regions of several liver-specific genes (Courtois et 
al., 1988; Cereghini et al., 1988; Grayson et al., 1988b; 
Kugler et al., 1988; Hardon et al., 1988; Vaulont et al., 1989; 
Frain et al., 1989). The f-INF-1 binding site has been shown to 
be essential for cell type-specific transcription in vitro 
(Monaci et al., 1988; Lichsteiner and Schibler, 1989), in 
transfectjon assays (De Simone et al., 1987; Heard et al., 
1987; Schorpp et al., 1988; Feuerman et al., 1989), or in 
transgenic mice (Tripodi et al., 1991). In the case of the 
albumin promoter, the HNF-1 binding site is not only essential, 
but also sufficient to drive liver-specific transcription 
(Ryffel et al., 1989; Lichsteiner and Schibler, 1989; Tronche 
et al., 1989). In addition, the albumin gene contains an 
upstream enhancer element, consisting of both positive and 
negative regulatory domains, which contributes both to tissue 
specificity and to maintaining the high rate of albumin 
transcription in hepatocytes (Herbst et al., 1989; Liu et al., 
1988; Pinkert et al., 1987). 
Structure And Possible Action Of Trans-acting Proteins. 
Many sequence-specific transcription factors are comprised of 
two critical regions, typically located on separable domains 
(reviewed by Ptashne, 1988), a DNA binding region responsible 
for affinity between the transcription factor and the DNA 
response element, and a transcriptional activation region. The 
transcription activation region is believed to function by 
directly or indirectly interacting with one or more of the 
general transcription factors and either recruiting that factor 
into the transcription complex or altering its conformation to 
a form that is better able to participate in the initiation of 
transcription (reviewed by Lillie and Green, 1990; Lin et al., 
1990). A number of different motifs have been identified among 
DNA-binding and transcription activation regions (reviewed by 
Ptashne, 1988). DNA-binding motifs include Zinc-fingers, 
leucine zippers, helix-loop-helix and helix-turn-helix. A major 
class of activation regions has a highly acidic region enriched 
in glutamate and aspartate (Hope and Struhl, 1986; Ma and 
Ptashne, 1987). Alteration of the sequence of acidic residues, 
without changing the negative charge, strongly affected 
activation potential (Giniger and Ptashne, 1987; Hope et al., 
1988). This result indicated that a specific structure in the 
acidic domain is required for function. Other activators have 
nonacidic regions, including the glutamine-rich activation 
domain of Spi (Courey et al., 1989) and the proline-rich 
CTF/NF-1 (Mermod et al., 1989). 
The mechanism by which a protein bound many base pairs 
from a gene activates transcription remains unclear. This 
stimulation is associated with an increased density of polil on 
a linked gene (Weber and Schaffner, 1985). Both in vivo and in 
vitro transcription factors bound to enhancers/UPEs are thought 
to interact with poiii and/or other factors, in order to 
promote transcription (Hai et al., 1988; Horikoshni et al., 
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1988; Allison and Ingles, 1989; Brandl and Struhi, 1989). The 
most plausible model which has been invoked to explain this 
interaction is the looping model. This proposes that initiation 
of transcription is facilitated by the interaction of 
enhancers/UPEs with proximal promoter elements via proteins 
bound to the DNA. The DNA between them is thereby looped out. 
DNA looping has been described in prokaryotes in several cases, 
including cooperative repressor binding over a distance, site-
specific recombination and replication (Dunn et al., 1984; 
Hochschild and Ptashne, 1986; Kramer et al., 1987; Wang and 
Giaever, 1988; Gralla, 1989). There is also some evidence for 
DNA looping in eukaryotes, where cooperative action or binding 
of transcription factors over a distance has been observed 
(Theveny et al., 1987; Schule et al., 1988; Cohen and Meselson, 
1988). 
The 5' flanking region of transcriptionally active genes 
can often be structurally distinguished as nucleosome-free 
deoxyribonuc leas e-hypersensitive zones occupied by DNA binding 
proteins (Gross and Garrard, 1988). Experiments indicate that 
formation and stabilization of transcription initiation 
complexes with sequence-specific transcription factors can 
competitively exclude histones and prevent inhibitory effects 
of nucleosome assembly on transcription in vitro (Woiffe and 
Brown, 1988; Workman et al., 1988). It is likely that there are 
multiple mechanisms by which initiation complexes are 
stabilized in vivo, and that different activation domains of 
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DNA binding transcription factors underly some of these 
mechanisms. Specific association between regulatory regions of 
active genes and nuclear scaffold proteins have also been 
demonstrated (Gasser and Laemmli, 1986); perhaps some 
activation domains contact proteins of the nuclear matrix. 
These interactions could facilitate transcription if, for 
example, they serve to tether genes to nuclear regions with 
locally high concentrations of other essential transcription 
factors. 
Future Prospects. 
Studies of DNA binding transcription factors in animal cells 
have led to the discovery that they are a remarkably diverse 
group, constructed from a variety of combinatorially arranged 
functional domains. The mechanism by which sequence-specific 
DNA binding factors affect different rate-limiting steps in 
transcription initiation are largely unknown, and future 
experiments will be aimed at understanding, at the biochemical 
level, how different transcription factors activate initiation 
and which proteins they interact with in order to accomplish 
this. 
It is sometimes possible to gain a greater understanding 
of the factors affecting gene expression by examining multigene 
families because subtle differences which lead to changes in 
regulation are not obscured. In certain cases the pattern of 
expression within a multigene family varies during development 
in different tissues and under the control of different 
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inducers. Examples include the tissue-specific expression of 
different mouse kallikrein genes (Mason et al., 1983; van 
Leeuwen et al., 1986), varying patterns of globiri synthesis 
during development, and the induction of metallothionein genes 
by glucocorticoids and heavy metals (Karin et al., 1984). The 
gene families encoding the rodent urinary proteins appear to be 
regulated in all three ways and an investigation of gene 
expression within this family is presented within this thesis. 
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Chapter 3: THE MOUSE MAJOR URINARY PROTEIN GENE FAMILY. 
The mouse major urinary proteins (MUPs) are encoded by a 
family of about 35 to 40 highly conserved genes (Hastie et 
al., 1979; Bishop et al., 1982). Most of these are members 
of two distinct groups, the group 1 genes and the inert 
group 2 pseudogenes (Bishop et al., 1982; Clark et al., 
1982; Held et al., 1987; Shahan et al., 1987a; Al-Shawi et 
al., 1989). Most group 1 genes are expressed exclusively 
in the liver, while a small subset are also expressed in 
the mammary glands of females (Shahan et al., 1987b; Shaw 
et al., 1983). Outwith group 1 and 2, some have been 
placed in two further groups (3 and 4). The group 3 genes 
are also expressed in the liver, but under hormonal 
control different from the group 1 genes (Kuhn et al., 
1984), and the group 4 genes are expressed in the 
lachrymal and salivary glands (Shahan et al., 1987a; 
1987b). 
Mup Gene Organisation And Structure. 
The group 1 and group 2 genes are organised in head to 
head pairs about 15 kb apart. With the 3' flanking regions 
each pair constitutes a 45 kb imperfect palindrome (Clark 
et al., 1984b; Bishop et al., 1985; see Figure 3.1A). The 
45 kb units are located on chromosome 4 (Clark et al., 
1982), and it is estimated that there are thirteen to 




Organisation and structure of the Mup genes. 
Diagrammatic representation of the 45 kb unit. Group 1 and 
group 2 genes are approximately 3.9 kb long (shaded). Open 
rectangles are regions of homology between the flanking regions 
of the two groups of genes. The homology is not continuous over 
the 11 kb 3' flanking region but is interrupted by regions of 
non-homology. Genes are in a head to head (divergent) 
orientation. The 45 kb gene pair structure constitutes the 
evolutionary unit of the Mup locus. 
A diagram to show the two main forms of the MUP mRNA. 
The two main MUP RNAs showing their structural relationship to 
the gene BS6 are shown. Short mRNA contains exons 1-6. Long 
mRNA contains exons 1-5, a short 5' region of exon 6 and the 
whole of exon 7. The greater part of liver MUP mRNA is in the 
long form and nearly all of this is transcribed from the group 
I genes. Exons are shown as boxes and the coding regions are 
shaded. Adopted from Clark et al., 1984a. 
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The upstream region of five group 1 and four group 2 
genes have been sequenced. Both group 1 and group 2 genes 
possess a TATA consensus sequence. The cap site of a group 
1 gene (Bs6) has been accurately mapped by primer 
extension and nuclease protection experiments, and is 
positioned at 31 bp downstream of the TATA box (Clark et 
al., 1985b). Approximately 25 bp upstream of the TATA box 
is a sequence CCATAC, which shows limited homology to the 
consensus for the CAAT box (Ghazal, 1986; Held et al., 
1987). The major differences observed in these genes are 
in the length and composition of a hypervariable A-rich 
region, 15 bp upstream from the TATA box. The promoter 
region of Mup genes contain a number of sequences showing 
homology to sites known to bind trans-acting regulatory 
factors. These include the glucocorticoid regulatory 
element (GRE), metal regulatory element (MRE), enhancer 
core sequences and NF1 binding sites. Of these only that 
for the glucocorticoid regulatory element occurs more 
frequently than expected by chance allowing for sequence 
length and base composition (Ghazal, 1986). 
The transcription unit of the Mup genes is 3.9 kb 
long and contains seven exons, the last of which is non-
coding (Clark et al., 1984a; see Figure 3.1B). There are 
alternative splice sites within the non-translated part of 
exon 6 giving rise to three different splicing 
configurations. Two different lengths of MUP liver mRNA 
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can be resolved by gel electrophoresis. The larger message 
is 10-20 fold more abundant in male mouse liver. 
The exon sequences of four group 1 genes and 
extensive nucleotide sequence of four group 1 cDNAs are 
known (Clark et al., 1985a; 1985b; Derman, 1981)). These 
encode proteins with an 18 amino acid signal peptide and a 
162 amino acid mature protein with an expected molecular 
weight of about 19,000 Daltons. The nucleotide sequence 
homology between the different group 1 genes is greater 
than 997 but they specify different proteins. 
Tissue-specificity And Sexual Dimorphism Of Group 1 Genes. 
In BALB/c adult male mice, NIUP mRNA is the most abundant 
class of liver mRNA, whilst in the female the most 
abundant species is serum albumin (Clissold and Bishop, 
1981). t1(JP mRNA constitutes around 87 of the total liver 
polyadenylated mRNA in males, this being five times higher 
than that of females and castrated males (Hastie and Held, 
1978; Hastie et al., 1979). Female mice show a simpler 
liver MUP pattern after in vitro translation, although 
treatment with testosterone induces a male-like pattern 
and results in the synthesis of normal male-like levels of 
MUP mRNA (Finlayson et al., 1965; Szoka and Paigen, 1978; 
Clissold et al., 1984). 
Mup genes are expressed not only in male and female 
liver, but also in small amounts in prelactational mammary 
gland (Shaw et al., 1983). Shahan and Derman (1984) have 
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detected MUP mRNA at a level of about 0.027 of total mRNA 
in the mammary gland. This was confirmed further by a 
report from Shahan et al (1987b) showing hybridization of 
mammary mRNA to a group 1 BU-specific oligonucleotide 
probe. In contrast McIntosh and Bishop (1989), using 
either a universal group 1 probe or two group 1 gene 
specific probes (BL1 and BS1), failed to detect any 
hybridization with RNA from prelactational mammary gland. 
A possible explanation for this observation is that there 
may well be expression of a mRNA that could react with 
these probes but which is below the level of detection 
(this is discussed in more detail in Chapter 5). 
Developmental Expression. 
In the liver, MUP mRNA is first detected in 3 week old 
male mice, full expression being reached only at 6-7 weeks 
after birth, when animals are sexually mature (Barth et 
al., 1982). Derman (1981) showed that the different levels 
of MUP mRNA in the livers of mice of different ages and 
sex, are reflected in differences in the rate of 
transcription. The Lachrymal gland has adult MUP mRNA 
levels at 2 weeks of age, the earliest time at which the 
lachrymal gland can be dissected. The submaxillary gland 
shows detectable levels of MOP mRNA at one week of age, 
maximal levels between 4-7 weeks and then a decrease. MOP 
mRNA in the mammary glands is first detected during the 
first pregnancy. 
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Proteins Related To MUP. 
In the rat, a homologous gene family codes for the alpha-
2u globulins (Kurtz, 1981a; Dolan et al., 1982). The 
alpha-2u globulins are encoded by a multigene family 
consisting of about 20 genes (Kurtz, 1981b). Comparison of 
a rat alpha-2u globulin gene (207) and a mouse Mup group 1 
gene (Bs6) showed that the transcription units are similar 
in structure and that the exonic sequences are about 80% 
homologous. Furthermore, alpha-2u globulin has a similar 
distribution of tissue-specific expression except that it 
is expressed at high levels in the preputial gland, 
whereas MUP is not (Maclnnes et al., 1986). In addition 
the rat genes are not expressed in the female liver 
whereas Mup genes are expressed in both male and female 
liver. Hepatic alpha-2u globulins are regulated by 
thyroxine, testosterone, glucocorticoid, growth hormone, 
insulin and oestrogen, unlike submaxillary gland alpha-2u 
globulin which does not appear to be under hormonal 
regulation (Motwani et al., 1980; Lynch et al., 1982; Roy 
et al., 1983; Laperche et al., 1983; Kulkarni et al., 
1985). 
It seems likely that the MUPs have an important role, 
as indicated by the large amount of urinary protein loss 
(at great expense to the animal); the highly amplified 
gene region; and the selective pressure to conserve the 
amino acid sequence. For some time, no biological function 
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had been assigned to the Mup gene products, although there 
was strong circumstantial evidence which suggested they 
may be involved in behavioural communications (Vandenbergh 
et al., 1976; Shaw et al., 1983). Only recently (Bacchini 
et al., 1992) has direct evidence shown that MUPs 
selectively bind the male pheromones 2-(sec- 
butyl)thiazoline and dehydro-exo-brevicornin, and 
concentrate them in the urine. This characterises the MUPs 
as sex pheromone-binding proteins. 
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Chapter 4: EXPRESSION OF THE HERPES SIMPLEX VIRUS TYPE 1 
THYMIDINE KINASE GENE. 
The coding region of the herpes simplex type 1 thymidine kinase 
gene (HSV1-tk) has been used extensively as a reporter 
sequence. In normal cells endogenous thymidine kinase catalyses 
the phosphorylation of thymidine to thymidine monophosphate in 
the salvage pathway of pyrimidine synthesis. The [-ISV1-tk gene 
encodes a novel thymidine kinase which is distinguishable from 
the cellular enzyme in immunogenicity, molecular weight, 
substrate specificity and electrophoretic mobility. The HSV 
gene is a delayed early, or beta viral gene (Garfinkle and 
McAuslan, 1974) and as such, its full expression during lytic 
viral infections requires the prior synthesis of the immediate 
early, or alpha, protein ICP4 (Leung et al., 1980; Post et al, 
1981; Watson and Clements, 1978; 1980). 
Transcription And Translation. 
The promoter region of HSV1-tk has been extensively analysed 
and shown to contain the TATA and CCAAT consensus signals and 
two GC rich repeated sequences within 105 bp upstream from the 
normal cap site (McKnight and Kingsbury, 1982; McKnight and 
Tjian, 1986). The transcribed portion of the gene is 
approximately 1300 nucleotides in length and contains no 
intervening sequences (Wagner, N.J. et al., 1981). A second 
reverse transcript has previously been observed in cells 
infected with [-ISV1 (Goinpels and Minson, 1986; Jacobson et al., 
1989). This unit overlaps the coding region of TK in the 
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opposite orientation having a predicted start at position 195 
(+1), a potential TATA box "TATATAAA" at position 220 (-25), 
and a CAT box in opposite orientation at position 271, 
"GGCCAATGA" (-76). 
The 5' end of the TK mRNA contains an untranslated region 
of 107 nucleotides followed by an open reading frame of 1128 
nucleotides which codes for a 376 amino acid full-length 
polypeptide. The TK mRNA contains three initiation codons which 
are all used to some extent both in vivo and in vitro (Marsden 
et al., 1983; Haarr et al., 1985). Three polypeptides of 
molecular weight 43000, 39000, and 38000 (43K, 39K, and 38K) 
are thus generated from a single gene such that their C-
terminal ends are identical, but the N-terminal ends are 
different (Marsden et al., 1983). The full-length polypeptide 
is the predominant product in HSV1-infected BHK cells and 
smaller amounts of the two truncated forms are also present. 
Certain drug-resistant mutations of HSV1-tk fail to produce the 
full-length polypeptide. One of these (twice isolated as KG111 
and TK4) is due to an amber mutation at Leu44. Another, delta 
1, lacks nucleotides -11 to +189 (deleting the first 45 codons) 
of the wild-type sequence. This removes the first initiation 
codon of the TK polypeptide. Delta 1 in particular overproduces 
the 38K polypeptide. 
Properties Of The Enzyme. 
HSV1-TK is composed of two identical subunits (Jamieson and 
Subak-Sharp, 1974) and the native enzyme has binding sites for 
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both 	the 	natural 	nucleoside 	substrates 	thymidine 	and 
deoxycytidine, and also for the phosphate donor, ATP. Several 
lines of evidence indicated that a region close to the N-
terminus of the polypeptide is involved in ATP binding. 
Firstly, a comparison of the predicted amino acid sequences of 
the TK polypeptide of HSV1 and HSV2 with that of a marmoset 
herpesvirus (Otsuka and Kit, 1984) revealed a region of 
homology in all three polypeptides corresponding to the 
sequence of amino acid residues between positions 49 and 66 in 
the primary sequences of EISV1-TK. Secondly, the amino acid 
residues 51 to 63, contained in this sequence, show homology 
with a sequence implicated in ATP recognition present in other, 
unrelated, ATP-binding enzymes (Otsuka and Kit, 1984; Walker et 
al., 1982; Liu and Summers, 1988). Finally, results from site-
directed mutagenesis of the predicted ATP-binding site (Liu and 
Summers, 1988) revealed that this segment is essential for the 
function of the TIC Characterisation of mutations that alter 
the affinity of TK for nucleoside substrates has indicated that 
amino acids 168 to 176 and amino acid 336 are involved in 
binding of the nucleoside substrate (Darby et al., 1986). 
While the substrate specificity of the cellular TK is 
essentially limited to thymidine, the viral TK is a general 
deoxypyrimidine kinase (Dubbs and Kit, 1964; Cooper, 1973; 
Jamieson et al., 1974; Chen and Prusoff, 1978); indeed even the 
purine analog acycloguanosine seems to be a good substrate for 
HSV1-TK. The viral enzyme is also more promiscuous in its 
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choice of phosphoryl donors, and will use CTP as well as ATP 
(Jamieson et al., 1974, Cheng and Ostrander, 1976). Another 
unique feature of the viral TK is its significant activity as a 
TMP kinase (Chen and Prusoff, 1978). Apparently, the enzyme is 
able to catalyse a second phosphoryl transfer with the 
formation of TDP as well as TMP. 
Use Of E-LSV1-tk As A Reporter. 
A promoter deleted tk gene can be conveniently isolated as a 
1759 bp jII-BstEII fragment containing 57 bp of leader 
sequence (Wilkie et al., 1979). It is inactive in gene 
expression studies but can be reactivated by insertion of DNA 
sequences that contain cis-acting regulatory elements. The TK+ 
phenotype can be efficiently selected over a TK- background by 
utilising growth conditions in which the pyrimidine salvage 
pathway enzyme, thymidine kinase, is necessary for survival 
(Littlefield, 1964). The growth medium HAT contains 
Hypoxanthine, Arninopterin and Thymidine. By inhibiting 
dihydrofolate reductase Aminopterin inhibits the de novo 
synthesis of dATP, dGTP and dTTP. Hypoxanthine is a substrate 
for the salvage pathway for dATP and dGTP and when in plentiful 
supply permits growth to be sustained by that pathway. 
Similarly, thymidine, which is essential for the synthesis of 
TTP, allows growth through a salvage pathway which is totally 
dependent on TK activity. 
Not only has the HSV1-TK coding region been used 
extensively as a reporter sequence in cell transfection 
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(Maitland and McDougall, 1977; Wigler et al., 1977), but it was 
also one of the first reporter genes used in work with 
transgenic animals (Brinster et al., 1981; Wagner E.F. et al., 
1981; Wagner T.E. et al., 1981). More recently it was adopted 
as a component of a system for destroying (ablating) specific 
cell types in transgenic animals (Borrelli et al., 1988; 
Borrelli et al., 1989; Heyman et al., 1989). The basis of the 
procedure is to direct the expression of viral HSV1-tk to the 
target tissue in a transgenic animal by coupling it to a 
tissue-specific promoter sequence. At this time, target cells 
may be killed by administering an antiherpetic agent, such as 
Acyclovir or Ganciclovir, to the transgenic mouse. These 
compounds are phosphorylated by the promiscuous HSV1-TK but not 
by cellular TK, and bring about cell death when incorporated 
into DNA. 
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Chapter 5: EXPRESSION OF A MUP BS6/HSVtk HYBRID GENE IN 
TRANSGENIC MICE. 
Systems available for studying the regulation of liver-
specific genes include livers from intact animals, liver 
slices, and primary hepatocytes. Work has been carried out 
on the expression of Mup genes in hepatocytes (Clayton and 
Darnell, 1983). However, when hepatocytes are plated 
transcription of the Mup genes is rapidly switched off. 
This results in a dramatic fall in the level of MOP mRNA 
to virtually zero in about 4 days (Spiegelberg and Bishop, 
1988). During the same period the level of transferrin 
mRNA rises by about two fold and alpha- fetoprotein mRNA 
appears de novo, showing that the pattern of gene 
expression seems to mimic liver regeneration. 
Liver derived cell lines, including hepatoma cells 
and immortalised hepatocytes, have been used to study the 
expression of some liver specific genes. However, no liver 
cell line has been identified which expresses the 
endogenous Mup genes. 
In an attempt to study the behaviour of a Mup 
promoter region in tissue culture, a plasmid containing 
2.2 kb of 5' flanking region from the group 1 Mup gene BS6 
(including the cap site), linked to the coding region of 
the Herpes simplex virus type 1 thymidine kinase gene 
(HSV1-tk) (Figure 5.1A), was introduced into rodent 
fibroblast cells (BHKtk- cells) by calcium phosphate co- 
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Figure 5. 1. 
Schematic representation of hybrid genes. 
The four major components of the plasmid constructs are shown. 
These include: 
the entire Simian virus 40 (Sv40) transcriptional control 
fragment containing the SV40 enhancer, early promoter and TATA 
sequence. 
A fragment of major urinary protein (Mup) gene BS6 
containing TATA and cap consensus, with approximately 2.2 kb of 
5' flanking region. 
The Herpes simplex virus thymidine kinase type 1 gene as 
a reporter. 
The bacterial SupF gene for the isolation of recombinant 
clones. 
The restriction site map shows key sites as follows: E, EcoRI; 
P, PvuII; Ps, PstI; H, Hindlil; K, Kpril. The BS6-tk-M fragment 
was separated from SV40 and vector sequences by digestion with 
Hindill, and BS6-tk-yF fragment was separated by digestion 
with EiindIII and KpnI. For other details see Material and 
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precipitation. The Mup promoter was inactive in the cell 
line in this configuration. However, activity was observed 
when the SV40 enhancer sequence was introduced upstream of 
the gene. Si nuclease and primer extension assays showed 
that transcription was faithfully initiated at the Mup cap 
site (Ghazal, 1986). This establishes BS6 as an active 
promoter, when coupled to the SV40 enhancer. 
To investigate the regulation of the complex Mup gene 
family, in an enviroment which is more compatible to that 
in which the endogenous gene is normally expressed, 
transgenic animals were used. Transgenic mice have been 
useful in defining the cis-acting regulatory elements of a 
number of tissue-specific and developmentally regulated 
genes, including beta-globiri, elastase, icnmunoglobulin, 
alpha- fetoprotein, and insulin (as discussed in Chapter 1 
and reviewed by Pairniter and Brinster, 1986; Cuthbertson 
and Klintworth, 1988; Gordon, 1989; Westphal, 1989). In 
this study, the tissue specificity, developmental control 
and hormonal regulation of a /FISV1-tk hybrid gene in 
transgenic mice is described. Expression of transgeflic 
mice carrying various other constructs, including a 
promoterless EISV1-tk gene, are also analysed. 
My contribution to the study of Mup gene expression 
was part of a broad team effort. Construction of the 
hybrid genes was performed by Melville Richardson, Raya 
Al-Shawi introduced the hybrid genes, by embryo pronuclear 
47 
microinjection, into the genome of mice and generated all 
the Go mice. Once these Go transgenics were produced I 
scored and maintained the trangenic lines, carried out the 
expression analysis on the various lines and interpreted 
the data that resulted from this analysis. 
Briefly, the fragment to be injected was isolated 
from the plasmid pSV-BS6-tk-SupF by digestion with Hindill 
and çpI (Figure 5.1B; Al-Shawi et al., 1988; see the 
Appendix for details of construction of the hybrid gene). 
This removes the SV40 enhancer and plasmid sequences. The 
bacterial amber suppressor tRNA gene SupF (Goldfarb et 
al., 1982) was added to the 3' region, to facilitate the 
rescue of the hybrid gene (BS6-tk-F) from the genomic 
DNA of transgenic mice. For the generation of the same 
fragment which lacks the SupF gene (BS6-tk-M) digestion 
was performed with Hindill only (Figure 5.1C). 
Results. 
Derivation of transgenic lines carrying the BS6-tk hybrid 
gene. Of 40 pups born, 11 were identified by Southern blot 
analysis as transgenic: 6 females and 5 males. One of the 
females (62) was mosaic and did not transmit the 
transgene to her offspring. However, the other five 
transgenic Go females transmitted the transgene to their 
progeny, and from these transgenic lines were established 
(Table 5.1). Go males 66 and 79 were mosaic and fertile 
but did not transmit the transgene to their offspring, and 
Table 5. 1. 
Transmission of foreign genes from Go to Gi transgenics. 
Go No. Sex Fertility Transgenic Copy 
Status line established Number 
40 F Fertile Yes 10 
46 F Fertile Yes 80 
58 F Fertile Yes 3 
62 F Fertile No ND 
64 F Fertile Yes 2 
78 F Fertile Yes 1 
66 H Fertile No ND 
79 H Fertile No ND 
48 H Sterile No ND 
49 N Sterile No ND 
51 H Sterile No ND 
ND 	- Not determined. 	Copy-numbers were determined in 
individuals from the third generation of transgenic lines. 
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the other three Go males (48, 49 and 51) were all sterile. 
Therefore no transgenic lines could be established from 
the males. The approximate number of copies of the 
transgene per diploid genome in each transgenic line is 
listed in Table 5.1. Keeping to the usage of Al-Shawi et 
al (1988), here a line is a group of male and female mice 
descended from the same Go female and containing the same 
transgene at the same position in the genome. 
Tissue-specific expression of the Mup BS6-tk hybrid gene. 
To examine the tissue-specificity of expression of the 
hybrid gene HSV1-TK assays were performed on tissue 
homogenates. Consistent with the classification of group 1 
genes as hepatic type genes, expression of the reporter 
function was observed in the liver of transgenic 
offspring. However, expression was also observed in the 
testis, preputial glands (modified sebaceous glands; 
Hummel et al., 1975) and in small amounts in the lachrymal 
and mammary glands. 
Protein homogenates were prepared from a variety of 
tissues of adult transgenic and control mice. E-ISV1 
thymidine kinase from the transgene was specifically 
detected by using a thymidine kinase assay (see Material 
and Methods) capable of distinguishing HSV1-TK from 
endogenous mammalian thymidine kinase. This involved the 
addition of 0.4 mM TTP to the assay (Jamieson and Subak-
Sharp., 1974) which in my hands, inhibited endogenous 
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thymidine kinase activities in different tissues by 93 to 
97°h. The same amount of TTP inhibited [-ISV1-TK by close to 
50°h, so that even relatively low levels could be measured 
quite accurately. 
Animals in three of the five lines (lines 46, 58, and 
78), showed similar patterns of expression, male mice 
expressing HSV1-TK activities at relatively high levels in 
the testis and preputial gland but at lower levels in the 
liver. In these lines the level of expression in the liver 
ranged from 1.9 to 14.2 U/mg protein. In comparison, the 
range of expression in the testis and preputial gland was 
41.6 to 141.3 U/mg protein and 10.4 to 83.5 U/mg protein, 
respectively (Table 5.2). 
In the fourth line (line 40) HSV1-TK activity was 
detected in the testis and preputial gland but not in the 
liver. In contrast, the fifth line (line 64) displayed 
activity in the testis and liver and not in the preputial 
gland. Expression was below the limit of detection in the 
kidney, muscle, submaxillary gland and brain (Table 5.3). 
Lines 58 and 64 showed a low but significant level of 
expression in the lachrymal gland. Expression was also 
observed in the mammary gland (see below). 
Northern blots of RNA from Liver, preputial gland and 
testis of line 58 were probed with a E-ISV1-tk specific DNA 
fragment from pTK1, which is directed against the 5' part 
of HSV1-tk gene (Probe A, Figure 5.1A). Transcripts were 
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Table 5.2. 
HSV1-TK activities in male tissues of Go and Gi transgenic 
mouse lines. 
	
Copy 	 Enzyme activity (a) in tissues 
Line 	no.  
Liver 	 Preputial gland 	Testis 
Control 0 0.018 + 0.007 (20) 0.16 	-I- 0.05 (22) 0.11 + 0.044 (16) 
Lines 
40 10 0.05 + 0.04 (4) 12.0 + 0.39 (2) 141.3 + 4.9 (4) 
46 80 1.90 + 0.34 (8) 83.5 + 11.4 (4) 139.0 + 17.6 (3) 
58 3 6.6 + 0.66 (7) 10.4 + 1.2 (7) 41.6 + 5.8 (7) 
64 2 1.46 + 0.24 (9) 0.66 + 0.16  45.5 + 4.3  
78a 1 14.2 + 1.2 (4) 51.0 + 14.0 (4) 58.2 + 11.7 (5) 
Go 
51 	0.74 	 3.2 	 25.0 
66 	1.0 	 9.5 	 1.5 
79 	0.0 	 0.0 	 0.0 
(a) Units per milligram of protein: means and standard errors. 
a, the numbers of animals assayed, is shown in parentheses. 
52 
Table 5.3. 
Expression of BS6-tk-SupF hybrid gene in tissues of 
male transgenic and control mice. 
Enzyme activity (a) in tissues 
Lachrymal 	 Submaxillary 
Line 	Brain 	 Kidney 	 Muscle 	
gland 	 gland 
Control 0.19 + 0.06 (8) 	0.05 + 0.02 (13) 	0.002 + 0.001(5) 	0.014 + 0.003 (7) 	
0.006 + 0.004 (6) 
Lines 
40 0.14 + 0.01 (2) 0.06 + 0.012 (4) 0.002 (1) 0.002 
(1) 0.0 (1) 
46 0.18 + 0.037 (3) 0.04 + 0.037 (3) 0.003 (1) 0.01 (1) 0.005 (1) 
58 0.50 (1) 0.03 + 0.02 (4) 0.0 (1) 2.1 	+ 	1.2  0.02 (1) 
64 0.3 ± 0.09  0.01 ± 0.003 (6) 0.016 + 0.01 	(4) 0.23 + 0.13  0.04 + 0.009 	(4) 
78 0.08 + 0.01 (3) 0.04 + 0.01 (4) 0.012 ± 0.01 	(3) 0.04 + 0.04 (3) 0.004 + 0.004 (3) 
(a) Units per milligram of protein: means and standard errors. 
n, the number of animals assayed, is shown in parentheses. 
observed in each case (Figure 5.2). The expected size of a 
transcript running from the BS6 cap site to the tk 
polyadenylation site is approximately 1.35 kb. An RNA 
transcript of approximately this size was detected in male 
liver and preputial gland RNA. A shorter transcript 
approximately 1.2 kb in length was identified in the 
testis. Each tissue contains a second smaller RNA, which 
in the liver and testis RNA is about 0.9 kb and in the 
preputial gland RNA is about 1 kb. In each case the 
smaller RNA transcript reacted with the tk probe to a 
lesser extent than the larger transcript. 
Mup genes are expressed not only in male and female 
liver, but also in small amounts in the prelactational 
mammary gland (Shaw et al., 1983). Shahan and Derman 
(1984) have detected MU? mRNA at a level of about 0.027 of 
total mRNA in the mammary gland. It was therefore of 
interest to examine transgenic mammary tissue using 
thymidine kinase assays, to determine whether the 
transgene is expressed in this tissue. Both virgin and 
prelactating mammary tissue from line 58 female and 
control female mice were analysed. As expected, all non-
transgenic virgin and prelactating female mammaries 
revealed no detectable levels of E-ISV1-TK activity. In 
contrast, both virgin and prelactating line 58 mammary 
tissue exhibited small amounts (approximately 1.4 U/ mg of 
protein) of HSV1-TK activity (Table 5.4). 
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Figure 5.2. 
An autoradiogram of a Northern blot to show the sizes of HSV1 
tk RNA in tissues from mice containing the BS6-tk-Sup 
transgene,. Total cellular RNA from the liver, testis an 
preputial gland from an adult male mouse was applied to a 08 
formamide gel, and after blotting, the filter was hybridize 
with an 840 bp PstI DNA fragment from pTK1. 
Lane 1 T-rSV1-tk specific markers, 
Lane 2 non-transgenic testis RNA, 
Lane 3 30ug of testicular RNA from mouse line 58, a 1 day 
exposure, 
Lane 4 15ug of testicular RNA from mouse line 58, a 1 day 
exposure, 
Lane 5 HSV1-tk specific markers, 
Lane 6 30ug of liver RNA from mouse line 58, a 7 day 
exposure, 
Lane 7 30ug of liver RNA from mouse line 58, 	a 2 day 
exposure, 
Lane 8 non-transgenic liver RNA, 
Lane 9 HSV1-tk specific markers, 
Lane 10 non-transgenic preputial RNA, 
Lane 11 lOug of preputial gland RNA from mouse line 58, a 7 da3 
exposure. 
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HSV1-TK activities in virgin and prelactating mammary glands. 
Enzyme activity (a) 
Tissue 	 Line 58 females 	Control females 
Virgin mammary gland 	1.45 ± 0.35 (2) 	0.048 ± 0.048 (2) 
Prelactating mammary gland 1.39 + 0.08 (3) 	0.043 + 0.009 (3) 
(a) Units per milligram of protein: means and standard errors. 
n, the numbers of animals assayed, is shown in parentheses. 
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Shahan et al (1987b) have proposed that the BU gene 
is the most abundantly expressed group 1 gene in the 
prelactational mammary tissue. This is inconsistent with 
the findings of McIntosh and Bishop (1989), who failed to 
detect any hybridization with RNA from prelactational 
mammary tissue, using either a universal group 1 probe or 
the BU and BS1 gene-specific probes. Several hypothesises 
may explain this observation, it is possible that there is 
no expression of MUP mRNA in the mammary gland. 
Alternatively, there is expression but it is not a group 1 
mRNA or it is a group 1 mRNA but one that is sufficiently 
different from the MUP11 probe and as such the gene-
specific oligonucleotides could be washed off the filter 
during the high stringency washes. Finally, there may be 
expression of a mRNA that could react with these probes 
but which is below the level of detection. 
The results presented here demonstrate that the 
hybrid 13S6-tk gene is expressed at a low level in the 
mammary gland of at least one line of mice, and that there 
was no significant difference in expression between virgin 
and prelactating mammary tissue. 
Developmental regulation of the BS6-tk hybrid gene in the 
liver and testis. Barth et al (1982) showed that MUP mRNA 
is first detected in male liver at about 3 weeks of age 
and rises to adult levels by approximately 6 weeks. To 
determine whether the transgene exhibited a similar 
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developmental pattern, I determined the levels of HSV1-TK 
present in livers from line 78 male transgenic animals and 
control littermates, prior to determining their transgenic 
status, at approximately 16, 21 and between 50-180 days of 
age, the latter animals being sexually mature. HSV1-TK 
activity just above background was observed in the liver 
of line 78 at just over 2 weeks of age (Table 5.5, and 
Figure 5.3). At 21-2,2 days a specific activity of 0.71 
U/mg of protein was observed, significantly above 
background. At this time an increase in the level of 
testosterone occurs (McKinney and Desjardins., 1973) 
leading eventually to sexual maturity. Maximum levels of 
expression were reached when the animals were sexually 
mature approximately 50-180 days after birth (Figure 5.3). 
The time of the onset of expression in the preputial gland 
could not be determined because the gland could not be 
located in prepuberal animals. It appears that at least 
some if not all the elements responsible for developmental 
control of liver expression are present within the hybrid 
gene, since the time period of expression of the hybrid 
gene corresponds approximately to the time that NIUP mRNA 
is first detected in the liver (Barth et al., 1982). 
Sexually dimorphic expression of the hybrid gene in the 
liver. [ISV1-TK levels in the liver of transgenic male and 
female mice reveal sex-specific differences. In three of 
five transgenic lines, male liver showed higher levels of 
Table 5.5. 
Time course of HSVI-TK expression in line 78 and control livers 
during sexual maturation. 
Male transgenic mice and non-transgenic littermates were 
sacrificed at the indicated ages, and protein extracts were 
isolated from livers and analysed by thymidine kinase assays. 
Enzyme activity (a) in livers 
AGE 
(Days) 	Line 78 males 	 Control males 
16 0.22 	+ 0.02 (2) 0.02 + 0.008 (3) 
21-22 0.71 (1) 0.01 	+ 0.01 (7) 
50-180 14.2 	± 	1.2 (4) 0 (1) 
(a) Units per milligram of protein: means and standard errors. 
n, the numbers of animals assayed, is shown in parentheses. 
Figure 5.3. 
Time course of HSV1-TK expression in livers during sexual 
maturation. 
The bars show the average HSV1-TK activity for cases in which 
more than one mouse was measured. The numbers of transgenic 
( ) and control littermates are shown in Table 5.5. 










16 	21-22 50-180 
AGE IN DAYS 
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activity than female liver (Table 5.6). The two exceptions 
were line 40, which shows no activity in liver of either 
sex, and line 64, in which male and female liver have 
similar activity levels. Of the three lines with sexually 
dimorphic activity, the male to female ratio of line 46 
was about 15, while the ratios in lines 58 and 78 were 
about 2 and 5, respectively. For comparison the average 
male/female ratio of liver group 1 NIUP mRNA is about 13 
(McIntosh and Bishop, 1989). McIntosh and Bishop (1989) 
used synthetic oligonucleotide probes to determine the 
relative levels of expression of three group 1 Mup genes 
(BL1, BS1 and BS6). They showed that all three are 
expressed in male liver, that two (BL1 and BS1) are 
expressed in female liver at quite different levels, and 
that all three are expressed at male-like levels in the 
livers of testosterone-treated females. RNA homologous to 
the BU-specific probe is the most abundant MUP RNA in 
both male and female liver and the average male/female 
ratio was 11 for BU mRNA and 250 for BS1 mRNA. However, 
BS6 is a member of a small sub-group of Mup genes the RNA 
products of which are indistinguishable. Consequently, the 
levels of expression of BS6 mRNA cannot be determined. 
This prevents any conclusions from being drawn between the 
levels of HSV1-TK in the livers of male and female 
transgenics and the rates of Mup transcription in the two 
sexes. 
Table 5.6. 
Sexually dimorphic expression of E-ISV1-TK in the liver of 
transgenic mouse lines. 







Control 	0.018 + 0.007 (22) 
40 0.05 + 0.04 (4) 
46 1.90 + 0.34  
58 6.6 + 0.66 (7) 
64 1.46 + 0.24  
78a 14.2 + 1.22 (4) 
0.013 + 0.004 (15) / 
0.0 + 0.0  / 
0.125 + 0.12 (ii) 15.2 
2.9 + 1.0  2.2 
1.75 + 0.4  / 
2.8 + 0.2 (2) 5.0 
(a) Units per milligram of protein: means and standard errors. 
n, the numbers of animals assayed, is shown in parentheses. 
Testosterone treatment induces HSV1-TK activity in the 
liver of transgenic females. The stable expression of the 
transgene allowed experiments to be carried out to 
determine whether the signals required for testosterone 
regulation were present within the 2.2 kb of 5' BS6 
sequence. The induction experiments were performed with 
females of line 46 which has the highest male/female HSV1-
TK expression ratio (Table 5.6). 
Seven transgenic and five non-transgenic female mice 
were implanted with testosterone pellets, and a further 
seven transgenics were implanted with placebo pellets 
(Samantha Martin demonstrated and supervised the 
implantation of these pellets). After 14 days the animals 
were sacrificed and the level of E-ISV1-TK in liver and (in 
some cases) kidney and preputial gland was measured (Table 
5.7). As expected the non-transgenic female mice treated 
with testosterone did not show any detectable levels of 
HSV1-TK in any of the tissues analysed. In all seven 
transgenic mice given a placebo instead of testosterone, 
the expression of the transgene was also undetectable. In 
contrast, in the seven transgenic mice given testosterone, 
HSV1-TK activities in the liver were induced, although to 
only 32% of male levels. 
No induction was detected in the kidney, which is not 
surprising since transgene expression has never been 
detected in this tissue. In contrast the female preputial 
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Table 5.7. 
Induction of the expression of the BS6-tk hybrid gene in line 
46 female liver. 
Enzyme activity (a) 
Female mice 
Non-Transgenic 	Transgenic 	TransgeniC 
Tissue 	+ Testosterone + Placebo + Testosterone 
Liver 	0.0 + 0.0 (5) 	0.0 + 0.0 (7) 	0.6 + 0.14 (7) 
Preputial 	0.04 	(2) 	0.0 	(2) 123.0 	(2) 
gland 
Kidney 	0.03 + 0.0 (3) 0.04 + 0.19 (3) 0.04 + 0.016 (3) 
(a) Units per milligram of protein: means and standard errors. 
n, the numbers of animals assayed, is shown in parentheses. 




1.9 + 0.34 (8) 
83.5 • 11.4 	(4) 
0.04 • 	0.04 (3) 
Cj.) 
gland showed increased [ISV1-TK activity, to levels 
comparable to those of normal males. In these treated 
females the preputial gland increased substantially in 
size. Presumably this increase reflects sexual 
differentiation of the tissue. 
These results demonstrate that the level of liver 
expression could be modulated from undetectable levels to 
low levels by testosterone administration to female mice. 
Therefore, all or most of the elements required for 
testosterone responsiveness are included within the 2.2kb 
5'flanking region of the hybrid gene. 
Removal of the bacterial SupF gene does not influence 
expression of the hybrid gene. The consistent expression 
of the BS6-tk-F gene in preputial gland and testis is 
unexpected, since the iY2 genes are not expressed in 
either tissue. For some genes inappropriate expression has 
been reported to be due to prokaryotic vector sequences or 
a new combination of sequences which activate its 
transcription in these tissues (Swanson et al., 1985). If 
the bacterial SupF gene which is incorporated at the 3' 
end of the hybrid gene were contributing to the expression 
pattern of the gene, its usefulness would be seriously 
reduced. To examine this possibility the BS6-tk-M hybrid 
gene, which lacks the SupF DNA fragment, was introduced 
into mice (Figure 5.1C). Five transgenic Go animals were 
obtained, two females (M42 and M12) and three males (Ml, 
M4 and M5). The two transgenic Go females transmitted the 
foreign gene to their progeny and from these, transgenic 
lines were established. Go male M4 was mosaic and fertile 
but did not transmit the transgene to its offspring, and 
the other two males, Nil and M5 were sterile. Therefore no 
transgenic lines could be established from the Go males. 
Animals from the two transgenic lines and two of the Go 
males showed a similar pattern of expression. Male mice 
expressed [-ISV1-TK activities at high levels in both the 
testis and preputial gland, but at a lower level in the 
liver (Table 5.8). In these mice the level of [-ISV1-TK 
expression in the liver ranged from 0.3 to 1.45 U/mg 
protein. In comparison, the range of expression in the 
testis and preputial gland was 9.1 to 210 U/mg protein and 
21.8 to 128 U/mg protein, respectively. No HSV1-TK 
activity was detected in male kidneys (Table 5.8). When 
the expression of the BS6-tk-M and BS6-tk-F constructs 
was averaged over all transgenic lines for which data were 
available, the tissue-specific pattern was found to be the 
similar (Table 5.9). The similarity of these results 
indicates that the SupF gene is not responsible for the 
testis and preputial gland expression. 
Aberrant expression in the preputial gland of line 64 is 
due to a chromosomal position effect. Animals in four of 
the five BS6-tk-F lines show relatively high levels of 
HSV'l-TK activity in the preputial gland (Table 5.2), the 
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Table 5.8. 
E-ISV1-TK activities of the BS6-tk-M hybrid gene in tissues of 
male transgenic and control mice. 
Enzyme activity (a) in tissues 
Male 	Liver 	Preputial gland 	Testis 	Kidney 
Control 0.03+0.03(3) 0.04 + 0.03(3) 0.34 + 0.03(3) 0.043 
Go males 
Ml 0.82 28.5 132 0.034 
M4 0.3 21.8 9.1 0.031 
Males from transgenic lines 
M42 0.6 128 210 ND 
N112 1.45 98 106 ND 
(a) Units per milligram of protein: means and standard errors. 
The number of animals assayed are shown in brackets and the 
number was 1 otherwise. 
q. 
Table 5.9 
Expression of HSV1-TK in tissues of lines of transgenic mice 
carrying the BS6-tk-SupF and BS6-tk-M constructs. 
Enzyme activity (a) 
Construct 	n(b) 	 Testis 	 Liver 	 Preputial gland 
Mean 1- SE(c) 	Range(d) 	Mean + SE 	 Range 	 Mean ± SE 	Range 
BS6-tk-SupF 	5 	85.12_+ 22.63 	41.6-141.3 	4.84 + 2.58 	0.05-14.2 	31.51 + 15.59 	0.06-83, 
BS6-tk-M 	2 	158 	+ 52.0 	105-106 	1.06 + 0.395 	0.66-1.45 	113.0 + 15.0 	98-128 
Units per milligram of protein. 
Number of transgenic lines studied. 
Mean of lines, + standard error. 
Range of lines. 
exception being line 64. To investigate this observation 
further, the foreign gene from line 64 was recovered by 
molecular cloning (performed by Jane Kinnaird) and 
reintroduced into the genome of mice by embryo pronuclear 
microinjection (Al-Shawi et al., 1990; see the Appendix). 
These second cycle animals are referred to as secondary 
transgenic mice (BS6-tk-F TR). Twelve transgenic Go 
animals were obtained: six females and six males. The six 
transgenic females transmitted the foreign gene to their 
progeny and from these, transgenic lines were established. 
Three of six Go males were sterile and the fertile Go 
males did not father transgenic offspring. Therefore, no 
transgenic lines could be established from the Go males. 
HSV1-TK assays showed expression in the liver and high 
expression not only in the testis but also in the 
preputial gland (Table 5.10). Indeed, [-ISV1-TK activity was 
present in the preputial gland of all the male mice 
analysed (Table 5.10). This expression pattern is 
characteristic of primary Go transgenic males containing 
the 13S6-tk-SupF hybrid gene, thus demonstrating that the 
lack of preputial gland expression in line 64 is due to 
chromosomal location and not to the foreign DNA itself. It 
can therefore be concluded that the expression of the 
transgene in line 64 is influenced by DNA sequences 















Enzyme activity in 
the preputial gland 
Enzyme activity 
in the liver 
0.21 	0.11 (9) 
	
0.03 + 0.005 (10) 
Table 5.10. 
Expression of HSV1-TK in the tissues of the secondary 
transgenic mice. 
Go Line 	Sex 	 Enzyme activity 
of Go in Testis (a) 
Control 	 0.11 + 0.044 (16) 
Secondary transgenic mice 13S6-tk-SupF(TR). 
A49* F 77.1 + 22.0 
B65* F 285.7 T 50.7 
~ 3 ~ 
3 
B56* F 1.77 T 1.0  
B85 F 180.0 T 22.0  
B73* F 5.9 T 2.3 3) 
B83* F 212.0 T105.0 2) 
A6 NI 36.7 - 1) 
A17 M 24.9 1) 
A45 NI 330.0 (1) 
A60 NI 38.8 (1) 
B27 NI 50.6 (1) 







* Founders of transgenic lines. 
(a) Units per milligram of protein; means and standard errors. 
n, the numbers of animals assayed, is shown in parentheses. 
M. 
Expression of a promoterless E-ISV1-tk gene in the testis of 
transgenjc mice. Testis expression was high in transgenic 
mice containing the BS6-tk-SupF, BS6-tk-M and BS6-tk-
SupF(TR) constructs. Arguing that expression of HSV1-tk 
might be independent of the attached tissue-specific 
promoters, analysis of transgenic lines containing a 
disabled E-ISV1-tk gene was undertaken. This hybrid gene is 
not coupled to any cellular promoter or enhancer and lacks 
sequences upstream of the TATA box which are required for 
its normal expression in frog oocytes and fibroblasts 
(McKnight et al., 1984; Eisenberg et al., 1985). Of the 
transgenic founder mice generated from the promoterless 
HSV1-tk hybrid gene ([ISV1-tkDS2), 5 were assayed: 4 male 
and 1 female. 3 Go males were fertile and of these 2 did 
not transmit the transgene to their offspring, in contrast 
to the third which did (TK22). Go male TK 22 had no testis 
HSV1-TK activity, and indeed showed no HSV1-TK activity in 
any tissue. This male presumably carried transcriptionally 
inert copies of the hybrid gene. The Go female transmitted 
the transgene to establish line TK16 and Gi males from 
line TK16 were all sterile. 3 of the 4 Go males and males 
of line TK16 expressed HSV1-TK at moderate to high levels 
in the testis (Table 5.11). Expression in other tissues 
was sporadic and, other than in the brain and lachrymal 
glands of TK16 males, at very low levels. These results 
show that the [-LSV1-tk coding region itself is important in 
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Table 5.11. 
HSV1-TK activities (pmol/min/mg. protein) in tissues of 
transgenic mice carrying a promoterless HSV1-tk gene (HsV1-
tkDS2). 
Go Transgenic Males 
Line TK16 
male 
Tissue 	Non-transgenic TK10 TK22 TK39 TK40 
control 
Fertile(a) Fertile Sterile Fertile(a) Sterile 
Testis 	0.11 23.15 0.16 37.75 4.25 
97.23 
Liver 	0.06 0.46 0.00 0.04 0.00 
0.07 
Preputial 	0.16 0.00 0.00 0.00 0.00 
0.28 
Kidney 	0.08 0.27 0.20 0.00 
0.00 0.08 
Brain 	0.20 ND(b) ND 0.35 0.07 
2.99 
Muscle 	0.00 ND ND 0.00 0.08 
0.00 
Lachrymal 	0.07 ND ND 0.03 0.00 
8.01 
Submaxillary 	0.03 ND ND 0.00 0.00 
1.02 
Fertile nontransmitting. 
ND, not determined. 
determining testicular rnisexpression. 
Developmental onset of E1SV1-TK expression in the testis. 
HSV1-TK assays were performed on testes extracts of 
transgenic mice at different ages, to determine at which 
point in spermatogenesis the transgene is activated. In 
the developing mouse testis a significant number of 
secondary spermatogonia begin to advance towards meiosis 
at about the same time. Consequently, at different times 
during the first spermiogenic 'wave' the testis contains 
different mixed populations of germ cells. Importantly, 
the stage of the most advanced cells changes with time 
(Nebel et al., 1961). The seminiferous epithelium from day 
6 animals contains only primitive type A spermatogonia and 
Sertoli cells. Type A and type B spermatogonia are present 
by day 8. At day 10, meiotic prophase is initiated, with 
the germ cells reaching the early and late pachytene 
stages by days 14 and 18, respectively. Secondary 
spermatocytes and haploid spermatids appear in increasing 
numbers between days 18 and 20 (Figure 5.4). Thus, an 
indication of the stage at which HSV1-TK is first 
expressed may be obtained by performing assays on total 
testis extracts throughout this developmental period. At 
approximately 8 days after birth, when the testis first 
becomes large enough to permit the assay, HSV1-TK activity 
was detected above background levels (Figure 5.5 and Table 

























































The 	temporal anpearance of spermatogenic cells in the 
prepuberal mouse testis. 
Data are expressed as percentage of total cells in the 
seminiferous epithelium. The cell counts were determined by 
classifying nuclei present in 50 cross sections of seminiferous 
cords chosen at random from the testes of three mice sacrificed 
at each designated age. Adopted from Beilve et al., 1977. The 
cell types are as follows: spermatogonia (J), primary 





DAYS AFTER BIRTH 
Figure 5.5. 
Developmental analysis of HSVI-TK expression in the testis of 
line 78 and line 40 mice. 
The bars show the average HSV1-TK activity for cases in which 
more than one mouse was measured. The numbers of transgenic 
mice from line 40 (j),  line 78 () and control littermates 
( ) are shown in Table 5.12. 
Table 5.12. 
Developmental analysis of HSV1-TK expression in the testis of 
line 78 and line 40 mice. 
Male transgenic mice and non-transgenic littermates were 
sacrificed at the indicated ages, and protein extracts were 







(a) in livers 
Control males 
Line 40 
6-8 0.48 + 0.11  0.11 + 0.02 (8) 
16 1.37 + 0.14 (3) 0.39 + 0.012 (3) 
25 6.33 + 0.48  0.22 + 0.046 (5) 
50-180 141.3 + 4.9 (4) 0 (1) 
Line 78 
16 0.67 + 0.32 (2) 0.11 + 0.05 (3) 
25 0.61 (1) 0.14 + 0.02 (7) 
50-180 58.2 + 11.7 (5) 0.022 + 0.02 (2) 
(a) Units per milligram of protein: means and standard errors. 
n, the numbers of animals assayed, is shown in parentheses. 
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occurred at about 25 days, the time at which haploid 
spermatids are becoming predominant. These findings show 
that expression occurs predominantly in post-meiotic 
spermatids and possibly also at low levels in the 
spermatogonia. 
Discussion. 
Relationship of HSV1-TK activities and mRNA levels. The 
data presented show that the BS6-tk-SupF gene is 
consistently expressed in the liver, testis and preputial 
gland of transgenic mice. Mice from the same lines were 
compared by Northern blot analysis to detect transcripts 
containing the E-LSV1-tk sequence (data compiled by Raya Al-
Shawi). The correlation between [-ISV1-TK activities and tk-
specific mRNA levels was good, indicating that the HSV1-TK 
activities directly reflect the rnRNA levels. Run-on 
experiments performed by Cheryl Jones (Al-Shawi et al., 
1988; see the Appendix), demonstrated that the different 
expression levels of E-ISV1-tk RNA in males and females are 
due to differential transcription, as is the case with MUP 
mRNA. 
Two main sizes of HSV1-tk specific RNA were present 
in the liver, testis and preputial gland of transgenic 
mice carrying BS6-tk-F. The longer of these in the 
testis is about 1.2 kb in length, significantly shorter 
than the 1.35 kb transcript found in the liver and 
preputial gland. The shorter transcript in the liver and 
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testis is around 0.9 kb and in the preputial gland 1.0 kb 
in length. When Northern blots were hybridized to a probe 
which corresponds to the 5' end of the [iSV1-tk rnRNA, the 
signal strength of the shorter testis RNA was less 
relative to the longer RNA. This is consistent with 
transcription initiation downstream of the cap site, a 
phenomenon previously observed in cell lines carrying 
integrated HSV1-tk genes (Roberts and Axel, 1982). This 
smaller transcript may give rise to an HSV1-TK 
polypeptide, which may contribute to the observed HSV1-TK 
activity. 
However, C. Jones showed that a single stranded 
riboprobe specific for the sense RNA from the 5' tk coding 
region failed to hybridize to the 0.9 kb band in 
testicular RNA (Al-Shawi et al., 1988; see the Appendix). 
This indicates that the 0.9 kb testis transcript is an 
antisense transcript, possibly related to the internal 
HSV1-tk reverse transcript previously reported (Gompels 
and Minson, 1986; Jacobson et al., 1989). Thus, 
translation of the 0.9kb transcript, if it occurs at all, 
cannot generate a HSV1-TK polypeptide or contribute to the 
E-ISV1-TK activity. The 0.9 kb liver and 1.0 kb preputial 
gland transcripts have not been further characterized. 
Tissue specificity of expression. HSV1-TK activity was not 
detected in kidney, muscle, submaxillary gland or brain. 
Low enzyme levels were observed in the lachrymal gland 
(Table 5.3) of two of five lines and in the mammary gland 
(Table 5.4) of the only line tested. HSV1-TK activities 
significantly above background were consistently detected 
in line 58 and line 64 lachrymal glands. Since expression 
in the lachrymal gland is line-specific it most probably 
relates to the different chromosomal integration events 
which characterize the different lines. However, the fact 
that expression was observed in two different transgenic 
lines raises the alternative possibility that the foreign 
gene is consistently expressed in the lachrymal gland but 
that in some lines the level of expression is below the 
limit of detection. 
Previous work indicated that MUP mRNA is present in 
mammary tissue (Shaw et al., 1983; Shahan and Derrnan, 
1984; Shahan et al ., 1987b). The presence of low amounts 
of HSV1-TK activity in mammary tissue in one of the 
transgenic lines (58) is therefore not unexpected. 
However, mammary tissue from only one line was examined, 
and further analysis will be needed to determine whether 
this phenomenon is a general one. 
Barth et a]. (1982) showed that MUP mRNA is first 
detected in male liver at about 3 weeks of age and rises 
to adult levels by approximately 6 weeks. Consistent with 
these observations, Held et al (1989) reported that a Inup 
/SV40 T-antigen transgene exhibited tissue specific and 
developmental regulation in transgenic mice. The /SV40 
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T-antigen transgene, which contained about 2.5 kb of 5' 
flanking region, exhibited expression in the liver of 
three different transgenic lines. The first line expressed 
the transgene at higher levels in male than in female 
liver, while the second line exhibited equal levels of 
liver expression in both sexes. The third line generated 
only two Fl females, which again expressed the transgene 
in the liver, but which did not breed so this line was 
lost. A developmental analysis of the expression of the 
Mup/SV40 T-antigen transgene showed that expression in the 
liver was first detectable at approximately three weeks of 
age. Similarly, the results presented here indicate that 
the BS6-tk-F transgene is expressed in the liver 
between 21 and 22 days of age. This corresponds to the 
time of onset of sexual maturity and increased levels of 
testosterone (McKinney and Desjardins, 1973). 
Sexually dimorphic expression and hormonal control. The 
expression of Mup genes in the liver is strongly dependent 
on testosterone, thyroxine and growth hormone (Clissold et 
al., 1984; Knopf et al., 1983; Norstedt and Palmiter, 
1984; Shaw et al., 1983; Spiegelberg and Bishop, 1988). 
The dependence on testosterone leads to sexual dimorphism 
in Mup expression and female expression can be induced to 
male levels by testosterone induction (Clissold et al., 
1984). The difference in expression levels reflects 
different rates of transcription in the two sexes (Derman, 
rI 
1981). My result show that in 3 of 4 transgenic lines, 
expression was lower in female than in male liver. When 
females of one of the sexually dimorphic lines was treated 
with testosterone, elevated levels of HSV1-TK activity and 
HSV1-tk RNA resulted. Northern blot analysis of mRNA from 
induced and noninduced female liver also showed induction 
of HSV1-tk RNA levels. Furthermore, run-on experiments 
performed by Cheryl Jones demonstrated that testosterone 
induction of HSV1-TK activities is controlled through 
transcriptional regulation. 
The results presented here indicate that the hybrid 
gene exhibits many of the characteristics of the 
endogenous group 1 Mup gene. Cis-acting elements 
responsible for hormonal regulation, as well as those 
responsible for liver expression and developmental 
regulation of the Mup gene appear to be localized within 
about 2.2 kb of 5' flanking BS6 DNA. This region(s) 
responsible for liver expression has been defined further 
by analysing transgenic mice harbouring a construct 
containing only the proximal part (to nucleotide -314) of 
the BS6 promoter (BS6Sau2-tk-SupF, Figure 5.1D). (Al-Shawi 
et al., 1991; see the Appendix). Measurement of mRNA and 
HSV1-TK levels showed that, although expression in the 
testis was high, there was no expression in the liver in 
any of the transgenic lines analysed. This indicates that 
cis-acting sequences responsible for liver expression are 
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located more than 314 bp away from the BS6 cap site. 
Inappropriate expression in the testis and preputial 
gland. Consistent misexpression of foreign genes has been 
observed before and may be explained in several ways 
(Behringer et al., 1988; Botterj et al., 1987; Low et al., 
1986). It is possible that the Mup genes are transcribed 
in the preputial gland and testis but the mRNA is not 
stable, whereas the hybrid transgene mRNA may be 
sufficiently stable to allow the production of HSV1-TK. 
This explanation is unlikely however, since a rat alpha 
2u-globulin transgene is expressed at a high level in the 
mouse preputial gland: it is improbable that there could 
be an extremely large difference in the stability of MUP 
mRNA and a highly homologous alpha 2u-globulin mRNA. 
Alternatively, the transgene might contain newly created 
sequences which activate expression in inappropriate 
tissues (Swanson et al., 1985). This explanation also 
seems unlikely since a j/SV40 T-antigen transgene was 
also found to be expressed in the preputial gland (Held et 
al., 1989). 
Another more plausible explanation for misexpression 
is that it is attributable to silencer sequences which 
normally inhibit the expression of the endogenous Mup gene 
in the preputial gland and testis, but which are located 
outside the promoter regions included in the hybrid 
constructs. A BS6 gene with the same promoter and an 
artificial mutation in exon 1 is expressed correctly (John 
Bishop, personal communication). This observation suggests 
that the control element is located downstream of the cap 
site, as is the case with many other genes (Franklin et 
al., 1991; Mauxion et al., 1990; Killen et al., 1988). 
Silencers might be sites for covalent modifications (e.g. 
methylation), they might initiate condensation into an 
inactive chromatin conformation or they might phase 
nucleosouies in an inappropriate manner. 
The homologous rat alpha 2u-globulins are expressed 
in the rat preputial gland and a rat alpha 2u-globulin 
transgene is consistently expressed at high levels in 
mouse preputial glands (da Costa Soares et al., 1987). One 
possible interpretation is that the natural rat alpha 2u-
globulin gene lacks a silencer sequence which is present 
in the mouse genes, resulting in its expression in the 
mouse preputial glands despite the presence in the mouse 
tissue of the corresponding trans-acting repressor protein 
(da Costa Soares et al., 1987) 
Misexpression of the BS6-tk hybrid gene in the testis and 
preputial gland are due to different causes. Testicular 
misexpression could be due to the same cause as preputial 
misexpression. If this were the case, the expression of 
alpha 2u-globulin in the rat testis and of the alpha 2u-
globulin transgene in the mouse testis would be 
anticipated. However, no alpha 2u-globulin specific mRNA 
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is 	detected 	in 	this 	tissue 	(Al 	Shawi, 	personal 
communication). This observation suggests that 
misexpression of the hybrid Mup gene in the preputial 
gland and testis have different causes. Two further 
observations support this conclusion. First, expression in 
the testis is promoter-independent while preputial gland 
expression is not. Secondly, expression in the preputial 
gland and not the testis occurs in transgenic mice 
containing a hybrid /SV40 T-antigen transgene (Held et 
al., 1989). 
HSV1-tk contains a cryptic • promoter which directs its 
expression to the testis. As shown above, 5 of 5 BS6-tk-
yF transgenic lines and 2 of 2 BS6-tk-M transgenic lines 
had a high level of HSV1-TK activity in the testis. 
Analysis of the secondary transgenic mice (BS6-tk-F TR) 
revealed 6 of 6 transgenic lines had expression in the 
testis. In all cases HSV1-TK was expressed in the testis. 
These results in addition to analysis of other constructs 
in our laboratory gave rise to the suggestion that the 
HSV1-tk coding region is important in determining 
testicular expression. One of these constructs, containing 
only 314 bp of BS6 5' flanking sequence (Figure 5. 1D 
BS6Sau2-tk-F), had low preputial gland expression and 
no expression in the liver (Al-Shawi et al., 1991; see the 
Appendix). However, expression in the testis was at a 
level similar to that observed with the 2.2 kb BS6 
promoter and 5' flanking region. More significantly, a 
thyroglobulin promoter and 5' flanking region directed 
expression of HSV1-tk at high levels in the testis of 
transgenic mice (Wallace et al., 1991). Some lines of mice 
transgenic for HSV1-tk linked to the mouse mammary tumour 
virus long terminal repeat also expressed HSV1-tk in the 
testis (Ross and Solter, 1985). In another case, a cosmid 
vector bearing the MHC class HE alpha gene and a HSV1-tk 
gene, were used to generate transgenic mice and the 
resulting mice were also found to express E-ISV1-tk in the 
testis. (Braun et al., 1990). 
Expression in the testis of transgenic mice which 
carry FISV1-tk coupled to different tissue-specific 
promoters suggested that the [-ISV1-tk reporter gene itself 
acts as a tissue-specific promoter. To test this directly 
transgenic mice carrying a promoterless HSV1-tk gene were 
generated and shown to express the transgene in the testis 
and to be sterile. 
From these results it may be concluded that ectopic 
expression of HSV1-tk in the testis is a common feature 
of transgenic mice carrying the E-ISV1-tk reporter. In all 
cases HSV1-TK was expressed at a similar level in the 
testis. The results therefore suggest that expression in 
the testis is a function of an internal promoter within 
the HSSJ1-tk structural gene or its associated 3' flanking 
region, which is active in the testis but not elsewhere. 
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This is discussed further in chapter 8. 
Line-specific effects and copy number. The relative 
expression levels in the liver, preputial gland and testis 
are line specific. Line-specific effects may be due to the 
foreign DNA itself, for example to mutation or 
rearrangement, or to the abnormal insertion of multiple 
copies of the foreign gene at a single site. 
Alternatively, expression might be modified by the 
chromosomal environment into which the DNA has been 
inserted. Gene expression is believed to depend partly on 
the organisation of chromosomal domains. A foreign gene 
inserted into a domain may in some cases take on the 
expression properties of the domain. Genes brought close 
to heterochromatic DNA are inactivated in Drosophila and 
mammals (Spradling and Rubin, 1983; Cattanach, 1974). Any 
of these changes may affect expression in different lines. 
The absence of preputial gland expression in line 64 (see 
Table 5.2) seems to be due to chromosomal location such 
that the expression of the gene is under the influence of 
flanking DNA sequences at the site of integration. This 
was demonstrated by cloning out the transgene from line 64 
and reintroducing it into recipient mice. The resulting 
transgenic offspring show expression of the transgene in 
the preputial gland (Al Shawl et al., 1989; see the 
Appendix). This is direct evidence of the effect of 
chromosomal position on transgene expression. 
The quantitative analysis of transgene expression is 
complicated because multiple copies of the genes are 
usually integrated in a tandem array, and there is no 
means of determining how many of these are functional 
templates for transcription. No correlation was found 
between the number of copies of BS6-tk integrated and the 
level of transcription (Table 5.2). This suggests that 
only a few of the genes are expressed or alternatively 
that expression level of each copy falls as the copy 
number increases (Palmiter and Brinster, 1986). The 
absence of gene dosage effects in transgenic mice has 
often been observed (Palmiter et al., 1982; McKnight et 
al., 1983; Overbeek et al., 1986; Morello et al., 1986: 
Davis and MacDonald, 1988) and in one study in which the 
measure of expression was transcription rate the same lack 
of correlation was observed (Davis and MacDonald, 1988). 
Chapter 6: INITIATION OF TRANSCRIPTION IN THE HYBRID GENE. 
The Northern blot data showed that the longest HSV1-tk-
specific transcript in the testis is about 1.2 kb in 
length, shorter than the 1.35 kb transcript expected from 
transcription initiated at the cap site of the BS6 gene, 
and observed in the liver and preputial gland. It was 
therefore of interest to determine the cap site of the 
1200 bp testis transcript. Here, I have determined the 
points of initiation of the tk transcripts in the male 
mouse testis by primer extension. 
Results. 
Primer extension experiments. The BS6 cap site was mapped 
by Clark et al (1985b), by primer extension analysis and 
Si mapping, at 30 + 1 bp downstream of the TATA box. To 
determine the start sites of transcription of the tk-
specific mRNA, primer extension assays were carried out, 
with two synthetic oligonucleotides. Primer A is 22 
nucleotides long and corresponds to nucleotides +107 to 
+125 from the BS6 cap site. Primer B is 23 nucleotides 
long and corresponds to nucleotides +347 to +369 (Figure 
6.1). The primers were end-labelled using T4 kinase and 
annealed with total RNA. The DNA primer was then extended 
upstream to the 5' end of the RNA using AMV reverse 
transcriptase. The lengths of the products of the reaction 
were determined using a 6% polacrylamide/urea denaturing 
gel (see Materials and Methods). RNA transcribed from a 
Figure 6.1. 
Restriction map of the 51  region of the hybrid gene showing its 
relationship to the probes used for RNase protection and 
oligonucleo tides used in primer extension. Open and closed 
boxes show the untranslated region and translated regions. Also 
shown are the MTJP TATA box and the proposed BS6 cap site as 
previously mapped in the liver by Clark et al (1985b). 









1009 bp EcoRI-BanI fragment of pTK1, inserted downstream 
of the T7 promoter was used as a control template. The 
extension of this RNA from primer A is expected to yield a 
product which is 256 bp long. Primer B should yield a 498 
bp extension product. The results observed are in 
agreement with the sizes expected. 
In these experiments, liver and testis RNA from 
transgenic lines 46 and 78 was examined. 
Although a wide variety of conditions was employed, 
no extension products were observed when total RNA or 
purified liver poly(A)+ RNA from transgenic mice was used 
together with either primer. Under all of these conditions 
the control template generated the expected extension 
products. The conclusions to be drawn are that either the 
primer extension assay is not sufficiently sensitive to 
detect the small amounts of HSV1-tk mRNA present in the 
liver or that the sequences corresponding to primer A is 
not present in the transcript. 
When primer B was employed together with total testis 
RNA from transgenic mice, extension products of 240 bp, 
225 bp, 210 bp, 200 bp, 161 bp and 128 bp were observed, 
the most prominent being 210 bp and 225 bp, (Figure 6.2, 
lanes 3 and 4). Additional extension products of 282 and 
139 nucleotides were observed with both wild-type and 
transgenic testis RNA templates and as such are presumably 
artefactual. These results show that none of the HSV1-tk- 
Figure 6.2. 
Electrophoretic analysis of the products of primer extension 
assays. 
Lane A: is a sequence ladder of M13 used to provide molecular 
weight markers. 
Lane I and 2: Primer extension of 20ug total RNA from non-
transgenic testis. 
Lane 3: Primer extension of 20ug total RNA from line 78 testis. 
Lane 4: Primer extension of 20ug total RNA from line 46 testis. 
Lane 5 and 6: Primer extension of 20ug total RNA from line non-
transgenic liver. - 
Lane 7: Primer extension of 20ug total RNA from line 78 liver. 
Lane 8: Primer extension of 20ug total RNA from line 46 liver. 
Lane 9: Primer extension control. Extension product of the 1009 
bp EcoRI-BanI fragment of pTK1. 
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specific transcripts present in transgenic testis are 
initiated at the previously-defined BS6 cap site. The 
longest transcript observed in the testis is initiated 127 
nucleotides downstream. The initiation sites of five of 
the six testis transcripts map to positions between the 
first and second ATG codons of the HSV1-tk reading frame 
(Figure 6.3). No extension products were observed from 
transgenic testis RNA when primer A was employed. This is 
understandable since primer A overlaps the initiation site 
of the longest transcript detected with primer B. 
Discussion. 	 - 
The primer extension results obtained using testis 
transcripts were confirmed using the more sensitive 
technique of RNase protection, using the method described 
by Krieg and Melton, 1987. The RNase protection data was 
provided by Stephen Harrison and Paul Smith. 
Table 6.1 lists the products obtained from primer 
extension and RNase protection data, respectively, and the 
distance of each of these fragments from the previously 
defined cap site (Clark et al., 1985b). The primer 
extension results for male testis map the start of 
transcription to sites that are approximately the same as 
those indicated in the RNase protection assays. The slight 
discrepency in size is probably due to the slightly 
different way RNA migrates in comparison to the sequencing 
DNA ladder (DNA and RNA molecules of the same chain length 
Figure 6. 3. 
The mapped transcription initiation sites of the six testis 
HSV1-tk-specific transcripts. 
The nucleotide sequence of the hybrid gene and part of its 
flanking region. The polylinker fusion region between the BS6 
promoter and the HSV1-tk sequence and the location of the cap 
site is shown. The first two ATG codons are underlined and the 
mapped transcription initiation sites of all the six testis tk-
specific RNAs are shown in boxes. The numbers indicate the 
distance, in base pairs, of each product from the previously 
mapped cap site. The predicted amino acid sequence of the TK 
protein is also given. 
Cap site 	Polylinker HSV1-tk sequence 
GGAGTGTAGCCAC /GATCCCC /GATCTTGGTGGCGTGAAACTCCCGCACCTCTTTGGCAAGCG 
CCTTGTAGAAGCGCGTATGGCTTCGTACCCCTGCCATCAACACGCGTCTGCGTTCGACCAGGC 
?A1aSerTyrProCysHisGlnHisAlaSerAlaPheAspGlnAl 
127 	 142 	 157 	167 
TGCGTTCTCGCGGCrAGCAACCGACGTJGCGTTGCCTCGCCGGCAGCAAGAAGC 
aA1aArgSerArgG1yHTsSerAsnArgArgP1rAlaLeuArgProArgArgGlnG1nG1uA1 




Table 6. 1. 
The table shows the sizes of the products obtained from primer 
extension and RNase protection assays. Also shown are the 
distances of each product from the previously mapped BS6 liver 
cap site (Clark et al., 1985b). 
RNA 	Size of PE Distance from Size of RNase Distance from 
species 	extension defined protection defined 
products cap site products cap site 
(bp) (bp) (bp) (bp) 
Liver 78 	/ / 307 -1 
235 72 
Testis 78 	240 127 175 134 
225 142 155 154 
210 157 148 161 
200 167 140 169 
161 205 105 206 
C'4 
do not co-migrate precisely at the same position). 
The EISV1-tk RNA molecules synthesized in the testis 
are truncated at their 5' ends and most lie between the 
normal ATG codon (Meti) and the second ATG codon (Met46). 
This adequately explains the fact that no full-length 
polypeptides are produced in the testis (see Chapter 7). 
Using the RNase protection method, Stephen Harrison showed 
that the same transcription products are present in 
transgenic mice carrying the E-ISV1-tk coding sequence in 
association with a number of different promoters. These 
include a truncated BS6 promoter which is inactive in the 
liver, the bovine thyroglobulin promoter which is active 
only in thyrocytes and a short inactive segment of the 
viral USV1-tk promoter (Al-Shawi et al., 1991; see 
Appendix). This observation leads to the conclusion that 
transcription of dSV1-tk in the testis is not directed by 
any of the tissue-specific promoters to which it has been 
coupled, but rather is due to an otherwise cryptic 
promoter which forms part of the I-ISV1-tk reporter sequence 
and which is active in the testis, in postmeiotic germline 
cells. 
The putative promoter within the HSV1-tk coding 
region, assumed to be located upstream of the sites of 
transcription, possesses properties associated with 
promoters of housekeeping genes. These properties include 
the initiation of transcription at multiple sites, the 
93 
absence of a conventional TATA box, and a relatively high 
GC content with the characteristics of a CpG island (Bird, 
1986; Gardiner-Garden and Frommer, 1987). However, it is 
clearly not a true housekeeping promoter since it does not 
exhibit widespread cellular expression. It is consistently 
expressed at a detectable level only in the testis. The 
location of this promoter is presently being investigated. 
RtTase protection analysis of liver RNA of transgenic 
mice from line 78 and 46 (using the same RNA as was used 
in primer extension analysis) revealed protected fragments 
of length 307 and 235 nucleotides in each line (Al-Shawi 
et al., 1991; see Appendix). The larger and most prominent 
protected fragment, obtained with liver RNA of transgenic 
mice, map the start of transcription at a site within one 
nucleotide of the predicted Mup gene cap site. This maps 
the 5' end of the transcript to 100 bp upstream from the 
initiation codon and 31 bp downstream from the TATA box. 
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Chapter 7: TRANSLATION OF HSV1-tk mRNA IN THE PREPUTIAL 
GLAND AND TESTIS OF TRANSGENIC MICE. 
In chapter 5 it was reported that two main sizes of E-1SV1-
tk specific RNA were present in the liver, testis and 
preputial gland of transgenic mice carrying BS6-tk-yF. 
The longer of these in the testis is about 1.2 kb in 
length, shorter than the 1.35 kb transcript predicted if 
transcription was initiated at the cap site of the BS6 
gene, and present in the liver and preputial gland. The 
second smaller transcript in the liver and testis is 
around 0.9 kb and in the preputial gland is 1.0 kb in 
length. The 0.9kb transcript in the testis is an antisense 
transcript as shown by its failure to hybridize to a sense 
RNA probe (Al-Shawi et al., 1988; see the Appendix). The 
smaller transcripts in the liver and preputial gland have 
not been characterised. Analysis of HSV1-TK activities 
revealed similar levels in the preputial gland and testis 
extracts, despite the fact that the preputial gland 
contains full-length HSV1-tk transcripts and the testis a 
smaller transcript length. The longest transcript in each 
tissue is the only one which could be expected to act as 
template for the synthesis of active thymidine kinase. 
The different transcript sizes, together with the 
similarities in enzyme activity, made it of interest to 
determine the nature of the polypeptides which are 
synthesised in the different tissues. 
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Results. 
Sizes of polypeptides related to HSV1-TK. To determine 
which polypeptides were immunologically related to HSV1-
TK, tissue extracts from transgenic and control mice were 
subjected to SDS-PAGE and transferred to nitrocellulose 
membranes. The filters were incubated with a polyclonal 
rabbit antiserum raised against HSV1-TK (which was a 
generous gift of William Summers) and bound antibody was 
detected using biotinylated anti-rabbit IgG followed by 
treatment with a streptavidin-alkaline phosphate conjugate 
(See Materials and Methods for a detailed protocol). 
As a positive control and to provide size markers, 
BHKtk- cells were infected with HSV1- strains 17 and 
CL101, and also the HSV1- mutant delta 1 (generous gift 
from Howard Marsden). Mutant delta 1, which was derived 
from CL 101, carries a deletion between -11 and +189 from 
the cap site. This region contains the first 45 codons of 
the reading frame including the initiation codon (Ml). The 
infected cell extracts were subjected to SDS-PAGE, 
electroblotted and incubated with antiserum (Figure 7.1). 
In cells infected with HSV1 strain 17 five major 
polypeptides reacted with E-ISV1-TK-specific antiserum: the 
full-length protein, Mr = 43,000, and smaller amounts of 
shorter polypeptides with Mr = 41,000, 39,000, 38,000, and 
35,000 (Figure 7.1, lanes 1 and 6) (Marsden et al., 
1983). The 39K and 38K forms were present in greater 
Figure 7.1. 
HSV1-TK-specific polypeptides produced by mutant and wild-type 
HSVI-infected cells,. BHKtk- cells were infected with the 
indicated viruses and proteins were subjected to SDS PAGE S 
transferred to a filter and developed with anti-HSV1-TK 
antibody as described in materials and methods. Molecular 
weights (X 1000) are indicated in the left margin. Positions of 
the 43K, 39K and 38K polypeptides are designated. 
Lane 1 Cells infected with HSV1-strain 17, 
Lane 2 Cells infected with the TK mutant delta 1, 
Lane 3 Cells infected with HSV1-strain CL 101, 
Lane 4 Mock-infected cells, 
Lane 5 Line 46 preputial gland extracts .(50ug). 
Lanes 6-8, loaded twice as much cell extract from: 
Lane 6, Cells infected with HSV1-strain 17; 
Lane 7, Cells infected with the TK mutant delta 1; 
Lane 8, Cells infected with FISV1- strain CL 101. 
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amounts in the HSV1 mutant delta 1, which did not produce 
the full-length polypeptides (Figure 7.1, lane 2 and 7). 
EiSV1 strain CL101 produced the full-length polypeptide and 
smaller amounts of the shorter polypeptides (Figure 7.1, 
lanes 3 and 4). Previous reports have demonstrated that 
the 39K and 38K polypeptides arise from translational 
initiation at the second and third AUG codons, as 
indicated by the results of elegant hybrid-arrest 
experiments; comparisons of the HSV1-TK proteins produced 
by cells infected with wild-type virus and the deletion 
mutant delta 1; and the relative sizes and charges of the 
various HSV1-TK proteins (Preston and McGeoch, 1981; 
Marsden et al., 1983; Haarr et al 1985). Sizing of the 
related E-ISV1-TK polypeptides obtained from the HSV1-
strains 17 and CL101, and also the HSV1- mutant delta 1, 
allowed the accurate sizing of the polypeptides obtained 
from the testis and preputial gland. 
Polypeptides present in extracts prepared with protease 
inhibitors. It has been reported that some I-ISV1 proteins 
made in certain cells have undergone limited proteolytic 
cleavage (Pereira et al., 1982; Zezulak and Spear, 1984). 
More recently, it was demonstrated that E-ISV1-TK undergoes 
limited proteolytic cleavage in extracts of E -LSV1-infected 
Vero cells (Irmiere et al., 1989). To investigate the 
effect of cellular proteases on HSV1-TK protein products 
in tissue extracts, protease inhibitors were added to the 
homogenisation buffer at the time of extraction. 
Table 7.1 shows the 4 major classes of proteases 
which may be encountered. A routine approach to inhibition 
of proteolysis, often quoted in the literature, is to add 
PMSF. As a strategy to inhibit all cellular protease this 
is inadequate as PMSF is only effective against serine 
proteases and has no effect on other classes of protease. 
A relatively new inhibitor, 3,4 DCI, inhibits serine 
proteases more rapidly. E64 and leupeptin are very 
effective inhibitors of cysteine proteases. Leupeptin, a 
peptide aldehyde derivative binds tightly to the active 
site of various serine and cysteine proteases. In contrast 
E64, a peptide analogue which reacts irreversibly with the 
thiol group at the active site, has a strong affinity only 
for cysteine proteases. Metallo-proteinases are best 
inhibited by chelating agents such as EDTA or 1 9 10-
phenanthroljne. Aspartic proteinases are less frequently 
encountered but can be inhibited effectively by Pepstatin. 
Line 46 (BS6-E-ISVtk-SupF) was used in the 
investigation of proteolysis since the hybrid gene is 
highly expressed in both the testis and the male preputial 
glands. A large number of polypeptides in the standard 
preputial gland extract reacted with anti-HSV1-TK 
antiserum (Figure 7.2, lane 3 1 Figure 7.3, lane 8-12). In 
the absence of the appropriate protease inhibitors the 
most prominent component in the preputial gland was a 
Table 7.1. 
Classes of endopeptidases. 
Protease 	Example Members 	 Inhibitors 
class 
Serine 	Trypsin, elastase 	 PMSF(Phenylmethane 
chymo trypsin, 	 sulphonyifluoride) 




Cysteine Papain, cathepsins 
Metailo- Thermolysin, meprin 
Aspartic Pepsin, cathepsin D 
Leupept in 
E-64 (L-trans-Epoxysuccjnyl-






polypeptide of 41K. Similar amounts of the full-length and 
38K polypeptides and smaller amounts of the 39K 
polypeptides were also present (Figure 7.2 lane 3). In 
addition a further polypeptide with Mr of about 35,000 and 
smaller polypeptides with apparent molecular weights 
ranging from 30,000 to 20,000 which were related to HSV1-
TK were present. Adding to the homogenisation buffer 
either Leupeptin or a general purpose mixture of protease 
inhibitors, containing 0.05mM E64, 0.1mM 3,4 DCI, and 
0.1mM 1,10 phenanthroline (Salvesen and Nagase, 1989) had 
no effect on the relative amounts and sizes of the HSV1-TK 
related polypeptides in the preputial gland extracts (data 
not shown). However, when preputial gland tissue was 
homogenised in the presence of 10mM or 20mM of each of the 
inhibitors TLCK and pHHB or of 20mM 3,4 DCI, the truncated 
polypeptide with Mr=41,000 virtually disappeared (Figure 
7.2, lanes 4-6). At the same time some of the smaller 
polypeptides in the preputial gland in the range Mr30,000 
to 20,000 either disappeared or decreased in amount. These 
treatments increased the intensity of the full-length form 
of HSV1-TK at the expense of the smaller molecular weight 
polypeptides, demonstrating that the 41K polypeptide and 
several smaller polypeptides are proteolytic products. 
Similarly, Irmiere et al (1989) showed that the 41K 
polypeptide present in HSV1-TK immunoprecipitates from 
infected Vero cells was also due to proteolysis. The 
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Figure 7.2. 
Effect 	of 	protease 	inhibitors 	on 	HSV1-TK polypeptides 	in 
extracts 	of 	transgenic 	preputial 	glands 	and testes. 	50ug 	of 
protein in the presence and absence of protease inhibitors, was 
loaded on each track. Proteins were transferred to a filter and 
developed with anti-HSV1-TK antibody 	as described 	in material 
and methods. Positions of the 43K, 	39K and 38K polypeptides are 
designated. 
Lane 1 and 13, HSV1-infected cells. 
Lanes 2-6, preputial gland extracts: 
lane 2, 	from non-transgenic mouse; 
lanes 3-6 from line 46 mice, 
lane 3 without additional protease inhibitors, 
lane 4 with 20mM DCI, 
lane 5 with 10mM TLCK + 10mM pHMB, 
lane 6 with 20mM TLCK +20mM pHMB. 
Lane 7, prestained markers. 
Lanes 8-12, 	testis extracts: 
lane 12, 	from non-transgenic control mouse; 
lanes 	811, 	from 	line 	46 	mice, 	lane 	8 	with 	20mM TLCK + 20mM 
pHMB, 
lane 9 with 10mM TLCK + 1OmMpHMB, 
lane 10 with 20mM DCI, 
lane 11 without additional protease inhibitor. 
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nature of the protease activity or activities present in 
mouse preputial gland extracts can be explored by 
examining the inhibitors which prevent such activities. 
3,4 DCI and TLCK, serine protease inhibitors seemed to 
prevent most of the protease activity, but so did pHMB, a 
cysteine protease inhibitor. Since pHMB is known to be a 
general protease inhibitor, it is possible that serine 
proteases are responsible for the phenomena reported here 
and elsewhere. 
The same pattern of HSV1-TK polypeptides was observed 
in the preputial gland extracts from the four transgenic 
lines that had high HSV1-TK activities (Figure 7.3, lanes 
8-13). In line 64 preputial gland extracts, which have low 
levels of HSV1-TK activity, the pattern was essentially 
the same, but the amounts of the polypeptides were low. 
The pattern is similar to that observed in HSV1-infected 
cells (Figure 7.2, lanes 1 and 6). This is strong 
circumstantial evidence that the mode of translation of 
the HSV1-tk mRNA is the same in the preputial gland as in 
HSV1-infected cells, i.e. that translational initiation 
occurs at each of the first three mnethionine codons. 
Testis extracts were similar to preputial extracts 
except that they essentially lacked the full-length 43K 
polypeptide and its 41K proteolytic product (Figure 7.2). 
Testis extracts were unchanged when prepared in the 
presence of proteolysis inhibitors, indicating that the 
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Figure 7.3. 
HSV1-TK-specific polypeptides in testis and preputial gland 
extracts from different BS6-tk-SupF lines of transgenic mice. 
50ug of tissue extract were subjected to SDS-PAGE, transferred 
to a filter and developed with antiEiSV1-TK antibody as 
described in materials and methods. Positions of the 43K, 39K 
and 38K polypeptides are designated. 
Lanes 1-6, testis extracts from: 
lane 1, non-transgenic control; 
lane 2, Line 40 (BS6-tk-SupF); 
lane 3, Line 46 (8S6-tk-SupF); 
lane 4, Line 58 (BS6-tk-SupF); 
lane 5, Line 64 (BS6-tk-supF); 
lane 6, Line 78 (BS6-tk-SupF). 
Lane 7 contains prestained markers. 
Lanes 8-13, contain preputial gland extracts from: 
lane 8, Line 40 (BS6-tk-SupF); 
lane 9, Line 46 (BS6-tk-SupF); 
lane 10, Line 58 (BS6-tk-supF); 
lane 11, Line 64 (BS6-tkSupF); 
lane 12, Line 78 (BS6-tksupF); 
lane 13, nontransgenic control. 
104 
1 	2 	3 
	






lack of the 43K polypeptide is not due to proteolysis. The 
pattern of E-ISV1-TK polypeptides was the same in testis 
from each of the five transgenic lines, all of which 
showed high levels of testis HSV1-TK activity (Figure 7.3, 
lanes 2-6). In some Western blots (Figure 7.2, lanes 8-
11), a trace of full-length polypeptide was detected. 
These results show that the pattern of polypeptides 
produced in the testis of the transgenic mice is very 
sharply skewed in favour of the 39K and 38K truncated 
forms, relative to translation in E-ISV1-infected cells or 
in transgenic preputial glands. 
The same translational patterns were also observed on 
Western immunoblot analysis with testis RNA from 
transgenic mice carrying BS6Sau2-tk-F, TG-tk-F and 
HSV1-tkDS2 constructs (Figure 7.4). These constructs 
contain respectively an ineffectual NIUP promoter, a 
promoter that directs expression to the thyrocytes, and no 
promoter. Transgenic mice carrying each of these produced 
the same truncated transcripts in the testis (Chapter 5). 
It was therefore expected that they would generate the 
same pattern of E-ISV1-TK polypeptides. These observations 
demonstrate that the production in the testis of a 
truncated transcript correlates with a lack of synthesis 
of the full-length I-LSV1-TK polypeptide, and substantial 
synthesis of the 39K and 38K forms, previously shown to be 
due to initiation of translation at the second and third 
105 
Figure 7.4. 
HSV1-TK-specific polypeptides in testis extracts from different 
lines of transgenic mice. 
The positions of the Hr 39,000 and 38,000 polypeptides are 
marked. 50ug of protein was loaded onto each track. 
Lane 1, HSV1infected cells. 
Testis extracts from: 
lane 2, non- transgenic control; 
lane 3, Line 64 (BS6-.tk-SupF); 
lane 4 2 Line 78 (BS6-tk-SupF); 
lane 5 1 Line 46 (BS6-tk-SupF); 
land 6 9 Line TK16 (HSV1-tkDS2-); 
lane 7, Line TG66 (TG-tk-SupF); 
lane 8, Line S87 (BS6Sau2-tk-SupF). 
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methionine codons of the reading frame (Preston and 
McGeoch, 1981; Marsden et al., 1983; Haarr et al 1985). 
Discussion. 
The complete nucleotide sequence of the thymidine kinase 
gene is known (Wagner, M.J. et al., 1981). The first ATG 
codon occurs 78 nucleotides from the BS6 cap site in BS6 
HSV1-tk (Figure 7.5). Twenty-nine nucleotides prior to 
this site is a region of the E-ISV1-tk gene partially 
complementary to the 3' end of the eukaryotic 18s 
ribosomal RNA (Figure 7.5). Such regions have been 
proposed as possible ribosome binding sites (Hagenbuchie 
et al., 1978). From the first ATG there is an open reading 
frame of 1128 nucleotides terminated by TGA. The gene 
codes for a protein of 376 amino acids, which based on the 
known composition of the amino acid sequence, has a 
molecular weight of 40,866. This compares with estimated 
molecular weights of 40,000 to 44,000 obtained from 
NaDodSo4/polyacylamjde gel electrophoresis (Preston, 1979; 
Cremer et al., 1979). The second and third ATG codons of 
the sequence are located 135 bases and 177 bases 
downstream from and in phase with the first ATG codon. By 
initiation at these codons proteins of molecular weights 
35 9 656 and 34,107 (Table 7.2) would be generated. These 
sizes are compatible with the 39K and 38K polypeptide 
molecular weights estimated by SDS-PAGE. A further 75 
bases downstream is a fourth in phase codon which, if used 
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Figure 7. 5. 
The nucleotide sequence of the hybrid gene and part of its 
flanking region. The polylinker fusion region between the BS6 
promoter and the HSV1-tk sequence and the location of the cap 
site are shown. The possible ribosome binding site, the ATG 
codons, and pplyadenylation signals are underlined The 
predicted amino acid sequence of the TK protein is also given. 
Cap site Polylinker HSV1-tk sequence 












eTyrThrThrGlnT-IisArgTeuAspG1nGlyGiuI leSerAlaGlyAspAla AdaValValMe 
GACAACCCCCCAGATAACAATGGGCATGCCTTATGCCGTGACCGACGCCGTTCTGGCTCCTCA 
ThrSerAlaGlnhleThrMetGlyMetProTyrAlaValThrASpAlaValTeUAlaPrOHi 
TGTC GGGGGCGAGGCTGGGAGTTCACATGC CCC GC C CC CGGC CC TC ACC CTCATCTTCGAC CC 
sValGlyGiyGluAlaGlySerSerHisAlaPrOPrOProAlaLeUThrLeuIlePheASPAr 


















TrThrPro G1yS er Il e ProTh r Ii e CyS A s pL euAlaArgThrPheAlrgGMet 
GGAGGCTAACTGAAACACGGAAGGAGACAATACCGGAAGCAACCCGCGCTATGACGGCAATAA 
yGluAlaAsn 
AAAGACAGAATAAAAC GCACGGGTGTTGGGTCGTTTGTTCATAAACGCGGGGTTCGGTC CCAG 




The number of amino acids used for full-length and truncated 
HSV1-TK polypeptides, initiating at each of the AUG codons. 
Also shown is the molecular weight of each polypeptide, based 
on the known amino acid composition. 
No. of amino acids per molecules initiating 
at each of the AUG codons 
First 	Second 	Third 	Fourth 	Fifth 
AUG AUG AUG AUG AUG 
No. of 
amino acids. 376 	331 	317 	292 	256 
mol.wt. 	40,866 	35,656 	34 1 107 	31,463 	27,575 
Estimated 	43K 	39K 	38K 	35K 	31K 
mol.wt. from 
SDS PAGE 
as an initiation codon, would give a polypeptide of 
molecular weight 31,463. 
Since the TK gene contains only one long open reading 
frame, the 43K, 41K, 39K, 38K and small molecular weight 
proteins could be related to proteolytic cleavage and/or 
secondary initiation of translation downstream from the 
first AUG codori. The addition of protease inhibitors 
during protein extraction showed that the 41K protein and 
also several small polypeptides present in preputial gland 
extracts are proteolytic products (Figure 7.2). In 
contrast, the testis extract was unaffected by the 
addition of protease inhibitors, showing that it does not 
proteolyse I-ISV1-TK (Figure 7.2). From this it can be 
argued that the truncated 39K and 38K polypeptides, which 
are the only HSV1-TK polypeptides present in significant 
amounts in testis extracts, are the primary translation 
products of the mRNA produced in the testis of transgenic 
mice carrying any of a number of different HSV1-tk 
constructs. The common features of these constructs are 
that they contain the coding region of the HSV1-tk gene, 
in the testis they generate a class of 5'-truncated mRNAs 
and also in the testis they express only the 39 and 38K 
HSV1-TK polypeptides. 
The evidence that the two truncated polypeptides (39K 
and 38K) in transgenic extracts result from initiation at 
the second and third AUG codons, is that these 
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polypeptides co-migrate with the truncated polypeptides 
found in HSV1-infected cells. Previous studies have 
demonstrated that the 39K and 38K polypeptides in FISV1-
infected cells arise by translational initiation at the 
second and third AUG codons (Preston and McGeoch, 1981; 
Marsden et al., 1983). Haarr et al (1985) obtained direct 
evidence from elegant hybrid arrest experiments and from a 
comparison of the TK proteins produced by cells infected 
with wild-type virus and HSV1-TK mutants. Mutant TK4 has 
an amber mutation between the first and second AUG codon, 
whereas mutant delta 1 has a deletion which removes the 
first AUG codon but leaves other AUG codons intact. Both 
mutants synthesise only the two truncated polypeptides. 
The synthesis of these polypeptides was examined more 
closely by means of hybrid-arrest-translation experiments 
employing a DNA oligonucleotide complementary to 50 
nucleotides at the 5' end of the HSV1-tk mRNA. When 
annealed with mRNA from cells infected with either wild-
type HSV1 or the TK4 mutant, the oligonucleotide prevented 
the synthesis not only of the 43K full-length polypeptide 
but also of the 39K and 38K polypeptides. This 
demonstrated that, in these cells, both of the truncated 
polypeptides arise from translation complexes initiated at 
the 5' end of the mRNA. This evidence suggests that the 
truncated HSV1-TK polypeptides observed in the preputial 
gland result from translation complexes initiated in the 
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same way. 
Translation of the 39K and 38K polypeptides was 
unaffected by the oligonucleotide, showing that a 
truncated transcript can support polypeptide chain 
initiation at the second and third ATG codons of the 
reading frame. The published data supports the conclusion 
that the testis E-ISV1-tk mRNA transcript, shown to be 
truncated at the 5'-end, is translated by polypeptide 
chain initiation at whatever 5'-terminal codons are 
available. 
It has been proposed that translational initiation in 
eukaryotes depends on a scanning mechanism whereby the 
initiation complex settles upon the first AUG triplet that 
it encounters. Recognition of this triplet depends to some 
extent upon the sequence immediately surrounding it, the 
consensus of which, from a comparison of several hundred 
eukaryotic translation initiation sequences, is CCRCCAUGG 
(Kozak, 1981, 1984). If the AUG sequence first encountered 
lies within an unfavourable context, some initiation 
complexes will form at the site but scanning will continue 
downstream. 
The sequences surrounding the first three AUG codons 
of the HSV1-tk genes are CGUAUGC, AAAAUGGC, and GGGAUGG. 
Thus the flanking sequences of the first and second codons 
conform poorly with the consensus. The third codon 
conforms better to the consensus. Thus it is not unlikely, 
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when a full-length transcript is present, that some 
initiation complexes will bypass the first and/or the 
second AUG codons and initiate on the third. This is the 
most likely explanation of the synthesis of smaller 
amounts of the 39K and 38K HSV1-TK polypeptides both in 
virus-infected cells and in the preputial glands of 
transgenic mice. 
When 	the 	first 	AUG 	codon 	is 	not 	present, 
translational initiation is expected to occur at the 
second and third AUG codons at a level correspondingly 
higher in relation to the absence of initiation at the 
first AUG. This is observed in the case of the delta 1 
deletional mutation of HSV1, which lacks the normal 5'-end 
of the mRNA. Similarly, the testis transcripts found in 
transgenic mice, carrying several different constructs 
that have as their only common factor the HS\T1-tk coding 
region, lack the 5'-end of the full-length mRNA, and also 
express mainly the 39K and 38K proteins. 
Properties of the truncated TK polypeptides. TK activity 
is similar in the preputial gland and testis extracts, 
despite the fact that the preputial glands contain mainly 
full-length TK and the testes mainly the truncated 38K and 
39K forms. Halpern and Smiley (1984) and Irmiere et al 
(1989) found that the mutant delta 1, which overproduces 
the 39K and 38K polypeptides, but fails to produce the 43K 
polypeptide, produces about 40% of the wild type TK 
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activity, showing that one or both of the 39K and 38K 
polypeptides has enzyme activity. These results 
demonstrate that the 38K and/or the 39K polypeptides 
retain part of the catalytic activity. Therefore, it 
appears that the amino terminus of the TK polypeptide is 
dispensable for catalytic activity. 
Although viruses that synthesize TK polypeptide 
lacking the first 45 amino acids appear to retain about 
40% of wild-type activity and sensitivity to most 
antiviral nucleoside analogs, delta 1 is resistant to 
bromovinyldeoxyuridine (BVdU) (Coen et al., 1989). An 
explanation for this result is that delta 1 is defective 
in the TtIP kinase activity of HSV1-TK. Such a defect could 
account for BVdU-resistance, because TMP kinase activity 
is required for efficient conversion of BVdIJ-monophosphate 
to BVdU-diphosphate (Fyfe, 1982; Ayisi et al., 1984). In 
agreement with this is a report that the TMP kinase 
activity of TK partially purified from cells infected with 
mutant delta 1 was greatly reduced relative to that of 
cells infected with wild-type HSV1 (Haarr and Flatmark, 
1987). These findings suggest that the first 45 amino 
acids of TK are necessary for full TMP-kinase activity. It 
has been suggested that the polypeptide initiated at the 
third AUG codon (38K), which lacks part of the the 
nucleoside binding consensus sequence (Liu and Summers, 
1988), is likely to have no TK or TMP activity but this 
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has not been demonstrated. 
The full functional significance of the 39K and 38K 
polypeptides remains unclear, although it should be noted 
that E-ISV1-TK is a multirner (Jamieson and Subak-Sharp, 
1974). The presence of the three polypeptide monomers 
(43K, 39K and 38K) could extend the range of protein-
protein complexes which might be formed. 
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Chapter 8: STERILITY IN MALE TRANSGENIC MICE IS CAUSED BY 
THE EXPRESSION OF HSV1-TK IN THE TESTIS. 
As previously described (Chapter 5), the HSV1-tk reporter 
sequence was expressed in the testis. In this chapter I 
describe an analysis of the fertility of transgenic 
animals in relation to the expression of E-ISV1-TK. 
Results. 
As noted in the previous chapters, 3 of 5 BS6-tk-F Go 
males (48,49 and 51) and 2 of 3 BS6-tk-M Go males (Ml and 
M5) were sterile (Table 8.1). None of the fertile Go males 
transmitted the hybrid gene to their offspring. In 
addition, in 7 of 7 transgenic lines derived from Go 
females the males were invariably sterile (Table 8.1). Two 
exceptional mice, one from line 58 and one from a BS6-tk-M 
line, each sired a single offspring of unknown transgenic 
status. No further offspring were sired despite repeated 
mating. These mice, and also all the completely sterile 
mice, were housed with two female mice each for a minimum 
of 7 weeks and plugged females in the normal way. The 
fertility of an equal number of non-transgenic male 
siblings was tested in the same way and found to be 
fertile. 
All of these established lines (BS6-tk-F and BS6-
tk-t4) which show consistent male sterility have a high 
level of HSV1-TK activity in the testis (Table 8.1). In 
contrast, line 40 shows no liver HSV1-TK activity and line 
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Table 8.1. 
Transmission from Go to GI transgenics and expression of HSVI-
TK in the testis of transgenic mice carrying the 2.2 kb 5' 
BS6 promoter linked to the HSVI-tk reporter gene. 







in Testis 	(b) 
Control 0.11 + 0.044 (16) 
Transgenic mice BS6-tk-jF 
40* F Sterile 1 141.3 + 4•9  
46* F Sterile I - 139.0 + 	17.6 (3) 
58* F Sterile 1 41.6 5.8 (7) 
62 F Fertile X 
64* F Sterile 1 45.5 -'- 	4.3 (9) 
78* F Sterile 1 58.2 + 	11.7  
66 M Fertile X 1.5 (1) 
79 M Fertile X 0.0 (1) 
48 N Sterile X 
49 M Sterile X 
51 M Sterile X 25.0 (1) 
Transgenic mice BS6-tk-N 
12* F Sterile 1 106.0 (1) 
42* F Sterile 1 210.0 (1) 
Ml M Sterile X 132.0 (1) 
M4 M Fertile X 9.1 (1) 
N5 N Sterile X 
* 	Founders of transgenic lines. 
Sterile or fertile males. 
Units per milligram of protein; means and standard errors. 
n, the numbers of animals assayed, is shown in parentheses. 
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64 shows no preputial gland HSV1-TK activity, although 
both lines are consistently male sterile. Thus testis 
expression of HSV1-TK is the likely cause of male 
sterility, and both liver and preputial gland expression 
can be ruled out as the sole cause. 
A similar fertility pattern was observed in the 
secondary transgenic mice (BS6-tk-yF TR). Three of 6 Go 
males were sterile and the fertile Go males did not father 
transgenic offspring (Table 8.2). Furthermore, 4 of 6 
transgenic lines showed male sterility which correlated 
with high levels of HSV1-TKin the testis (Table 8.2). 
Transgenic mice harbouring the disabled E-ISV1-tk reporter 
gene also exhibited sterility in most cases. Of the 5 Go 
animals (4 males and 1 female) that were assayed, 3 Go 
males were fertile and of these 2 did not transmit the 
transgene to their offspring (Table 8.2). The Go female 
established line TK16 and Gi males from line TK16 were all 
sterile. 3 of the 4 Go males and males of line TK16 
expressed E{SV1-TK at moderate to high levels in the testis 
(Table 8.2). 
Effects of E-ISV1-TK expression. Exceptions to the sterility 
of transgenic males were observed. Two of 6 secondary 
transgenic (BS6-tk-F) mice lines were fertile and 
transmitted the transgene to their offspring (Table 8.2, 
mice B56 and B73). These fertile lines had a relatively 
low level of FISV1-TK activity. One possible explanation is 
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Table 8. 2. 
Transmission from Go to GI transgenics and expression of HSV1-
TK in the testis of transgenic mice containing the BS6-tk-SupF 
and HSVI-tkDS2 constructs. 







in Testis 	(b) 
Control 0.11 + 0.044 (16) 
Secondary transgenic mice BS6-tk-SupF(TR). 
A49* F Sterile 77.1 + 22.0 (3) 
B65* F Sterile .1 285.7 + 	50.7 (3) 
B56* F Fertile - 1.77 + 	1.0  
B85* F Sterile .1 180.0 + 22.0  
B73* F Fertile 5.9 + 	2.3 (3) 
B83* F Sterile 212.0 +105.0 (2) 
A6 M Fertile X 36.7 (1) 
A17 M Fertile X 24.9 (1) 
A45 N Sterile X 330.0 (1) 
A60 M Sterile X 38.8 (1) 
B27 N Sterile X 50.6 (1) 
1350 N Fertile X 5.6 (1) 
Transgenic mice HSVI-tkDS2 
TKI6* F Sterile .1'  97.23 (1) 
TKIO N Fertile X 23.15 (1) 
TK22 N Fertile j 0.16 (1) 
TK39 N Sterile X 37.75 (1) 
TK40 N Fertile X 4.23 (1) 
* 	Founders of transgenic lines. 
Sterile or fertile males. 
Units per milligram of protein; means and standard errors. 
n, the numbers of animals assayed, is shown in parentheses. 
119 
that lower expression levels do not cause sterility and 
that there is a threshold level of E-ISV1-Tk above which 
sterility occurs. In line 78 and 64 which exhibit a 
moderate level of expression in the testis (58.2 and 
45.4U/mg of protein, respectively), sperm counts were 
normal but sperm motility was reduced and males were 
sterile. In transgenic male mice from line 40 or 46 which 
have high levels of TK expression in the testis (141.3 and 
139U/mg of protein, respectively), sperm counts were very 
low, malformed non-motile sperm were present and males 
were again sterile. Therefore, the severity of the lesion 
is greater when TK expression in the testis is at its 
highest. All the female transgenics exhibited normal 
fertility and no HSV1-TK activity was detected in ovaries 
of BS6-tk-F lines 40, 46 9 58, and 64 (Table 8.3). 
Discussion. 
Male sterility and expression of the EISV1-tk reporter in 
the testis. The constructs employed in this work and that 
of other investigators utilize two promoters with entirely 
different tissue-specificity. One directs expression to 
the liver under the control of growth hormone. The other 
directs expression to the thyroid under the control of 
TSH. In both cases E-ISV1-TK was expressed at a similar high 
level in the testis and caused male sterility. 
Furthermore, the HSV1-tk reporter gene itself, when 
disabled by removal of its distal regulatory element, 
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Table 8.3. 
E-ISV1-TK activities in the female ovaries of transgenic mouse 
lines. 
Line 	 Enzyme activity (a) in the ovaries 
Control 	 0.0 	(4) 
40 	 0.0 	(1) 
46 	 0.0 	(1) 
0.027 (1) 
64 	 0.0 	(1) 
(a) Units per milligram of protein. 
n, the numbers of animals assayed, is shown in parentheses. 
caused male sterility. From these results it may be 
concluded that irrespective of properties of the promoter, 
ectopic expression of E-ISV1-tk frequently occurs in the 
testis of transgenic mice and results in male sterility. 
A number of transgenic mice bearing HSV1-tk alone or 
driven by the metallothionein promoter showed normal 
fertility (Palmiter et al., 1982; Palmiter and Brinster, 
1986). However, the level of expression in testis was not 
monitored in these animals, and may have been below the 
threshold necessary for infertility. Several other 
examples have been reported. Some lines of mice transgenic 
for HSV1-tk linked to the mouse mammary tumour virus long 
terminal repeat expresses HSV1-tk in the testis (Ross and 
Solter., 1985) and are sterile. In another case, a cosmid 
vector bearing the MHC class IIEalpha gene and a HSV1-tk 
gene was used to generate transgenic mice and the 
resulting mice were sterile (Braun et al., 1990). To 
ascertain the cause of the sterility, various subfragments 
of the cosrnid were tested in transgenic mice and only 
those pieces of DNA that include some of the Ealpha 
flanking chromosomal DNA and the HSV1-tk gene resulted in 
male sterility. Transgenic male mice bearing an IFN-gamma 
transgene driven by the mouse metallothionein promoter 
were also sterile (Iwakura et al., 1988). Here, too, HSV1-
tk gene expression (from the plasmid vector) was found in 
the testis. Finally reduced male fertility was also 
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reported in transgenic mice bearing HSV1-tk driven by an 
immunoglobulin gene enhancer and promoter (Heyman et al., 
1989), although the researchers did not assess the 
expression of HSV1-tk in the testis. 
Braun et al (1990) also showed that the complete 
HSV1-tk gene alone did not effect fertility, when 
introduced into transgenic mice, despite the presence of 
E-ISV1-tk rnRNA and protein in germ cells. These mice exhibit 
a lower level of expression, in comparison to the Ealpha-
HSV1-tk construct, and it may be that this level is below 
the threshold necessary for sterility. Since the truncated 
E-ISV1-tkDS2- gene caused sterility, the possibility arises 
the HSV1-tk promoter prevents this. 
Causes of male sterility. Available evidence suggests that 
a high level of HSV1-TK activity in the haploid spermatids 
is the likely cause of male sterility. The enzyme could 
exert an effect in a number of ways which disrupt the 
cellular metabolism of nucleic acid precursors. First, its 
substrate specificity is different from that of the 
cellular enzyme, and it efficiently phosphorylates 
mononucleotides as well as nucleosides (Chen and Prusoff, 
1978; Veerisetty and Gentry, 1985), a fact used to 
advantage for the killing of cells with ganciclovir, an 
analog that is incorporated into DNA to arrest replication 
(Heyman et al., 1989). Second, the high levels of 
phosphorylated products produced by the enzyme could 
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inhibit the normal pathway of pyrimidine metabolism 
(Kelley, 1983). Third, HSV1-TK may be active at times in 
the cell cycle when the cellular enzyme is normally 
repressed (Hofbauer et al., 1987; Merrill et al., 1984) 
and if so could interfere with some vital cellular 
function. Finally, since spermatids have completed DNA 
replication, it is possible that enzymes are induced that 
degrade deoxynucleotide inonophosphates. Consequently, the 
expression of HSV1-tk might establish a futile cycle of 
thymidine phosphorylation and dephosphorylation at the 
expense of ATP. Indeed sterile mice have non-motile 
spermatozoa and this may suggest a simple depletion of 
ATP. 
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Chapter 9: SYNTHESIS AND ANALYSIS OF ETHYNYLTHYMIDINE, A 
COMPETITIVE INHIBITOR OF HSV1-TK. 
In most cases the E-ISV1-TK activity in the testis rendered the 
transgenic male mice sterile. In an attempt to restore 
fertility in transgenic male mice or at least reduce HSV1-TK 
activity, synthesis of a thymidirie analogue which is a non 
toxic competitive inhibitor of HSV1-TK was undertaken. A report 
by Nutter et al (1987) described in detail the use of such an 
inhibitor. In this chapter I describe the effects of 5'-
ethynyl-thymidine (5'-Et-dThd) as a selective inhibitor of 
HSV1-TK (in vitro and in vivo). 
Results. 
Synthesis of 5'-Et-dThd. 5'-Et-dThd (1-(2,5,6-trideoxy-B-D-
erythro - hex-5_enofuranosyl)...5_fflethyluracjl) was synthesized, as 
described in Materials and Methods, by the protocol employed by 
Sharma and Bobek, 1978. 
Activity of 5'-Et-dThd against viral and cellular thymidine 
kinase activities in vitro. To investigate the usefulness of 
the compound, its effects on viral and cellular thymidine 
kinases were examined. Extracts of BHK fibroblasts, which 
possess an active cellular tk gene (BHKTK), and extracts of BHK 
cells, which stably express a j/HSV1-tk gene (BHKHSVTK) but 
which lack the cellular kinase, were utilized for this purpose. 
Extracts of transgeriic testis which actively expressed the 
j/HSV1-tk transgene were also utilized. The activity of 
cellular TE( is regulated by end-product inhibition to a much 
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greater extent than HSV1-TK, and endogenous cellular activity 
can be selectively inhibited by the addition of 0.4mM dTTP 
(Jamieson and Subak-Sharp, 1974). In my hands, the addition of 
0.4mM dTTP inhibited cellular TK activities by approximately 
92% and HSV1-TK by approximately 50%. This property was 
utilized in the assays for tissue-specific expression of the 
transgene in mice and is employed in this investigation. 
BHKTK and BHKHSVTK cell extracts were prepared from sub-
confluent monolayers and thymidine kinase assays were performed 
in the presence of different concentrations of 5'-Et-dThd (see 
Materials and Methods). Incubations were conducted at 37 ° C for 
60 minutes. 5'-Et-dThd inhibited cellular thymidine kinase only 
slightly (Figure 9.1, BHKTK). In contrast, both BHKHSVTK and 
testis extract were inhibited by 5'-Et-dThd. 50% inhibition of 
HSVI.-T[( was observed at a concentrations of about 40uM in each 
case. These data confirm the report by Nutter et al (1987) who 
observed selective inhibition of [-ISV1-TK relative to human 
thymidine kinase in the presence of 5'-Et-dThd. 
Inhibition of HSV1-TK and lack of inhibition of cellular 
thymidine kinase in cells in culture. When cells are cultured 
in the growth medium HAT, which contains Hypoxanthine, 
Aminopterin and Thymidine, survival is dependent on the 
pyrimidirie salvage pathway enzyme, thymidine kinase 
(Littlefield, 1964). Aminopterin inhibits the de novo synthesis 
of dATP, dGTP and dTTP from dihydrofolate. Hypoxanthine is a 
substrate for the salvage pathway for dATP and dGTP and 
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Figure 9.1. 
The effect of 5'-Et-dThd 	on in vitro thymidine kinase 
activity. 
Extracts from BHKTK (0), containing no dTTP, BHKHSVTK (0), 
containing dTTP, and testis (s), containing dTTP, were 
examined by thymidine kinase assays, for their sensitivity to 
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therefore allows these nucleotides to be synthesised. Thymidine 
is essential for the synthesis of dTTP and is totally dependent 
on an active tk gene. BHKHSVTK cells are totally dependent on 
the viral thytnidine kinase for survival and proliferation in 
HAT medium. To determine whether 5'-Et-dThd treatment would 
inhibit the proliferation of BHKHSVTK cells in HAT medium, 
exponentially growing cells were exposed to various 
concentrations of 5'-Et-dThd, (see Materials and Methods). 
When BHKHSVTK cells were exposed to 5'-Et-dThd for 5 days, 
cell proliferation was strongly inhibited (Figure 9.2). In 
contrast the exposure to 5'-Et-dmd of BE-IKTK cells, which are 
totally dependent on cellular thymidine kinase, had no effect 
on cell proliferation (Figure 9.2). These experiments show that 
5'-Et-dmd is not excluded from fibroblasts and exhibits no 
toxicity over the range of concentrations tested. Furthermore, 
5'-Et-dThd specifically inhibits the viral TK. Figure 9.2 shows 
that 50% growth inhibition was observed at a 5'-Et-dThd 
concentration of 80uM (Figure 9.1). 
Effects of 5'-Et-dThd on antiviral activity of antiherpetic 
agents. The pathogenic effects of HSV infection have led to the 
development of nucleoside analogs that inhibit virus 
multiplication. Both Acyclovir (ACV) and Ganciclovir (GCV) are 
phosphorylated by HSV1-TK, but not by the cellular kinase. The 
phosphorylated compound is lethal to cells. Consequently, virus 
infected cells are killed, but uninfected cells are not. If 5'-
Et-dThd competes effectively with ACV or CCV in the HSV1-TK 
128 
Figure 9.2. 
The effect of 5 1 -Et-dThd on cells in culture in the presence 
of HAT medium. 
	
BHKTK ( 	) and BHKHSVTK (0 ) cells were exposed to various 
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phosphorylation reaction it should increase cell survival in 
the presence of the antiherpetic agent. 
The effect of 5'-Et-dThd on the survival of BHKHSVTK cells 
in the presence of ACV and GCV was determined using medium not 
supplemented with HAT. The experiment was similar to the one 
just previously described. Cells were plated at low density and 
approximately 15 hours later 5'-Et-dThd was added. After a 
urther 24 hours either a 3uM ACV or luNi GCV was added and the 
ultures were incubated for an additional 96 hours. Viable 
ells were again identified by trypan blue exclusion. 
Figure 9.3 shows that in the presence of 5'-Et-dThd cell 
;urvival increased with increasing 5t_Et_dThd  concentration. At 
5'-Et-dThd concentration of 500uNl 5'-Et-dThd survival was 90°h 
(ACV) and 807 (GCV). This is in agreement with the observation 
pf Nutter et al (1987) who showed using the virus yield assay 
that 5'-Et-dThd reversed the antiviral activity of five 
nucleoside analogs, including ACV and GCV, which require viral 
kinase for their action. The concentration of 5'-Et-dThd which 
gave 507 survival was 175ut4 for cells exposed to 3uNl ACV and 
265uM for those exposed to luNi GCV. 
Effect of 5'-Et-dThd on transgenic mice. The amount of 5'-Et-
dThd available was limiting, so that only a few experiments 
could be performed on transgenic and control animals. 
Transgenic male mice from line 58 were employed, since this 
line expressed the lowest amount of HSV1-TK in its testis. 
Adult transgenic and control male mice were exposed daily to 
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Figure 9. 3. 
Che effect of 5 1 -Et-dThd on antiviral activity of antiherpetic 
igents. 
he antiviral activities of 3uM 	acyclovir () and luM 
ancic1ovjr (0 ) in the presence of 5'-Et-dThd were determined 
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5'-Et-dThd by intraperitoneal injection and sacrificed as 
detailed in Table 9.1. Drug treatment was at 0.47mg/g, to give 
an overall concentration of about lOOuM. I showed previously 
that this concentration is effective in tissue culture cells. 
Seven transgenic and three non-transgenic mice were 
injected with 5'-Et-dThd, and a further three transgenics were 
tnhected with PBS. At various times, the animals were 
sacrificed and the levels of TK in testis, liver and preputial 
land was measured (Table 9.1). As expected the non-transgenic 
mice treated with 5'-Et-dThd did not show any detectable levels 
f TK, in the tissues analysed. In - all transgenic mice given 
BS, the expression of the transgene was as expected. In all 
animals tested the organs removed appeared normal, with no 
kpparent toxic effects, due to the presence of 5'-Et-dThd. 
Since only one mouse was analysed at most time points it 
as difficult to assess the significance of these results. 
entatively, the mouse from line 58 which had been exposed to 
'-Et-dThd for 5 days appears to have a significant decrease in 
activity in comparison to the control mice. This appears to be 
the case in all of the three expressing tissues examined. In 
the testis, liver and preputial gland tissues, there was a 
48%, 29°h and 36% decrease in enzyme activity at 5 days, 
respectively, in comparison to the untreated transgenic 
animals. These preliminary experiments appears to indicate that 
5'-Et-dThd has an affect on TK activity in transgenic animals. 
Further analysis is necessary to confirm these findings. 
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Table 9. 1. 
HSV1-TK activity in tissues of control and transgenic male mice from 
line 58, which had been exposed to 5'-Et-dThd for different time durations. 
Enzyme activity (a) in tissues. 
Exposure 
• time to 
5'-Et-dThd Testis Liver Preputial gland 
Control lhr,24hr,5days 0.07 + 0.1 (3) 0.0 (3) 0.0 (3) 
Line 58 PBS only 35.1 + 10.2 (3) 7.2 + 1.4 (3) 	10.8 + 0.7 	(3) 
Line 58 15min 29.3 	(1) 7.7 (1) 9.4 (1) 
Line 58 lhr 34.1 	(1) 9.5 (1) 6.2 (1) 
Line 58 2hr 40.6 + 2.1 (2) 7.2 + 0.1 (2) 	8.5 + 2.4 	(2) 
Line 58 7hr 25.2 	(1) 7.8 (1) 9.0 (1) 
Line 58 24hr 25.1 	(1) 7.4 (1) 9.4 (1) 
Line 58 5days 20.5 	(1) 5.1 (1) 6.9 (1) 
(a) Units per milligram of protein: means and standard errors. 
n, 	the numbers of animals assayed, 	is shown in parentheses. 
)iscussion. 
rhe thymidine analog 5'-ethynylthymidine was a potent inhibitor 
)f HSV1-induced thymidine kinase and showed no inhibition 
against mammalian thymidine kinase under the conditions tested. 
1hen tested alone, 5'-ethynylthymidine exhibited no toxicity, 
)ut antagonized the toxic effects of two compounds (ACV and 
;CV) which require EISV1-TE( for their action. Therefore, it 
appears that 5'-Et-dThd not only competes with thymidine but 
lso with ACV and GCV. Furthermore, preliminary experiments 
erformed on transgenic animals indicate that 5'-Et-dThd may 
ause a decrease in HSV1-TK activity, although further analysis 
Ls necessary to determine whether this phenomenon is a general 
)ne 
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Chapter 10: MATERIALS AND METHODS. 
Enzymes. 
Restriction and DNA/RNA modifying enzymes were purchased 
from either Amersham International or Pharmacia, and were 
used with the buffers supplied or as directed by the 
supplier. 
Northern Blotting and DNA Probes. 
Total RNA was extracted from homogenised mouse tissues in 
guanidinium thiocyanate and pelleted through a caesium 
chloride gradient as described by Chirgwin et al (1979). 
Once the tissue is removed and after a phosphate buffered 
saline (PBS) wash, a solution of 4M guanidinium 
thiocyanate, 0.5% w/v sodium N-lauryl sacosinate, 25mM 
sodium citrate, 0.1% w/v Sigma antifoam A and O.1M beta-
mercaptoethanol, was added to the appropriate tissue. The 
resulting solution was homogenised for a few minutes, 
followed by layering over 1.2mls of 5.7M caesium chloride 
buffered with 25mM sodium acetate (pH 5) and centrifuged 
at 36K, 20 ° C for 12 hours. The pelleted RNA was 
resuspended in imi of 7.5M guanidine hydrochloride, 25mM 
sodium citrate (pH 7), 5mM DTT and precipitated twice, 
once with 0.025 volumes of 1M acetic acid, 0.5 volumes of 
ethanol and once with 2mls double distilled water, 0.1 
volumes of 2M sodium acetate and 2 volumes of ethanol. The 
RNA was finally resuspended in double distilled water. 
Northern blot analysis was carried out as described 
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by Church and Gilbert (1984), using hybond-N (Amersham) 
nylon membranes and the double-stranded DNA probes were 
labelled by a variation of the method of Feinberg and 
Vogeistein (1984). The tk probe was an 840 bp PstI 
fragment of pTK1 which overlaps 806 bp between the point 
of fusion with the Mup promoter region and a PstI site 
internal to the TK coding region (Wagner, M.J. et al., 
1981; McKnight et al., 1981). 
Protocol For Primer Extension. 
The synthetic oligonucleotides were purchased from the 
Oswell DNA Service, Chemitry Department, Edinburgh 
University. Concentrations of oligonucleotide in water 
were determined by measuring the A260 of the solution. The 
probes (oligonucleotides) were labelled to a specific 
Is 	 9 
activity of 5 x 10 to 2 x lO, using gamma- 32 P ATP and T4 
polynucleotide kinase as described by Niaxarn and Gilbert 
(1980). Primer extension assays were carried out according 
to Ghosh et al (1980). In a microcentrifuge tube 0.2pmols 
of end labelled primer was mixed with 20ug of TK total 
RNA, 2u1 of 5 x hybridisation buffer (50mM PIPES pH 6.5 1 
2M NaCl) and water to a final volume of lOu].. After 
sealing with paraffin oil, the eppendorf tube was 
denatured at 90 ° C for 5 minutes and left at the annealing 
temperature of 55 ° C for 6 hours to overnight. After 
annealing, 90ul of extension reaction buffer (50mM Tris-
HC1 pH 8.2, 10mM DTT, 6mM MgCl2, 0.5mM each of dATP, dCTP, 
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dGTP, dTTP, 2.5 g of actinomycin D and 15 units of AMV 
reverse transcriptase), was added to the sample tube. The 
extension reaction was carried out at 42 ° C for 60 minutes 
and terminated by extraction with phenol/chloroform twice. 
This is followed by precipitation with 7.5M ammonium 
acetate and 2.5 volumes of ethanol. After an overnight 
precipitation the samples were centrifuged, rinsed twice 
with 70% ethanol, dried and loaded on to a 6% 
polyacrylamide/ 8M urea gel. Gels were fixed for 20 
minutes in 10% methanol, 10% acetic acid, dried and 
exposed directly to X-ray film. 
Tissue Culture Methods. 
The cells used in the experiments were baby hamster kidney 
fibroblasts (Macpherson and Stoker, 1962) which were grown 
at 37 ° C in CO2 in Dulbeccos Modified Eagles Medium (DMEM) 
supplemented with 3.7g/litre sodium hydrogen carbonate, 
10% foetal calf serum, penicillin (lOOug/ml) and 
streptomycin (lOOug/ml). Cultured vessels were purchased 
from NUC. Cells were detached by trypsinisation with 
0.25% trypsin, 0.02% £DTA. 
Cell Growth Inhibition. 
Cells, BHKTK and BHKHSVTK, were seeded at low density in 
DMEM containing 10% foetal calf serum in the presence of 
HAT. Approximately 15 hours later various concentrations 
of 5'-Et-dThd were administered to the cultures. After a 
total of 5 days cells were detached by trypsin treatment 
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and resuspended in medium. Viable cells were recognized by 
trypan blue exclusion, cell numbers were determined by an 
average of at least two cultures for each concentration. 
Infection Of B[-IKtk- Cells. 
A monolayer of BHKtk- cells was infected at 10 PFU/cell 
with [iSV strain 17, Cl 101 or the TK mutant delta 1, which 
were kindly provided by Howard Marsden. After 1 hour the 
cells were washed once with phosphate buffered saline, 
replaced with DMEM and incubated overnight. Next day the 
cells were harvested in a denaturing buffer, which 
containing 0.05M Tris HC1, pH 6.8 9 2% SDS, 5% beta-
inercaptoethanol, 10% glycerol and bromophenol blue. The 
cells were heated at 100 ° C for 2 minutes and stored at 
-70 ° C until needed. 
Herpes Simplex Thymidine Kinase Assay. 
Thymidine kinase assays were carried out as described by 
Brinster et al (1981), but 0.4mM dTTP was added to inhibit 
endogenous thymidine kinase (Jamieson and Subak-Sharp., 
1974). 
Mice were sacrificed and organs were rinsed in cold 
PBS. Tissues were homogenised (Polytron homogenizer) in 
homogenisation buffer containing 10mM potassium chloride, 
2mM magnesium chloride, 10mM Tris (pH 7.5), 1mM ATP, 10mM 
sodium fluoride and 50mM aminocaproic acid, (pH 7.4). The 
extracts were pelleted by centrifugation (10000g, 4 ° C for 
10 minutes). The enzyme assay is described by Brinster et 
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al (1981) and is based on the conversion of radiolabelled 
thymidine to thymidine phosphate. A 15u1 aliquot of tissue 
supernatant was added to 75u1 of reaction mixture 
containing 10mM magnesium chloride, 150mM Tris (pH 7.5), 
10mM ATP, 25mM sodium fluoride, 10mM beta-mercaptoethanol 
and 15uCi of tritiated thymidine (90 Ci/mmol, Amersham). 
The mixture was incubated at 37 ° C. The 3 H-TMP produced was 
measured by spotting 25u1 of mixture onto DEAE-81 paper 
(Whatman) discs at time intervals 30, 60 and 120 minutes. 
The discs were washed 4 times, 10 minutes each, in 10mM 
Tris (pH 7.5) with shaking and dried under vacuum at 80 ° C. 
The radioactivity on the filters was determined by liquid 
scintillation counting (scintillant was 5g/1 PPO, 0.3g/l 
dimethyl POPOP in toluene). The tissue extracts were 
stored at -70 ° C. The assaying of thymidine kinase in 
tissue culture cell extracts was as above, but with the 
following refinements. The cells were harvested by washing 
twice in ice cold PBS before they were scraped off into 
5mls of PBS and pelleted by centrifugation. A further 
washing with 5mls of PBS and centrifugation followed, 
before the cells were taken up in 200u1 of homogenisation 
mix. The cells were pelleted by centrifugation after being 
lysed by sonication at 4 ° C for 5 hours. The unit of 
thymidine kinase activity is the amount of enzyme which 
catalyses the formation of 1 pmol of TMP in 1 minute. 
The soluble protein content of the cell extracts were 
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estimated by the Bradford method (Bradford, 1976), using 
the Bio-Rad assay system. This is a dye-binding assay 
based on the differential colour change of a dye in 
response to various concentrations of protein. 
Protein Analysis. 
Preparation and use of tissue extracts in SDS-PAGE. Tissue 
extracts were homogenized in the same homogenization 
buffer as was used in thyrnidine kinase assays, and where 
indicated the addition of further protease inhibitors were 
added. Following homogenization tissue extracts were 
centrifuged at 10K, 4 ° C for-10 minutes, the supernatant 
removed and protein assays were carried out to determine 
the concentration. SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) was performed on a 12% separating gel with a 4% 
stacking gel, according to Laemmli (1970). 
Electroblotting and immunostaining of blotted proteins. 
After electrophoresis, the proteins were transferred to 
nitrocellulose by using a homemade semi-dry Trans-blotting 
apparatus. The blotting assembly was prepared in a 
sandwich configuration, with the nitrocellulose membrane, 
which had previously been soaked in distilled water, 
placed on the side of the gel facing the anode in the 
blotting unit. Whatman type 3MM chromatography paper was 
soaked in blotting buffers, details of the buffers used 
and the sandwich set up are shown in Figure 10.1. 
Electroelutjons were performed at 200rnA for 1-2 hours at 
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Figure 10.1. 
Assembly for electrophoretic blotting procedure. 
Electrophoretic transfer of proteins from SDS-polyacrylamide gels to 
nitrocellulose filters. The apparatus is assembled as follows: on top of 
the anode plate are successively placed, 2 sheets of 3MM chromatography 
paper soaked in Anode 1 buffer (0.3M Tris, 20% Methanol), 1 sheet of 3MM 
chromatography paper soaked in Anode 2 buffer (25mM Tris, 20% Methanol), 
a sheet of nitrocellulose filter paper soaked in distilled water (DE-120), 
the gel, 2 sheets of 3MM chromatography paper soaked in Cathode buffer 
(25mM Tris, 20% Methanol, 40mM Hexanoic acid) and finally the Cathode 
plate is placed on top. 
Cathode plate 
3MM paper + Cathode buffer 
Polyacrylamide gel 
Nitrocellulose+ DH20 
3MM paper + Anode 2 buffer 
3MM paper + Anode 1 buffer 
Anode plate 
4 ° C. After transfer was complete, the nitrocellulose was 
blocked by incubating in BLOTTO (5% w/v nonfat dry milk, 
0.01% Antifoam in PBS) for 4 hours at room temperature 
with gentle agitation (Johnson et al., 1984). The same 
reagent used for blocking was utilized as a carrier for 
primary and secondary antibodies. The blots were reacted 
with primary antibody, 1:250 of anti-rabbit E-LSV1-TK, 
(which was a kind gift of William Summers), overnight at 
room temperature with agitation. This was followed by 
three 15 minute washes with 0.5% Tween 80 in PBS, before 
incubation with the second antibody, 1:400 anti-rabbit Ig-
biotinylated (Amersham), for 2-3 hours at room 
temperature. Blots were then washed as described above, 
followed by treatment with a 1:1000 streptavidin-alkaline 
phosphatase conjugate (Ainersham), for 45 minutes at room 
temperature. The membrane was then washed a third time and 
suspended in its substrate system to develop colour. Which 
in the case of alkaline phosphatase conjugate was 7mM 5-
bromo-4-chloro-3-indolylphoshate (BCIP), 6mM nitroblue 
tertrazolium (NBT) in 0.1M Tris/HC1 pH 9.5, at room 
temperature for about 20 minutes. Development results in 
brown protein bands that indicate specific reactivity, 
which were immediately photographed. 
Staining and destaining of SDS-polyacrylamide gels and 
membrane blots. The gels were stained with Coomassie 
brilliant blue R-250 (0.27. in 1% TCA, 7.4% acetic acid, 
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50% methanol) for approximately 2 hours followed by 
destaining in 7% acetic acid/ 23% ethanol. Membrane blots 
were stained in 0.2% (w/v) Coomassie brilliant blue R-250, 
50% methanol, 10% acetic acid for 10-15 minutes. The blots 
were then destained in 45% methanol, 7% acetic acid for 5-
10 minutes. 
Synthesis of 5'-Et-dThd. 
5'-Et-dThd 	 (1-(2 9 5 9 6-trideoxy-B-D-erythro-hex-5_ 
enofuranosyl)-5-methyluracil) was synthesized as described 
by the method employed by Sharma and Bobek, 1978. The 
synthesis consists of five steps. Briefly 3'-0-
Acetyithyrnidine (Figure 10.2A) was dissolved in dimethyl 
sulfoxide containing dicyclohexylcarbodiimide and 
phosphoric acid. The solvent was evaporated to dryness and 
the residue was partitioned between water and ether. After 
removal of dicyclohexyl-urea by filtration, a further 
ether extraction was performed and the aqueous solution 
was added to an excess of 2 9 4-dinitrophenylhyclrazine in iN 
sulphuric acid. After chilling the dinitrophenyihydrazone 
of 3'-0-acetylthymidine-5'-aldehyde was removed by 
filtration (Figure 10.2B). 
3'-0-Acetylthymidine-5 t -aldehyde (Figure 10.2B) was 
condensed with (dibromomethylene)triphenylphosphorane in 
methylene chloride. The mixture was evaporated to a small 
volume and chromatographed twice on a dry silica gel 
column, eluting with benzene/ethyl acetate. The combined 
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Figure 10.2. 
The five major compounds involved in the synthesis of 5'-
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fractions were dissolved in methanol, where 1-(2,5,6-
trideoxy-6 , 6-dibromo-3-O-acetyl-B-D-erythro-hex-5-
enofuranosyl)-5-methyluraci}.) (Figure 10.2C) crystallized 
within 30 minutes. 
A solution of the product in Figure 10.2C, in excess 
of sodium methoxide in methanol was neutralized with Dowex 
50 (H+) resin and filtered. The resin was washed with 
methanol, combined, and evaporated to a small volume where 
1-(2, 5, 5-trideoxy-6 , 6-dibromo-B-D-erythro-hex-5- 
enofuranosyl)-5-methyluracil (Figure 10.2D) crystallized. 
A solution of the product in Figure 10.2D, in dry 
tetrahydrofuran was treated with n-butyl-lithium. The 
mixture was stirred, neutralized with acetic acid, 
evaporated and co-evaporated with ethanol. The crude 
material was chromatographed on a dry silica gel column 
using ethyl acetate as eluant. After evaporation and 
crystallization from ethanol, the desired product was 1-
(2,5, 6-trideoxy-B-D-erythro-hex-5-enofuranosyl)-5- 
methyluracil (Figure 10.2E), which is abbreviated to 5'-
ethynyl-thymidine (5' -Et-dThd). 
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ABBREVIATIONS USED IN THE TEXT 
A adenine 
ACV acyclovir 
AFP alpha-fetoprotein gene 
AMV avian myeloblastosis virus 
APRT adenosylphosphoribosyltransferase 
ATP adenosine 5' 	triphosphate 
BCIP 5-bromo-4--chloro-3-indolylphoshate 
BHK baby hamster kidney cells 
BLOTTO bovine lacto transfer'- technique optimizer 
bp base pair 
BPV bovine papilloma virus 
BSA bovine serum albumin 
BVdU 5-bromovinyldeoxyuridine 
C cytidine 
CAT chioramphenicol acetyl-transferase 
cDNA DNA copy of RNA 
CTF cellular transcription factor 
d deoxyribo- 
dATP deoxyadenosine triphoshate 
DCI dichioroisocoumarin 
dCTP deoxycytidine triphosphate 
DEAE diethylaminoethyl 
dGTP deoxyguanosine triphosphate 
DHFR dihydrofolate reductase 
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DMEM dulbecco's modified Eagles medium 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
dpm depositions per minute 
dTMP deoxythymidine monophosphate 
DTT dithjothreotol 
dTTP deoxythymidine triphosphate 
E64 L- trans-Epoxysuccinyl- leucylamido 
(4-guanidino) butane 
EDTA diaminoethanetetra-acetic acid 
ES embryonic stem 	-- 
G guanine 
GCV ganciclovir 
GH growth hormone 
GRE glucocorticoid responsive element 
HAT hypoxanthine, aminopterin, 	thymidine 
HNF-i hepatocyte nuclear factor-1 
E-IPRT hypoxanthine phosphoribosyl transferase 
hsp heat shock protein 
HSTF heat shock transcription factor 
HSV herpes simplex virus 
IGF-I insulin-like growth factor I 
IFN interferon 
kb kilobase pair 
LTR long terminal repeat 
Met methionine 
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ME{C major histocompatibility complex 
MMTV mouse mammary tumour virus 
MRE metal regulatory element 
mRNA messenger RNA 
MT rnetallothjonejn 
MUP major urinary protein 
MUP major urinary protein gene 
MW molecular weight 
NBT nitroblue tertrazolium 
NFl nuclear factor 1 
PAGE polyacrylamide gel eléctrophoresis 
pfu plaque forming unit 
PBS phosphate buffered saline 
pH -log 	[H-i-] 
pHMB para-hydroxymercurjbenzoate 
PIPES Piperazine - N,N'-bis[2-ethanesulfonic acid] 
PMSF pheny lmethanesulphonylf luo ride 
polli polymerase II 
poly(A) RNA polyadenylated RNA 
POPOP 1, 4- bis -2- ( 4-methyl_5_pheny1oxazo1yl)...bezjn 
PPO 2,5-diphenyloxazole 
r ribo- 
RNA ribonucleic acid 
RNase ribonuclease 
rRNA ribosomal RNA 
Si single strand specific nuclease 
148 
SDS sodium dodecyl sulphate 
SP1 specific transcription factor 1 
SV40 simian virus 40 
T thymidine 
TCA tris .- [hydroxymethyl] - aminomethane 
tk thymidine kinase (gene) 
TK thymidine kinase (enzyme) 
TLCK tosyl-lysine chioromethyl ketone 
TNIP thymidine monophosphate 
Tris tris - [hydroxymethyl] - aminomethane 
tRNA transfer RNA 
TSH thyroid stimulating hormone 
TTP thymidine triphosphate 
U uridine 
UASs upstream activator sequences 
UPEs upstream promoter elements 
UTP uridine triphosphate 
w/v weight per volume 
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A hybrid gene was made by fusing the 2.2-kilobase 5' promoter region of a mouse group 1 major urinary 
protein (Mup) gene to the coding region of the herpes simplex virus type 1 thymidine kinase gene (HSV tk) and 
introduced into the genomes of mice by microinjection. Transgenic G0 males were sterile, or when fertile did 
not transmit the foreign gene, and the transgenic male descendants of G 0 females were also sterile. Seven 
"lines" - were established by breeding from G 0 females and their transgenic female descendants. Six lines 
expressed HSV thymidine kinase activity in the liver, and activity correlated perfectly with the presence of HSV 
tk RNA. In three of four lines examined, expression was lower in female than in male liver, and in these lines 
the same sex difference was observed in the rate of run-on transcription of the foreign genes in liver nuclei. 
When females of one of the sexually dimorphic lines were treated with testosterone, the levels of HSV 1k RNA 
and thymidine kinase activity were increased, although not to male levels. In these aspects of liver expression, 
and also in a lack of expression in seven other tissues, the hybrid gene exhibits many of the characteristics of 
an endogenous group 1 Mup gene. However, the gene was also expressed (at high levels) in the preputial gland 
and testis, two tissues in which Mup genes are not expressed. The gene, when introduced into five of the seven 
lines, carried a copy of the Escherichia coli supF gene attached beyond the 3' end of the HSV tk gene, but this 
did not affect the overall expression pattern. All of the lines were male sterile and expressed HSV thymidine 
kinase in the testis, but one line showed no activity in the liver, and another showed none in the preputial gland. 
Testicular expression is therefore the likely cause of sterility. Data are described which suggest that the causes 
of misexpression in the preputial gland and testis are different. Since expression in each tissue occurred in 
several lines, the structure of the hybrid gene must be responsible in each case. Five intensively studied lines 
showed at least four consistently different patterns of relative expression in preputial gland, testis, male liver, 
and female liver. These differences do not correlate in any way with the copy number of the foreign gene in the 
different lines and must be due to some other aspect of line-specific integration. 
The mouse major urinary proteins (MUPs) are coded for 
by a family of about 35 genes clustered on chromosome 4 (3, 
12, 23). Four groups of Mup genes have been identified, the 
largest of which are the group 1 genes and the probably inert 
group 2 pseudogenes (3, 12, 25, 35, 51; R. Al-Shawi, P. 
Ghazal, A. J. Clark, and J. 0. Bishop, submitted for publi-
cation). Most group 1 genes are expressed exclusively in the 
liver, while a small subset are also expressed in the mam-
mary glands of pregnant females (50, 52). Of the two smaller 
groups, the group 3 genes are also expressed in the liver, but 
under hormonal control different from the group 1 genes 
(35), and the group 4 genes are expressed in the lachrymal 
and salivary glands (50, 51). 
Female mouse liver contains at least five times less MUP 
mRNA than male liver (23), although expression in females 
may be rather variable (I. McIntosh and J. 0. Bishop, 
unpublished data). The difference in mRNA levels reflects 
different rates of transcription in the two sexes (18), and 
male levels of expression can be induced in females by 
administration of testosterone (14, 58). Relevant to the work 
presented here, the group 1 genes are regulated by circulat-
ing testosterone (14, 58). We are attempting to identify the 
regions in Mup genes which lead to their tissue specificity 
and hormone responses. Because liver cell lines which 
synthesize MUP are unknown, we are employing transgenic 
* Corresponding author.  
mice for this purpose. In the first instance we have studied 
the expression of a hybrid gene which contains as a reporter 
the herpes simplex virus type 1 thymidine kinase gene (HSV 
tk) attached to the putative promoter region of the group 1 
Mup gene BS6 (11, 13). The hybrid gene was expressed in 
the liver of transgenics, and in three of five lines it displayed 
a level of sexual dimorphism comparable to that of the Mup 
genes. Unexpectedly, it was also expressed consistently and 
at high levels in both preputial gland and testis. In all other 
tissues examined, RNA and protein products of the hybrid 
gene were absent, except that in one line there was expres-
sion in the lachrymal gland. Transgenic males were sterile, 
probably because of the presence of HSV thymidine kinase 
activity in the testis. 
MATERIALS AND METHODS 
Construction of hybrid genes. Plasmids were based on 
pSV2gpt (43), retaining the 341-base-pair (bp) PvuII-HindIIl 
simian virus 40 (SV40) enhancer-early promoter region and 
the 2,293-bp Ps'uIl-EcoRI portion of pBR322 containing the 
origin of replication and the 3-lactamase gene. The SV40 
enhancer in cis configuration is known to activate the BS6 
promoter in transfected rodent fibroblasts, allowing us to 
confirm before microinjection that the construct directs the 
synthesis of thymidine kinase. Between the Hindill site and 
the EcoRI site the following fragments were inserted (an 
asterisk shows that the site was blunt-ended with DNA 
4821 
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polymerase I): an approximately 2.2-kilobase (kb) Hindill-
Sau3A1 fragment of Mup gene BS6 (13); seven nucleotides 
of polylinker (GATCCCC); and a 1,759-bp BgIII*BsrE1I* 
fragment of HSV tk from plasmid pTK1 (59). The plasmid 
pSV-BS6-tk-supF was .completed with a 10-bp Sall*-  
BamHI* fragment of the M13tg130 polylinker (31), a 400-bp 
AluI-XbaI fragment of P1VX containing the Escherichia co/i 
supF gene (49), and a 36-bp XbaI-EcoRI fragment of the 
M13tg130 polylinker. Plasmid pSV-BS6-tk-M was completed 
with a 57-bp SalI*EcoRI  fragment of the polylinker. The 
fragments for microinjection were prepared by digestion 
with Hindlil and KpnI (BS6-tk-supF) or Hindill alone 
(BS6-tk-M), preparative agarose electrophoresis, electroelu-
tion, purification with Elutips (Schleicher and Schuell), 
phenol extraction, and repeated ethanol precipitation, and 
were dissolved in double-distilled water at a final concentra-
tion of 1.5 J.gIml. 
Transgenic animals and lines. C57BL/6J X CBA F 1 females 
were superovulated by treatment with pregnant mare's se-
rum and human chorionic gonadotropin (27) and mated with 
F1 males. About 2 p1 of DNA solution was injected into the 
more convenient pronucleus of each egg, and eggs were 
incubated in culture medium overnight. Two-cell embryos 
were introduced into pseudopregnant MF1 foster mothers. 
Transgenic mice were identified by Southern blot analysis of 
tail DNA. Transgenic females were mated to C57BLI6J x 
CBA F1 males. Copy number estimates of the transgene 
were determined from Southern blot data. 
Assessment of fertility. Male mice were housed with two 
female mice each, for a minimum of 7 weeks. Females were 
checked daily until vaginal plugs were seen. The fertility of 
an equal number of nontransgenic male siblings was tested in 
the same way, and all were found to be fertile. 
Thymidine kinase assay. Thymidine kinase assays were 
carried out as described (6), but 0.4 mM TTP was added to  
inhibit endogenous thymidine kinase (29). Each determina-
tion involved equal portions of duplicate assays taken at 
three time intervals. The unit of thymidine kinase activity is 
the amount of enzyme which catalyzes the formation of 1 
pmol of TMP in 1 mm. Protein was determined by the 
Bradford method (5). 
Northern blots and run-on transcription. RNA was pre-
pared by a guanidinium thiocyanate method (9), and North-
ern blot analysis was performed as described (54) using 
Hybond-N (Amersham) and random-primed probe synthesis 
to a specific activity of approximately io cpm/p.g. Probe A, 
the BamHI-to-BamHI HSV fragment of pTK1 (59), overlaps 
the HSV portion of the two constructs completely. Probe B, 
an 840-bp PstI fragment of pTK1, overlaps 806 bp between 
the point of fusion with the BS6 promoter region and a PstI 
site internal to the tk coding region. Marker RNA was made 
by run-off transcription of plasmid DNA containing a 1,922-
bp EcoRI-PvuII fragment of pTK1 inserted in the polylinker 
region of pT7.1 (United States Biochemicals) 10 bp down-
stream of the T7 RNA polymerase transcription initiation 
site. The plasmid was digested separately with AccI, BanI, 
SmaI, and Nan, and each fragment was transcribed in the 
presence of low-specific-activity [3H]UTP to generate RNA 
fragments 434, 1,009, 1,306, and 1,816 nucleotides long. 
After recovery, these were combined to make a set of 
markers. Run-on transcription assays were performed as 
described (54). The plasmid target sequences were pTK1, 
MUP11 (10), and LVB6 (54). 
RESULTS 
We linked 2.2 kb of 5'-BS6 sequence to HSV tk, with the 
junction point between the BS6 cap site and the HSV tk 
initiation codon (Fig. 1). To facilitate the rescue of the hybrid 
gene from the genomic DNA of transgenic mice, the BS6-tk- 
BS6 sequence 	 HSV tk sequence 
Cap site 	Sau3AI 	89111 	 AT6 
66A6T6TA6CCAC/6ATCCCC/GATCTT66T66C6T6AAACTCCC6CACCTCTTT66CAA6C6CCTT6TA6AA6C6C6TAT66CT 
	
robeA1 	 I K robeB 
1 	Ps 	 4 
I 	I 




pBR 	 SVEP 	B56 	 HSVtk 	SupF 
FIG. 1. Structures of hybrid genes. The restriction site map shows key sites as follows: E, EcoRI; P, Pvull; Ps, Pstl; H, Hindlll; K, KpnI; 
1, the Sau3A1-polyliriker-BgIlI fusion between the BS6 promoter and the HSV ik sequence, shown in the nucleotide sequence above; 2, the 
BsEII-Sall fusion between the HSV sequence and the M13tg130 polylinker. The BS6-tk-M fragment was separated from SV40 and vector 
sequences by digestion with HindIll, and the BS6-tk-supF fragment was separated by digestion with Hind!!! and KpnI. For other details see 
the text. 
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TABLE 1. Transmission of foreign genes from 
G0 to G 1 transgenics 
G0 line Sex 
Total 
1 offspring G 
Transgenic ( 
40" F 44 4(9) 
46" F 58 15 (26) 
58" F 31 11 (35) 
62 F 18 00 
64" F 21 6 (29) 
78" F 26 13 (50) 
66 M 49 0(0) 
79 M 31 00 
48 M Sterile 
49 M Sterile 
51 M Sterile 
Founders of transgenic lines 
supF construct contains the bacterial amber suppressor 
tRNA gene supF (19). This hybrid gene, freed from the SV40 
and vector sequences, was microinjected into the pronuclei 
of fertilized mouse eggs. Of 40 live-born pups, 11 were 
identified as transgenic. From these, five "lines" were 
established, all from G 0 females (Table 1). Here a line is a 
group of male and female mice descended from the same G 0 
female and containing the same transgenic insertion of 
foreign DNA. 
Expression of the hybrid gene in liver, testis, and preputial 
gland. Expression of the hybrid gene was studied by probing 
Northern blots with probes specific for HSV ik and by 
assaying HSV thymidine kinase activity in tissue homoge-
nates. Group 1 MUP mRNA is present in male and female 
liver and also in small amounts in the prelactation mammary 
gland, but not in other tissues (25. 50). The foreign HSV tk 
mRNA and thymidine kinase activity, however, were con-
sistently present not only in male and female liver but also in 
testis and in preputial glands. 
The expected size of a transcript running from the BS6 cap 
site to the ik polyadenylation site is 1.3 kb. An RNA of this 
size was detected in male liver RNA from four of five lines, 
in testis RNA of five of five lines, and in male preputial gland 
RNA of four of five lines. The amount of this RNA is lowest 
in liver and highest in testis (Fig. 2). Each tissue contains it 
second smaller RNA that reacts with the tk probe to the 
same (testis) or a lesser (liver, preputial gland) extent than 
the 1.3-kb RNA. The smaller liver and testis RNAs are about 
0.9 kb, and the preputial gland RNA is about 1 kb in size. 
Figure 2 was obtained after hybridization with probe tk-A 
(Fig. 1), which spans the entire HSV tk mRNA and the 
3'-flanking region. When blots were hybridized with the 
shorter probe 1k-B, which corresponds to the 5' end of the 
HSV tk mRNA, the signal strength of the shorter liver and 
testis RNAs was less relative to the 1.3-kb RNA. This i ~ 
consistent with transcriptional initiation of these RNA 
downstream of the cap site, a phenomenon previously ob-
served in cell lines carrying integrated HSV ik genes (47). 
The lengths of the smaller RNAs and their signal intensitie' 
relative to the 1.3-kb RNA. are consistent within each 
transgenic line. No RNA that reacted with the HSV tk probe 
was detected in male lachrymal gland, salivary gland. 
spleen, heart, kidney, muscle, or brain. 
The five transgenic lines were compared more intensively 
by means of thymidine kinase assays (Table 2). Tissues of 
three G 0 males were also examined in this way. In our hands 
the addition of 0.4 mM TTP to the assay (29) inhibited 
endogenous thymidine kinase activities in different tissues  
by 93 to 97, and the residual endogenous activity in each 
tissue was quite consistent. The same amount of TIP 
inhibited HSV thymidine kinase by about 509, so that even 
relatively low levels could be measured quite accurately. In 
most cases in which both mRNA determinations and enzyme 
activity measurements were made, the two were in broad 
agreement. Exceptions were the detection of low enzyme 
levels but no mRNA in line 64 female liver (see Table 4) and 
line 58 lachrymal gland (Table 2). In particular, the enzyme 
assays confirmed the expression of the foreign gene in the 
liver of four of five lines and, at higher levels, in the preputial 
glands of four of five lines and testes of all five lines (Table 
3). 
If the .cupF gene which is incorporated at the 3' end of the 
hybrid gene were contributing to the expression pattern of 
the gene, its usefulness would be seriously reduced. To 
examine this possibility, the BSO-tk-M hybrid gene, which 
lacks the supF DNA fragment (Fig. 1), was also introduced 
into mice. Five transgenic G0 animals were obtained, and 
two transgenic lines were established from G  females. 
Thymidine kinase assays again showed expression in liver 
and higher expression in testis and preputial gland (Table 2). 
The similarity of these results to those obtained with the 
construct which contains .s-upF indicates that the supE gene 
does not influence the expression of this hybrid gene. 
Two features of the expression of the foreign gene are line 
specific. (i) Sporadic or occasional expression: we observed 
thymidine kinase expression in the lachrymal gland of one of 
four lines tested, and the absence of preputial gland expres-
sion in one of five lines and of liver expression in one of five 
lines (Table 2). (ii) Relative levels of expression: the relative 
levels of expression in different tissues are also line specific 
(Table 3). With the exception of lines 58 and 78, each line 
shows a different expression pattern. Line-specific features 
of expression in transgenics most probably relate to the 
different chromosomal integration events which characterize 
the different lines. 
Sexually diniorphic expression of the BS6 -tk hybrid gene. In 
three of five transgenic lines, male liver showed higher levels 
-4 




I of It 
I It 	ll\ i,, kN,\ ii 	 Hi 	II 1eunI 	House. Total 
cellular RNA from tissues of an adult male mouse of line 46 was 
applied to the gel. 30 p.g to each track except for 10 ig of preputial 
gland RNA. The filter was hybridized with probe A and exposed for 
(A) 24 hand (B and C) 3 days. B and C are two printings of the 3-day 
exposure. SVEPtk. RNA from BHKtk - cells stably transformed 
with a plasmid containing HSV ik linked directly to the SV40 
enhancer-early promoter region: —ye liver, nontransgenic liver 
RNA. 
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G0 ' 	Total" Mean activity' Lines" 
Transgenic (BS6-zk-M) 
G0 ' 	 Total Mean activity ' 
Controls": mean 
activity ± S.E. 
(no. of mice assayed) 
Liver 4/5 2/3 6/8 3.8 2/2 1/1 3/3 0.8 0.015 ± 0.007 (12) 
Preputial gland 4/5 2/3 6/8 25 2/2 1/1 3/3 79 0.103 ± 0.033 (10) 
Testis 5/5 2/3 7/8 64 2/2 1/1 3/3 119 0.069 ± 0.028 (8) 
Lachrymal gland 1/3 0/1 1/4 2.1 0/1 ND 0/1 0.023 ± 0.008(4) 
Salivary gland 0/3 0/1 0/4 0/1 ND 0/1 0.008 ± 0.003 (6) 
Brain 0/3 0/3 0/6 0/1 ND 0/1 0.270 ± 0.029 (10) 
Kidney 015 0/2 0/7 0/1 0/1 0/2 0.051 ± 0.012 (21) 
Muscle 0/3 ND 0/3 0/1 ND 0/1 0.009 ± 0.002 (4) 
" Nontransgenic liltermates. 
" Lines founded from G0 females; lines positive/lines tested. 
'G0 males, individuals positive/individuals tested. ND. Not determined. 
d  One 6,, male showed no activity in any tissue. 
Thymidine kinase activity, units per milligram of protein, mean of line means and G0 values (positive lines and G0s only), not weighted for numbers of 
determinations per line mean. Among the G males there are potential mosaics, which will depress the average values. Zero values were not significantly different 
from endogenous values measured under the same conditions. 
of HSV thymidine kinase activity than female liver (Table 4). 
The two exceptions were line 40, which shows no activity in 
liver of either sex, and line 64, in which male and female liver 
have similar activity levels. Of the three lines with sexually 
dimorphic HSV ik activity, the male-to-female ratio of line 
46 was about 10, while the ratio in lines 58 and 78 was about 
4. These ratios compare with a ratio of 5 to 10 in liver MUP 
mRNA levels (23: McIntosh and Bishop, in preparation). 
As noted above, HSV tk RNA was present in male liver 
RNA of four of five lines (lines 46. 58, 64. and 78). HSV ik 
RNA was detected in liver of line 58 females but not in liver 
of line 46 or 64 females, presumably because of the low 
levels of RNA present. (Line 78 females have not been 
examined.) 
The different levels of MUP mRNA in male and female 
liver reflect different transcription rates (18). It was therefore 
of interest to determine by run-on transcription measure-
ments whether the different expression levels of the trans-
gene in males and females are also due to differential 
transcription. The experiments were controlled by simulta-
neously measuring the run-on transcription of the group 1 
Mup genes and also of the apolipoprotein Al genes, which 
do not show sexually dimorphic expression (T. Spiegelberg 
and J. 0. Bishop, unpublished data). The results (Fig. 3 and 
Table 5) support the hypothesis that the levels of HSV 
thymidine kinase activity in liver of male and female trans-
genics reflect different rates of transcription in the two sexes. 
In line 40, which has no thymidine kinase activity in the liver 
of either sex, no HSV ik transcription was detected. In line 
46, which has thymidine kinase activity in the livers of both 
TABLE 3. I-ISV thymidine kinase activities in male 
tissues of transgenic mouse lines 
Copy Thymidine kinase" in tissue Line no. Liver Preputial gland Testis 
40 10 0.05 ± 0.04 (4) 12.0 ± 0.39 (2) 140 ± 6.7 (3) 
46 80 1.9 ± 0.32 (8) 83.1 ± 19.9 (2) 139 ± 17.6 (3) 
58 3 5.82 ± 1.15 (3) 9.9 ± 2.6 (3) 31 ± 10.5 (3) 
64 2 1.52 ± 0.71 (2) 0.04 ± 0.03 (2) 48 ± 6.0 (2) 
78 1 12.73 ± 1.85 (3) 32.1 ± 5.3 (3) 62 ± 8.4 (3) 
" Approximate. 
" Units per milligram of protein; means and standard errors. Parentheses 
indicate n.  
sexes, but at a much lower level in females, transcription 
was detected in male but not female liver nuclei. In lines 58 
and 78, which have a male/female liver thymidine kinase 
activity ratio of about 4, the male/female run-on transcrip-
tion ratios were 6.5 and 2.5. respectively. Line 46 contains 
about 80 tandemly arranged copies of the hybrid gene per 
cell, while lines 58 and 78 contain about 3 and 1 copies, 
respectively (Table 3). Transcription rate, in common with 
enzymatic activity, is clearly independent of copy number. 
The Mup gene target sequence used in these experiments 
is expected to react with all of the group 1 Mup gene 
transcripts. Our best estimate of the level of expression of 
BS6 is that it accounts for 25% or less of total Mup gene 
mRNA in male liver (McIntosh and Bishop, in preparation). 
By an independent estimate based on cDNA cloning fre-
quency. an mRNA identical to BS6 mRNA has been shown 
to be very abundant in male liver mRNA (51). In the male 
transgenics the rate of run-on transcription of HSV 1k is 
about 15% as high as that of all of the Mup genes taken 
together (Table 5). We recall that a proportion of the liver 
HSV tk mRNA is unexpectedly small in size (Fig. 2). How 
much of the primary transcript corresponds to this smaller 
mRNA is not known, and consequently a rigorous quantita-
tive interpretation of the run-on data is not possible at this 
time. However, they do suggest that the rate of transcription 
of the hybrid gene in line 58 and line 78 liver is comparable 
to that of the endogenous BS6 gene. 
Testosterone induction of HSV thymidine kinase activity. 
We have observed considerable variation in expression 
between individuals within each transgenic line (see stan- 
TABLE 4. Sexually dimorphic expression of HSV thymidine 
kinase in liver of transgenic mouse lines 
Enzyme activity" 	 t test " Line 	
Male 	 Female 	 (P) 
40 	0.05 ± 0.04 (4) 0 (3) 
46 1.9 ± 0.32 (8) 0.17 ± 0.16 (8) 	<0.001 
58 	5.82 ± 1.15 (3) 1.49 ± 0.1 (2) <0.1 
64 1.52 ± 0.71 (2) 2.35 ± 0.32 (2) 
78 	12.73 ± 1.85 (3) 2.80 ± 0.59 (3) 	<0.01 
Units per milligram of protein: means and standard errors. Parentheses 
indicate ,,. 
" Probability that male and female samples are drawn from the same 
population. 
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TABLE 5. Run-on transcription of BS6-ik and Mop genes in 	 A 	 B 
transgenic liver 	
- 	 Fl 	F2 	13 	Fl 	12 	F3 
Transcription rate" Thymidine kinase activity5 
Line 
Male Female 	M/F Male Female M/F 
40 0 0 0 0 
46 0.15 0 1.9 0.17 10.1 
58 0.13 0.02 	6.5 5.8 1.5 3.8 
78 0.2 0.08 2.5 12.7 2.8 4.3 
" The data are based on densitometer readings of autoradiographs. Each 
value is the ratio of the HSV ik measurement to the Map measurement 
obtained from male liver nuclei in the same experiment. Variation within and 
between experiments was compensated by normalizing the other measure-
ments to the run-on value observed for apolipoprotein Al with RNA from the 
same incubation of nuclei. 
Average thymidine kinase activity measurements from Table 4. 
dard errors in Tables 3 and 4), which could complicate the 
interpretation of testosterone induction experiments. For 
this reason the induction experiments were carried out with 
females of line 46. which consistently show very low HSV 
thymidine kinase activity in the liver (Table 4). Testosterone 
pellets were implanted subcutaneously 12 to 14 days before 
the livers were analyzed. Control transgenic littermates were 
sham-operated at the same time. Testosterone treatment did 
not elicit any change in thymidine kinase activity in non-
transgenic female liver. The results (Fig. 4A) clearly show 
that HSV thymidine kinase activity is induced by testoste-
rone. Northern blot analysis of mRNA from induced and 
noninduced female liver showed induction of HSV 1k RNA 
levels (Fig. 413). 
Liver I-ISV thymidine kinase activity in the induced fe-
males was on average 37% of the level in noninduced males, 
whereas in normal females MUP is induced to male levels 
(14. 58). This difference may relate to the very low HSV 
thymidine kinase levels in livers of noninduced line 46 
females. For example, if. like the a,-globulin genes (36). 
Mup genes are repressed by estrogen, the hybrid genes in 
line 46 may be more sensitive to estrogen repression. Other 
explanations are of course possible. The results, however. 
do show clearly that in line 46 the expression of the hybrid 
gene is induced by testosterone. 
Sterility of male transgenic mice that carry the BS6-tk 
hybrid gene. Three of five BS6-tk-supF G o males and two of 
three BS6-ik-M G 0 males were sterile. None of the fertile G0 
males transmitted the hybrid gene to their offspring. In 
addition, in seven of seven transgenic lines the males were 
invariably sterile. Two exceptional mice, one from line 58 
t  
	
MUP • 	4 	I 
pUC8 
LPAI • 	• 
Ml 	Fl 	M2 
FIG. 3. SeX diffeicnec in run-on transcription rate of the BS6-ik 
hybrid gene in transgenic liver. Ml. Transgenic male: Fl, transgenic 
female: M2, nontransgenic male. Immobilized target sequences: tk, 





II 	12 	13 	Ml 	ml- 
FIG. 4. Induction of the expression of the BS6-:k hybrid gene in 
line 46 female liver. (A) HSV thymidine kinase levels. Fl, Transge-
nic females, testosterone induced: F2, transgenic females, sham 
operated: F3, nontransgenic females, testosterone induced: Ml. 
transgenic males; M2. nontransgenic males. Thymidine kinase is 
expressed as picomoles of TMP formed per minute per milligram of 
soluble protein. (B) HSV ik RNA and MUP mRNA. Poly(A) RNA 
was partially purified by treating liver RNA with Hybond-mAP 
(Amersham), and 30 .i.g was applied to each track. The filter was (1) 
hybridized with probe B and then (2) stripped and rehybridized with 
group 1 MUP cDNA probe MUP11. Fl, Transgenic females, 
testosterone induced: F2. transgenic females. sham operated; F3, 
nontransgenic females, testosterone induced. 
and one from a BS6-rk-M line, each sired a single offspring of 
unknown transgenic status. No further offspring were sired 
despite repeated mating. These mice, and also all the com-
pletely sterile mice tested, plugged females in the normal 
way. The female transgenics exhibited normal fertility. 
While no HSV thymidine kinase was detected in ovaries 
(data not shown), expression in the follicles themselves 
would be obscured by the large excess of nongerminal 
tissue. The transgenic males have reduced sperm counts, 
and most of the spermatozoa are structurally abnormal to 
varying degrees. Thus sperm maturation seems to be im-
paired rather than absolutely blocked, and this is confirmed 
by the two offspring sired. 
DISCUSSION 
Consistent tissue-specific expression and sexual dimor-
phism. We have shown that a 2.2-kb group 1 Mup gene 
promoter region and cap site consistently direct synthesis of 
the HSV 1k reporter gene to the liver, preputial gland, and 
testis. Expression in the liver mirrors the expression of the 
endogenous group 1 Mup genes; three of four lines showed 
differential expression in males and females, and when 
females of one of the lines were treated with testosterone, 
elevated levels of both HSV tk RNA and thymidine kinase 
activity resulted. Thus many or all of the cis-acting signals 
necessary for correct Mup expression in the liver appear to 
be present within the 2.2-kb promoter fragment. Run-on 
experiments showed that the different levels of HSV 1k RNA 
and thymidine kinase activity in males and females are due at 
least in part to different rates of transcription. By analogy 
with the mechanism of action of other steroid hormones (61), 
the data suggest that testosterone, through its receptor, is 
acting on sequences within the 2.2-kb BS6 promoter region 
to increase transcription. As yet it is not known whether the 
cis-acting signals responsible for the effects of thyroxine and 
growth hormone on MUP RNA synthesis in the liver (33, 54) 
are also present. 
In the livers of lines 58 and 78, both of which carry a small 
number of foreign genes, the rate of HSV 1k transcription 
4826 	AL-SHAWl ET AL. 	 MOL. CELL. BIOL. 
seems to be comparable to that of it Map gene. The steady-
state level of HSV tk RNA, although not measured with 
accuracy, is known to be very much less than that of MUP 
RNA, implying that the stability of the HSV tk RNA is less 
or that its processing is defective. The low HSV ik RNA 
content of liver is reflected in low levels of HSV thyrnidine 
kinase protein. In line 78 liver, the most highly expressing, 
the thymidine kinase (having allowed for TTP inhibition) 
forms about 25 pmol ofTMP per min per mg of soluble liver 
protein. Taking the soluble protein content of a liver to be 
100 mg and the specific activity of purified HSV thymidine 
kinase as 67 nmol of TMP formed per min per mg (8). the 
total amount of HSV thymidine kinase protein in the liver is 
about 0.04 mg. This may be compared with a MUP produc-
tion rate of 10 mg per male mouse per day (58). 
Consistent misexpression. It is frequently found that a 
foreign gene is correctly expressed in transgenic mice, 
sometimes to the extent that the timing of expression is 
correct (for example, see references 1. 22. 34, 40, 46. and 
57). Misexpression is most often observed with hybrid genes 
like the BS6-tk fusion gene described here. So long as 
misexpression is consistent, its study can lead to insights 
into mechanisms of gene regulation. Also, insight into mis-
expression is important in relation to attempts to direct the 
synthesis of proteins to novel tissues for commercial pur-
poses (21, 53). 
The consistent expression of the BS6-M gene in preputial 
gland and testis is unexpected, since the Mup genes are not 
expressed in either tissue. While the level of expression both 
of RNA and of thyrnidine kinase activity in both tissues is 
higher, sometimes much higher, than in liver, we have not 
measured transcription rates in these tissues, and the differ-
ences may be due to RNA processing or stability differences 
rather than to transcription rates themselves. 
Consistent misexpression of foreign genes has been ob-
served before (2, 4, 38, 42, 45, 56). If, as seems likely, it is 
due to changes in transcriptional behavior rather than in-
creased RNA stability, it may be explained in either of two 
ways. Either (i) the hybrid gene lacks (is-acting "silencer" 
sequences which are required for repression of the endoge-
nous gene in preputial gland and testis and which are located 
outside the 2.2-kb promoter region, or (ii) it contains newly 
created sequences or a new combination of sequences which 
activate its transcription in these tissues (56). We are pres-
ently attempting to distinguish between these alternatives. 
The c,-gIobulins, the rat homologs of the Mup genes, 
show a similar pattern of gene expression (37. 39). A clear 
difference in the expression of the rat and mouse genes. 
however, is thata,,,-globulin is expressed at a high level in 
male and female preputial gland. while Mup is not expressed 
in the preputial gland (24. 39). However, ana,,-globulin 
gene is expressed as a foreign gene in the preputial glands of 
transgenic mice (16). One interpretation of this observation 
is that the natural rat gene lacks a silencer sequence which is 
present in the mouse genes. resulting in its expression in 
mouse preputial glands despite the presence in the mouse 
tissue of the corresponding trans-acting repressor protein 
(16). The BS6ik hybrid gene was consistently expressed not 
only in male and female preputial glands but also in testis. If 
misexpression in preputial gland and testis were due to the 
same cause, we might expect there to he a,,,-globulin expres-
sion in rat testis. However, no c2 1-globulin niRNA could he 
detected by Northern blotting (data not shown). Appropriate 
controls showed that the testis RNA used in this experiment 
was not degraded. This observation suggests either that the 
misexpression of the hybrid Map gene in preputial gland and  
testis has different causes, or else, if there is a common 
cause, that it is independent of the causes of a,-globulin 
expression in rat and mouse preputial glands. Two observa-
tions suggest that different causes bring about the misexpres-
sion of the hybrid gene in the preputial gland and testis. 
First, expression in the testis occurs in a transgenic line with 
no preputial gland expression. Second, the smaller preputial 
gland and testis RNAs differ from each other in size and in 
their hybridization to different probes. 
Despite some variability between mice within each trans-
genic line, the pattern of expression levels in liver, preputial 
gland. and testis is line specific. Line-specific effects are 
assumed to he clue to the uniqueness of different chromo-
somal integration events. These events differ in several 
ways. Different sites may contain different numbers and 
different arrangements (head-to-head, head-to-tail, tail-to-
tail) and rearrangements of the integrated foreign genes. In 
addition, flanking DNA sequences at different chromosomal 
sites of integration are thought possibly to influence tran-
scription of the foreign genes through 'position effects...In 
the present case no correlation has been detected between 
copy number and expression in any tissue (Table 3), a 
common observation in transgenics (17. 44). The question of 
whether the different patterns of expression are due to 
arrangements, rearrangements, or position effects has not 
been addressed. Lines 58. 64, and 78, all of which contain a 
small number of integrated gene copies, provide convenient 
models with which to distinguish these causes. 
Transgenic male sterility is due to HSV thymidine kinase 
activity in the testis. All of the established lines show both 
consistent male sterility and a high level of HSV thymidine 
kinase in the testis. In contrast, line 40 shows no liver HSV 
thymidine kinase activity and line 64 shows no preputial 
gland HSV thymidine kinase activity, although both lines are 
consistently male sterile. Thus testis expression of HSV 
thymidine kinase is the likely cause of male sterility, and 
both liver and preputial gland expression can be ruled out as 
the sole cause. 
Minor exceptions to the sterility of transgenic males were 
observed. First, three G 0 males (two carrying BS6-tk-s11pF 
and one with BS6-tk-M) sired offspring, none of which were 
transgenic. G 0 male 79 had no testis HSV thymidine kinase 
activity, and indeed showed no thymidine kinase activity in 
any tissue. This male presumably carried transcriptionally 
inert copies of the hybrid gene and in addition was a mosaic 
with nontransgenic germ cells. G 0 male 66 had a very low 
level of testis HSV thymidine kinase activity (60% over the 
endogenous level, after discounting TTP inhibition). This 
male may he explained in either of two ways. He may have 
had a mosaic germ line, with the implication that germ cells 
carrying the transgene were ineffectual or possibly very few 
in number. Alternatively, he may have had it nontransgenic 
germ line, carrying the active hybrid gene in testicular 
somatic tissue. Expression in the third G 0 male, which 
carries BS6-t?-M, has not yet been examined. Secondly. 2 
G 1 transgenic males, out of 21 G 1 and G, males tested, each 
sired a single offspring, but although repeatedly mated 
thereafter failed to sire more. This shows that the sterile 
males form some functional sperm. The mice are oligosper-
mic rather than aspermic. 
Some lines of mice transgenic for HSV tk linked to the 
mouse mammary tumor virus long terminal repeat express 
HSV thymidine kinase in the testis (48) and are also sterile 
(S. Ross and D. Softer. personal communication). However, 
at least one fertile mouse line which expresses HSV thymi-
dine kinase in the testis has been reported (32). In this case 
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the HSV 1k gene was under the control of its natural 
promoter. Thus expression of HSV thyniidine kinase in the 
testis does not invariably lead to sterility. One possible 
explanation is that lower expression levels do not cause 
sterility; the HSV thymidine kinase activity level in the 
fertile line is about 3 times the endogenous level (32). 
whereas the lowest level among our sterile lines (line 58) is 
about 12 times the endogenous level. However, since the 
testis contains several cell types with different functions and 
since sperm differentiation is a slow process accompanied by 
changes in both the germ cells and accessory cells (60), an 
alternative explanation is that sterility is linked to expression 
in particular cell types or at particular developmental stages. 
This explanation is especially plausible because HSV tA 
expression is under the control of different promoters in the 
different experiments. Furthermore, the expression of the 
mouse mammary tumor virus tA hybrid gene which confers 
sterility may, like that of BS6-tk, be induced by testosterone 
(7. 15). 
Given that sterility is due to HSV thymidine kinase 
expression in one or more testis cell types, there are several 
ways in which the enzyme could have its effect. First, its 
substrate specificity is different from that of the cellular 
enzyme, and it efficiently phosphorylates deoxycytidine 
(28). Second, the high levels of phosphorylated deoxynu-
cleosides produced by high levels of the enzyme will inhibit 
the normal pathway of pyrimidine phosphate metabolism 
(30). Third. HSV thymidine kinase may be active at times in 
the cell cycle when the cellular enzyme is normally re-
pressed (26. 41, 55). Any of these could perturb cellular 
metabolism, primarily of nucleic acid precursors, but with 
secondary effects on related pathways. Transgenic mice 
expressing a mutant form of dihydrofolate reductase. which 
is also involved in pyrimidine metabolism, show reduced 
growth, reduced female fertility, and morphological defects 
(20). 
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Unusual aberrant expression of a foreign gene in a particular transgenic mouse line is often attributed to 
chromosomal position effect, although proof of this is lacking. An alternative explanation 
is that expression has 
been modified by the arrangement of multiple copies of the foreign gene at the insertion site or by mutation or 
gene rearrangement. We have distinguished between these explanations in the case of one particular transgenic 
line by recovering the aberrantly expressed foreign DNA and reintroducing it into the mouse genome to 
produce secondary transgenic mice. The expression pattern of the gene in the secondary transgeniC mice was 
normal, showing that this case of aberrant expression is due to a chromosomal position effect. 
insertion site (1, 2, and 3 copies respectively). One of these 
lines (line 64) has negligible HSV TK activity in the preputial 
gland. The expression pattern of line 64 mice has been the 
same for four generations of outcrossing. Here we report 
experiments exploring the cause of the aberrant preputial 
gland expression in line 64. 
The foreign DNA inserted into the chromosome of a 
transgenic line is the result of a unique set of molecular 
events that occur in the pronucleus after microinjection. A 
small set of foreign DNA molecules (effectively two in the 
case of line 64) is joined together and becomes integrated 
into a site on a single chromosome. In principle, unusual 
expression of the foreign DNA may be due to either of two 
sorts of effects. One class of possible effects relates to the 
foreign DNA itself: these include point mutation, damage 
due to breakage and rejoining, and effects due to the prox-
imity and juxtaposition of more than one copy of the foreign 
DNA fragment. A second class of possible effects relates to 
the chromosomal environment into which the DNA has been 
inserted: regions of the same chromosome, which may be 
close to or far from the insertion site, may modulate the 
expression of the gene, perhaps in the way that enhancers 
modulate promoter activity or possibly in other ways. This 
second class has been called chromosomal position effect. 
To distinguish between the two classes of effects, one a 
property of the foreign DNA itself and the other a property 
of the chromosome in the neighborhood of the foreign DNA, 
we recovered the foreign genes from line 64 DNA by 
molecular cloning and reintroduced them by embryo pronu-
clear microinjection into the genome of mice. We refer to 
first cycle transgenic animals such as line 64 mice as primary 
transgenic mice and to transgenic mice produced in the 
second cycle as secondary transgenic mice. If the arrange-
ment of the DNA at the insertion site of the primary 
transgenic animal is the cause of its unusual expression, we 
would expect to observe the same expression pattern, i.e., a 
lack of expression in the preputial glands, in the secondary 
transgenic mice. If, on the other hand, the unusual expres-
sion is due to a chromosomal position effect, then the 
expression pattern of the secondary transgenic mice should 
be the same, in general, as that of primary transgenic mice, 
i.e., with expression occurring in the preputial glands in 
most cases. The results show that the lack of expression in 
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To date, most transgenic mice have been produced by 
embryo pronuclear microinjection. As far as is known, the 
foreign DNA is integrated into the chromosomes at random. 
Integration usually occurs at only one chromosomal site in a 
given embryo, but the number of copies of the input DNA 
that become integrated varies from one to hundreds (see, for 
example. Lacy et al. 122]). When integration occurs at more 
than one site, the different sites can be segregated from each 
other by mating the founder (G 0) animal to nontransgenic 
mice. A set of related mice all of which carry the same 
configuration of foreign DNA at the same integration site is 
a transgeflic line. 
Several studies have demonstrated that in transgenic mice 
derived from different microinjected embryos, the same 
foreign gene is expressed to different degrees. Although the 
number of copies of the foreign gene varies greatly from one 
integration site to another, there is no general relationship 
between copy number and level of expression (9, 17, 23). 
When the foreign gene is expressed in more than one tissue, 
variation in expression may confer on the mice different 
patterns of tissue-specific expression. 
Because there is considerable variation in expression 
between individual mice, comparisons are most convincing 
when transgenic lines are established. By measuring expres-
sion levels in several individuals of a line, environmental 
variation and variation due to genetic background is can-
celed out. We previously reported results obtained in this 
way (1). The DNA fragment that we introduced into the 
mouse genome consists of a 2.2-kilobase-pair (kb) major 
urinary protein (MUP) gene promoter and 5'-flanking region 
linked to the herpesvirus 1 (HSV) thymidine kinase (TK) 
gene coding region. At its 3' end, beyond the HSV TK gene 
polyadenylation site, the DNA fragment carries a copy of the 
bacterial SupF gene. In four of five transgenic lines, HSV 
TK activity and HSV TK mRNA are present in the liver, the 
tissue in which the endogenous MUP gene promoter is 
active. However, four lines have high levels of HSV TK 
activity in the preputial gland, and all five have high levels in 
the testis. Three of the lines are of particular value because 
each has a small number of foreign DNA sequences at the 
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TABLE 2. Expression of the BS6 TK-SupF hybrid gene 
in tissues of second-generation secondary 
transgenic male mouse lines 
G, no. 
TK activity (pmol/min per mg of protein) 
Testis 	Preputial gland Liver 
A49.1 121 	 47.2 0.82 
B65.2 387 251 27.1 
B56.5 0.74 	 40.4 0.00 
B56.11 0.82 56.3 0.02 
B56.9 3.74 	 28.3 0.06 
secondary transgenic mice, the levels of expression in the 
three tissues varied independently of each other. TK activity 
levels were determined in five other tissues, lachrymal 
gland, submaxillary gland, brain, skeletal muscle, and kid-
neys. As in the case of the primary transgenic mice (1). the 
TK activities in these tissues were very low and indistin-
guishable from those observed with control nontransgenic 
mice (data not shown). 
Structures of the foreign DNA in the secondary transgenic 
mice. As an alternative, the loss and subsequent recovery of 
peputial gland expression might be explained by DNA 
rearrangement. If the particular arrangement of the genes in 
line 64 caused the loss of expression, for example by 
interactions between the two genes, then expression might 
be recovered in the secondary transgenic mice if the genes 
became rearranged in such a way as to reverse the original 
effect. 
It is inherently unlikely that an appropriate rearrangement 
would have occurred in all of the nine secondary transgenic 
mice examined (Tables 1 and 2). However, it is necessary to 
show that this DNA fragment does not undergo a consistent 
rearrangement and also to demonstrate that the secondary 
transgenic mice carry the intended DNA fragment. The 
organization of the DNA in several secondary transgenic 
mice was therefore examined by Southern blot analysis, 
using as a probe a fragment of the HSV TK gene. Digestion 
with Sstl released from line 64 DNA four fragments that 
hybridized with the probe. Two of these were 2.2 kb in size. 
and the others were 2.6 and 2.8 kb. Digestion with BglII  
released probe-positive fragments of 4.9 and 5.5 kb (Fig. 
3A). The presence of SstI or BgIlI fragments of other sizes 
would indicate that rearrangements had occurred, the most 
likely of which is a junction between the foreign DNA and 
the chromosomal DNA of the secondary transgenic animal. 
The DNA of four G 1, secondary transgenic mice was exam-
ined after separate digestion with Ssil and Bg1IL. In each 
case the predominant hybridizing bands were the expected 
bands (Fig. 3A), showing that most of the foreign DNA 
fragments were not rearranged in a way that disturbed these 
patterns. The BgIlI digests of DNA samples A17 and B27 
each showed an additional faint hybridizing band (Fig. 3B). 
These bands probably represent junction fragments between 
chromosomal DNA and the foreign DNA insert. 
The lambda 2.1 recombinant contains a single Hind III site. 
If the DNA in the secondary transgenic lines takes the usual 
form of a direct tandem array, digestion with HindLIl will 
produce mainly unit-size HSV TK-positive fragments. In 
addition, each insertional array will have a flanking junc-
tional fragment of a different length at each end. In most 
cases, such fragments may be expected to hybridize with the 
probe. The same is true of lambda 1.2, which has two 
Hindill sites close together, except that the predominant 
fragment will be shorter than unit length by an amount equal 
to the 0.8-kb length of DNA between the two Hindill sites. 
The DNA of three secondary transgenic mice was examined 
after Hindu! digestion. In each case, the expected band was 
present (Fig. 313 and data not shown). 
Male descendants of secondary transgenic females. The five 
primary transgenic lines that carry the BS6 TK-SupF hybrid 
gene are all male sterile, and the founder in each case was a 
transgenic female (1). All of the male transgenic mice in each 
of the primary lines inherit their foreign genes from the 
mother, and it is therefore possible that the foreign gene 
insert in line 64 is genetically imprinted (15. 25, 29, 37) during 
female germ line maturation. If so, the property of being 
imprinted must be peculiar to the insertion of foreign DNA in 
line 64, since the foreign gene is expressed in the preputial 
glands of the other primary transgenic lines. Imprinting, if it 
occurs, might be due either to a chromosomal position effect 
or to the arrangement of the foreign DNA at the insertion 
site. In either case, the secondary transgenic G o males would 
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FIG. 3. Southern blot analysis of G, ) secondary transgenic mice. (A)SsfI and BglII digests. Lanes: 1, lambda 2.1 X SstI (five-copy marker): 
2, A6 x  SsiI; 3, A6 x BgIIl; 4, A17 X SsII: 5, A17 x BglIl: 6, B27 X Ssil; 7. B27 x BglIl; 8, B50 x Sstl: 9. B50 )< BglIl; 10. lambda 2.1 
x BgIII (five-copy marker): 11. lambda 2.1 x Smal (five-copy marker): 12, kilobase size ladder (Bethesda Research Laboratories). (B) Lanes: 
1. A17 x Sstl: 2.A17 x Bg/lI: 3. A17 x Hindlll: 4, B27 x Svil.5. B27 '< BgIll.  
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Unusual aberrant expression of a foreign gene in a particular transgenic mouse line is often attributed to 
chromosomal position effect, although proof of this is lacking. An alternative explanation is that expression has 
been modified by the arrangement of multiple copies of the foreign gene at the insertion site or by mutation or 
gene rearrangement. We have distinguished between these explanations in the case of one particular transgenic 
line by recovering the aberrantly expressed foreign DNA and reintroducing it into the mouse genome to 
produce secondary fransgenic mice. The expression pattern of the gene in the secondary transgenic mice was 
normal, showing that this case of aberrant expression is due to a chromosomal position effect. 
To date, most transgenic mice have been produced by 
embryo pronuclear microinjection. As far as is known, the 
foreign DNA is integrated into the chromosomes at random. 
Integration usually occurs at only one chromosomal site in a 
given embryo, but the number of copies of the input DNA 
that become integrated varies from one to hundreds (see. for 
example. Lacy et al. [221). When integration occurs at more 
than one site, the different sites can be segregated from each 
other by mating the founder (G 0) animal to nontransgenic 
mice. A set of related mice all of which carry the same 
configuration of foreign DNA at the same integration site is 
a transgenic line. 
Several studies have demonstrated that in transgenic mice 
derived from different microinjected embryos, the same 
foreign gene is expressed to different degrees. Although the 
number of copies of the foreign gene varies greatly from one 
integration site to another, there is no general relationship 
between copy number and level of expression (9, 17, 23). 
When the foreign gene is expressed in more than one tissue, 
variation in expression may confer on the mice different 
patterns of tissue-specific expression. 
Because there is considerable variation in expression 
between individual mice, comparisons are most convincing 
when transgenic lines are established. By measuring expres-
sion levels in several individuals of a line, environmental 
variation and variation due to genetic background is can-
celed out. We previously reported results obtained in this 
way (1). The DNA fragment that we introduced into the 
mouse genome consists of a 2.2-kilobase-pair (kb) major 
urinary protein (MUP) gene promoter and 5'-flanking region 
linked to the herpesvirus 1 (HSV) thymidine kinase (TK) 
gene coding region. At its 3' end, beyond the HSV TK gene 
polyadenylation site, the DNA fragment carries a copy of the 
bacterial SupF gene. In four of five transgenic lines, HSV 
TK activity and HSV TK mRNA are present in the liver, the 
tissue in which the endogenous MUP gene promoter is 
active. However, four lines have high levels of HSV TK 
activity in the preputial gland, and all five have high levels in 
the testis. Three of the lines are of particular value because 
each has a small number of foreign DNA sequences at the 
' Corresponding author. 
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insertion site (1, 2, and 3 copies respectively). One of these 
lines (line 64) has negligible HSV TK activity in the preputial 
gland. The expression pattern of line 64 mice has been the 
same for four generations of outcrossing. Here we report 
experiments exploring the cause of the aberrant preputial 
gland expression in line 64. 
The foreign DNA inserted into the chromosome of a 
transgenic line is the result of a unique set of molecular 
events that occur in the pronucleus after microinjection. A 
small set of foreign DNA molecules (effectively two in the 
case of line 64) is joined together and becomes integrated 
into a site on a single chromosome. In principle, unusual 
expression of the foreign DNA may be due to either of two 
sorts of effects. One class of possible effects relates to the 
foreign DNA itself: these include point mutation, damage 
due to breakage and rejoining, and effects due to the prox-
imity and juxtaposition of more than one copy of the foreign 
DNA fragment. A second class of possible effects relates to 
the chromosomal environment into which the DNA has been 
inserted; regions of the same chromosome, which may be 
close to or far from the insertion site, may modulate the 
expression of the gene, perhaps in the way that enhancers 
modulate promoter activity or possibly in other ways. This 
second class has been called chromosomal position effect. 
To distinguish between the two classes of effects, one a 
property of the foreign DNA itself and the other a property 
of the chromosome in the neighborhood of the foreign DNA, 
we recovered the foreign genes from line 64 DNA by 
molecular cloning and reintroduced them by embryo pronu-
clear microinjection into the genome of mice. We refer to 
first cycle transgenic animals such as line 64 mice as primary 
transgenic mice and to transgenic mice produced in the 
second cycle as secondary transgenic mice. If the arrange-
ment of the DNA at the insertion site of the primary 
transgenic animal is the cause of its unusual expression, we 
would expect to observe the same expression pattern, i.e., a 
lack of expression in the preputial glands, in the secondary 
transgenic mice. If, on the other hand, the unusual expres-
sion is due to a chromosomal position effect, then the 
expression pattern of the secondary transgenic mice should 
be the same, in general, as that of primary transgenic mice, 
i.e., with expression occurring in the preputial glands in 
most cases. The results show that the lack of expression in 
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MATERIALS AND METHODS 
Transgenic mice and TK assays. Transgenic mice were 
produced by pronuclear microinjection as described previ-
ously (1). The same report contains a description of the TK 
assay procedure. Trans.gnic mice were routinely identified 
by the oQlymerase chain reaQtj.an .g.tijLPNA as the 
template and 	for the Supfgene. 
Recovery of the foreign gene insertion from line 64 DNA. 
High-molecular-weight DNA was prepared from a crude 
preparation of liver nuclei by standard sodium dodecyl 
sulfate- proteinase K extraction and deproteinization. A 200-
p.g sample of DNA was partially digested with Mboi and 
fractionated on a 10 to 40% sucrose density gradient. Frac-
tions containing 15- to 25-kb fragments were identified by 
agarose gel electrophoresis, pooled, and used for library 
construction. DNA from the bacteriophage lambda vector 
EMBL3A (11) was digested with BamHl. the DNA was 
recovered and annealed, and the vector arms were isolated 
by gradient centrifugation. Each ligation was performed with 
1 I.Lg of vector arms and 0.2 p.g of fractionated line 64 DNA. 
In vitro packaging with Gigapack Plus extract (Stratagene) 
gave a yield of 3.8 x 10 6  plaques per p.g of mouse DNA when 
assayed on a SupF Escherichia co/i host (ED8654 [3]). 
When plated on a Sup ° host (MC1061 [5]), the number of 
viable plaques obtained was lower by a factor of approxi-
mately 2.5 x iO. Of 12 plaques, 8 reacted with an HSV TK 
gene probe. 
DNA blotting procedures. To map restriction enzyme sites 
to genomic DNA. 10-p.g samples were digested appropri-
ately and run on 0.8 or 0.5% agarose gels. The DNA was 
depurinated and transferred to Hybond-N (Amersham 
Corp.) and fixed by UV cross-linking. HSV 1K-specific 
bands were detected by using the PstI fragment of the HSV 
1K gene, labeled with 32P to a specific activity of 10 to iou , 
and the hybridization method of Church and Gilbert (6). 
Recombinant clones were mapped by using probes spe-
cific for the HSV TK gene, the MUP BS6 gene promoter 
fragment, and the SupF gene. Transfers were by the alkaline 
blotting method of Reed and Mann (24), and hybridization 
was in lx SSC (0.15 M NaCl, 0.015 M sodium citrate) 
containing 0.3% low-fat dried milk and 50 jig of denatured 
salmon sperm DNA per ml. 
RESULTS 
Structure of the foreign DNA and patterns of tissue-specific 
expression in lines 58, 64, and 78. The structures of the 
chromosomal insertions of foreign DNA in the primary 
transgenic lines 58, 64. and 78 are summarized in Fig. 1. The 
structure of the line 64 insertion was determined by mapping 
bacteriophage lambda clones (see below). Those of the line 
58 and line 78 insertions were deduced from Southern blots 
of genomic DNA (data not shown). Line 64 contains two 
copies of the foreign DNA in direct tandem arrangement. 
The two copies are separated by a short (about 500 base 
pairs) intervening DNA sequence of unknown origin. The 
two copies and the flanking regions of chromosomal DNA 
are contained within a 17.5-kb Hindlil fragment. Line 58 
contains three copies of the foreign DNA in direct tandem 
arrangement, with short terminal deletions at the junction 
points between fragments. All three copies are contained 
within a 20-kb Hindlil fragment. Line 78 contains about 1.3 
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—4.2--4-2 
M 	 M 	 M 	 H 
58 
147 
M 	 M 	M 
i78 
FIG. 1. Structures of the foreign gene chromosomal insertions in 
primary transgenic lines. The map of the line 64 insertion is based on 
cloned sequences (Fig. 2); the others are based on DNA blotting 
data. The lengths shown are in kilobases. Symbols: continuous line, 
mouse chromosomal DNA; open box, MUP BS6 gene promoter 
region; filled box below line, HSV TK structural gene: filled box 
above line. SupF sequence; open-ended box, uncertainty about the 
precise junction point; vertical wavy line, shortening of the map. 
Restriction enzyme sites: H. Hindlll; M. Sinai. 
copies of the foreign DNA, again in direct tandem arrange-
ment and with a short deletion at the junction between the 
nearly complete 5' copy and the truncated 3' copy. Two 
SmaI fragments with a combined length of 17.5 kb contain 
the line 78 insert and extensive flanking regions. From these 
results it is clear that each line carries a small number of 
foreign genes in a unique arrangement. 
The pattern of expression of HSV TK in these three lines 
and two others, each of which contains 10 or more copies of 
the gene, has been described in some detail (1). The expres-
sion observed in the liver in each case (Table 1) was 
expected in that the resident MUP gene promoters are active 
in liver. Expression was also observed in two tissues in 
which the resident MUP gene promoters are not active, 
namely, the testes and preputial glands. Expression in the 
preputial gland appears to be a function of the MUP gene 
promoter. since it has been observed in ot4iV,.transgenic 
mice carrying different M UP gene constructs kjg) Of the five 
lines originally described, four express the hybrid gene in the 
preputial glands and all five express it in the testis (1). In 
fact, HSV TK activity in preputial glands of line 64 mice was 
above the background assay level observed with nontrans-
genic preputial glands (Table 1). However, the activity was 
respectively 20 and 60 times less than the activities present 
in line 58 and line 78 preputial glands. The liver activity level 
in line 64 mice was also lower than activities in lines 58 and 
78. The levels of testis activity were much the same in the 
three lines. 
Recovery of the line 64 foreign DNA by molecular cloning. 
Several previous studies have used the bacterial SupF gene 
to facilitate recovery of foreign DNA from transfected (33) 
and retrovirus-infected (26, 32) cells, and the principle of the 
method is well known (30). We have routinely included a 
3'-terminal SupF gene in foreign DNA introduced into the 
mouse germ line and have presented evidence that in at least 
one case it does not influence expression of the gene with 
which it is associated (1). 
Clones carrying the SupF gene and positive to a HSV 1K 
gene probe were isolated from a genomic library of line 64 
DNA constructed in the lambda vector EMBL3A (see Ma-
terials and Methods). The restriction sites of the cloned 
fragments were congruent with each other and with a restric-
tion site map of the relevant region of line 64 genomic DNA, 
showing that the DNA had not become rearranged during 
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TABLE 1. Expression of the BS6 TK-SupF hybrid gene in tissues of primary and secondary transgenic male mice 
TK activity (pmollmin per mg of protein) 
Group 	
Testis 	 Preputial gland 	 Liver 
Control 




SeTidrffaiigenic mouse nos. 







0.25 ± 0.08 (6) 0.23 ± 0.10(7) 0.02 ± 0.004 (7) 
140 ± 6.7 (3) 12.0 ± 0.39(2) 0.05 ± 0.04 (4) 
139 ± 17.6(3) 83.1 ± 19.9(2) 1.9 ± 0.32 (8) 
31.1 ± 10.5 (3) 9.9 ± 2.6 (3) 5.8 ± 1.15 (3) 
62.4 ± 8.4 (3) 32.1 ± 5.3 (3) 12.7 ± 1.85 (3) 
40.8±2.9(7) 0.65 ± 0.17 (7) 
36.7 17.6 0.01 
24.9 47.9 3.14 
330 196 19.6 
38.8 80.3 2.26 
50.6 7.8 0.42 
5.6 1.4 1.20 
Mean ± standard error (number of observations). 
b  From Al-Shawi et at. (1). 
Fertile nontransniitting male: other males were sterile. 
reisolation (Fig. 2). One clone (not shown) had the structure 
expected to result from a reciprocal recombination event 
between nonidentical copies of the foreign DNA during 
bacteriophage multiplication: that is, it contained a single 
copy of the foreign DNA sequence flanked by the same 
regions that flanked the tandem gene pair in the other clones. 
Expression pattern in secondary transgenic mice of the 
foreign DNA insertion recovered from line 64. Clones 1.2 and 
2.1 were chosen for introduction into the mouse genome. 
Two clones were used rather than one because a single clone 
iriThe E. co/i host. If the two clonesbëiñTh -same WäV 
iñThëcorytransgenic mice, this may he assumed not 
to be the case. Both clones contained the entire (9 kb) 
tandem insertion and similar amounts of flanking chromo-
somal DNA (Fig. 2). In each case, the entire cloned frag-
ment, consisting of the tandem insert and the flanking DNA, 
could be separated from the vector arms by digestion with 
Sail, which cleaves the small polylinker sequences of 
EMBL3A but does not cleave either cloned fragment. The 
fragments were freed from vector arms by agarose gel 
electrophoresis and introduced into mouse embryos by 
direct pronuclear microinjection. 
An analysis ofH$YJIK activiy in tissues of six G 0 males 
isiThiiized in Table 1. Three of these mice were fertile 
sterile..Bàflitypes of reproductive behavior are characteris- 
tic of prirnrG transgeni-aI 	ainjngtç BS6 
TK-SupF hybrid gene; of five prim 	mates, two were 
fe?tilUTnohTrärismitting and three were steril (1). Fertile 
nontransmlffmgG () males are mosaics, and males of the five 
established lines are sterile (1). HSV TK activity was present 
in the preputial glands of all six males (Table 1). The activity 
levels in different G 0 males were highly variable, but the 
highest value (male A45) was greater than the highest value 
observed among the primary transgenic lines (Table 1 and 
reference 1). Furthermore, the distribution of values did not 
overlap that of seven line 64 males. The significance of this 
is the greater since the secondary transgenic male with the 
lowest preputial gland expression is a mosaic. Thus, the 
negligible enzyme activity in the preputial glands of line 64 
mice was not preserved when the tandem gene pair was 
recovered and introduced into secondary transgenic ani-
mals. It may therefore be concluded that the very low 
preputial gland activity is due to the chromosomal environ-
ment around the insertion site in line 64, in other words, to 
chromosomal position effect. Since the cloned DNA con-
tained the regions immediately flanking the line 64 foreign 
DNA, the position effect presumably originates from more 
distant regions of the chromosome. 
The activity in the liver and testis of the secondary 
transgenic G0 males was also variable (Table 1). In this 
respect, the secondary transgenic lines resembled the five 
primary transgenic lines. Interestingly, in both primary and 
AT H H 	TI 	B LT 	I M 88 IT 	I M BB B TI B 	H I BH I I M HT 









FIG. 2. (A) Cloned segments of line 64 DNA. Symbols: continuous line, mouse chromosomal DNA: open box. MUP BS6 gene promoter 
region: filled box below line. HSV 1K structural gene: filled box above line, SupF sequence. Restriction enzyme sites: B. Ba,nHI; H, HindlIl: 
T, S,vgl; M. Smal; L. BgIII. The precise junction points of the two foreign DNA fragments with the chromosome and with the extra fragment 
of DNA between them have not been precisely mapped. (B) Length of sequence present in six lambda EMBL3A recombinants. 
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TABLE 2. Expression of the BS6 TK-SupF hybrid gene 
in tissues of second-generation secondary 
transgenic male mouse lines 
no. 
TK activity (pmoL/min per mg of protein) 
Testis 	 Preputial gland Liver 
A49.1 121 	 47.2 0.82 
B65.2 387 251 27.1 
B56.5 0.74 	 40.4 0.00 
B56.11 0.82 56.3 0.02 
B56.9 3.74 	 28.3 0.06 
secondary transgenic mice, the levels of expression in the 
three tissues varied independently of each other. TK activity 
levels were determined in five other tissues, lachrymal 
gland, submaxillary gland, brain, skeletal muscle, and kid-
neys. As in the case of the primary transgenic mice (1), the 
TK activities in these tissues were very low and indistin-
guishable from those observed with control nontransgenic 
mice (data not shown). 
Structures of the foreign DNA in the secondary transgenic 
mice. As an alternative, the loss and subsequent recovery of 
peputial gland expression might be explained by DNA 
rearrangement. If the particular arrangement of the genes in 
line 64 caused the loss of expression, for example by 
interactions between the two genes, then expression might 
be recovered in the secondary transgenic mice if the genes 
became rearranged in such a way as to reverse the original 
effect. 
It is inherently unlikely that an appropriate rearrangement 
would have occurred in all of the nine secondary transgenic 
mice examined (Tables 1 and 2). However, it is necessary to 
show that this DNA fragment does not undergo a consistent 
rearrangement and also to demonstrate that the secondary 
transgenic mice carry the intended DNA fragment. The 
organization of the DNA in several secondary transgenic 
mice was therefore examined by Southern blot analysis, 
using as a probe a fragment of the HSV TK gene. Digestion 
with Sstl released from line 64 DNA four fragments that 
hybridized with the probe. Two of these were 2.2 kb in size, 
and the others were 2.6 and 2.8 kb. Digestion with BglII  
released probe-positive fragments of 4.9 and 5.5 kb (Fig. 
3A). The presence of SstI or BgIII fragments of other sizes 
would indicate that rearrangements had occurred, the most 
likely of which is a junction between the foreign DNA and 
the chromosomal DNA of the secondary transgenic animal. 
The DNA of four G 0 secondary transgenic mice was exam-
ined after separate digestion with SstI and Bg!II. In each 
case the predominant hybridizing bands were the expected 
bands (Fig. 3A), showing that most of the foreign DNA 
fragments were not rearranged in a way that disturbed these 
patterns. The BglII digests of DNA samples A17 and B27 
each showed an additional faint hybridizing band (Fig. 313). 
These bands probably represent junction fragments between 
chromosomal DNA and the foreign DNA insert. 
The lambda 2.1 recombinant contains a single HindIII site. 
If the DNA in the secondary transgenic lines takes the usual 
form of a direct tandem array, digestion with Hindlil will 
produce mainly unit-size HSV TK-positive fragments. In 
addition, each insertional array will have a flanking junc-
tional fragment of a different length at each end. In most 
cases, such fragments may be expected to hybridize with the 
probe. The same is true of lambda 1.2, which has two 
HindIll sites close together, except that the predominant 
fragment will he shorter than unit length by an amount equal 
to the 0.8-kb length of DNA between the two HindIII sites. 
The DNA of three secondary transgenic mice was examined 
after Hindlil digestion. In each case, the expected band was 
present (Fig. 313 and data not shown). 
Male descendants of secondary transgenic females. The five 
primary transgenic lines that carry the BS6 TK-SupF hybrid 
gene are all male sterile, and the founder in each case was a 
transgenic female (1). All of the male transgenic mice in each 
of the primary lines inherit their foreign genes from the 
mother, and it is therefore possible that the foreign gene 
insert in line 64 is genetically imprinted (15, 25, 29, 37) during 
female germ line maturation. If so, the property of being 
imprinted must be peculiar to the insertion of foreign DNA in 
line 64, since the foreign gene is expressed in the preputial 
glands of the other primary transgenic lines. Imprinting, if it 
occurs, might be due either to a chromosomal position effect 
or to the arrangement of the foreign DNA at the insertion 
site. In either case, the secondary transgenic G 0 males would 
123456789101112 	 1 	2345 
_ 	—11.1 	 16-5 - 
— 	 —5-5 
—4.9 
dMW 	 —.4-1 
— 	 - 
— 	 - 
-- Now - 
B 
FIG. 3. Southern blot analysis of G 0 secondary transgenic mice. (A) SstI and BgIlI digests. Lanes: 1, lambda 2.1 x SsiI (five-copy marker); 
2, A6 x SstI; 3, A6 X BgllI: 4, A17 x SstI; 5, A17 x BgIlI; 6, B27 x SstI; 7. B27 X BgllI: 8, B50 x SsiI: 9. B50 X BgIlI; 10, lambda 2.1 
X Bg(II (five-copy marker): 11, lambda 2.1 x SmaI (five-copy marker): 12, kilobase size ladder (Bethesda Research Laboratories). (B) Lanes: 
1, A17 x SsrI; 2, A17 x BgtII; 3, A17 >( HindlIl; 4, B27 x Sstl: 5. B27 >< BgIII. 
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not show the imprinted phenotype (i.e., the same phenotype 
as line 64) because the foreign genes that they carry have not 
passed through the female (or any) germ line since they were 
recovered by molecular cloning. Thus, up to this point we 
have not excluded the possibility that negligible expression 
in the preputial gland is due to a gene arrangement or to 
some other alteration that invites imprinting. 
This possibility was tested by analyzing the progeny of 
three secondary G 0 transgenic females. Three transgenic 
male descendants of BSÔ and also transgenic male descen-
dants of A49 and B65 were analyzed (Table 2). As was the 
case with two of the G 0 males, expression in the preputial 
glands of all of these males was high. This experiment 
excludes the possibility that the low preputial gland expres-
sion in line 64 is related to a genomic imprinting effect 
dependent on the structure of the foreign gene or to the 
immediate chromosomal environment. It remains possible 
that the chromosomal position effect that we have identified 
acts through imprinting, but this does not affect the central 
conclusion that it is a position effect. 
DISCUSSION 
When a foreign DNA fragment is introduced by embryo 
pronuclear microinjection, the chromosomal integration 
sites usually contain many copies of the fragment. These are 
generally arranged in a direct tandem array (other arrange-
ments are found infrequently), and the arrays probably arise 
by homologous recombination between different identical 
copies of the foreign DNA fragment. The process of integra-
tion is essentially stochastic and cannot be controlled. Con-
sequently, any set of transgenic mice made by introducing 
the same foreign DNA fragment is inevitably made up of 
individuals that carry different numbers of fragments at the 
chromosomal integration site (or at each site if there are 
more than one). It is generally found that the level of 
expression of the foreign gene is independent of its cp 
number. Underlying this, each individual chromosomal in-
tegration complex is associated with a different level of 
expression. As we (1) and others (9, 39) have shown by 
comparing transgenic lines, the expression level is a herita-
ble property of the integration complex. 
Integration complexes differ in a number of ways. First, 
there is the copy number referred to above. Then, although 
most arrays of foreign DNA consist of direct tandem re-
peats. some contain other arrangements such as inverted 
repeats and different sorts of fusions between internal parts 
of two copies of the foreign DNA (rearrangements). The 
junctions between the array and the chromosome generally 
involve sequences internal to the foreign DNA (7. 8. 40). 
Arrays may contain fragments of DNA from elsewhere in the 
genome or from unknown sources (40). Finally, the DNA 
may in principle be damaged by nucleotide substitutions or 
small deletions. Any or all of these changes may affect 
expression in different cases, and changes that affect the 
expression of one gene may not affect another. Copy-
number-dependent expression in erythroid fetal liver and in 
T cells has been observed in transgenic mice carrying 
particular chromosomal regions associated with the beta-
globin and CD2 loci (13, 14, 28). In neither case is it clear 
whether these act by overcoming effects due to the chromo-
somal environment or effects due to the arrangement of the 
gene array, where the copy number is greater than one. 
The question we have addressed here is whether the level 
of expression is in some way dictated by chromosomal 
location, as opposed to the effects listed above. We selected 
- 
a transgenic line with unusual ex ression and with a low 
oreign D 	c 
easi y. The expression pattern o t e oreign ne in this line 
is unusual in that the level of expression is extremely low in 
just one of the three tissues in which it is expressed in other 
lines. Thus, the gene is not totally inactive as it would be if 
it had suffered a major lesion or if it were uniformly 
methylated. When the foreign gene pair was reisolated from 
line 64 and reintroduced into secondary transgenic mice, 
expression in the preputial gland was restored. The same 
general approach was previously used to study the cause of 
the inactivation of an HSV TK gene that had become 
expressionally inert while inserted into the chromosomes of 
an L-cell line. In that case too, the activity of the gene was 
restored when it was recovered and reintroduced into the 
genome of a cell (4). At least two of our secondary trans-
genics showed some rearrangement of the foreign DNA. 
Any one of these rearrangements could in principle have 
reversed the effect of a previous rearrangement. It is highly 
unlikely, however, that this could have happened in every 
case, while on the other hand it is very likely indeed that the 
foreign genes were integrated into entirely new chromo-
somal locations in the secondary transgenic tines. Thus, the 
conclusion that negligible preputial gland expression in line 
64 is due to a chromosomal position effect is a strong one. 
Since the immediate chromosomal flanking regions were 
reisolated and reintroduced along with the insert, the posi-
tion effect must be due to influences originating from more 
distant parts of the chromosome. 
P-element-mediated transformation of the Drosophila ge-
nome leads in most cases to the insertion of solitary foreign 
DNA molecules into the chromosome. This system therefore 
lends itself to the detection of chromosomal position effects 
without the complication of tandem arrays and major rear-
rangements of the foreign DNA. Moderate negative effects 
attributed to chromosomal position have been reported (12, 
36). In these cases, mutational changes and small rearrange-
ments of the foreign DNA were not excluded as possible 
causes of the reduced expression. 
The provirus form of a retrovirus is inserted into the 
chromosome by a special mechanism at any one of a very 
large number of potential sites (32) as a solitary sequence 
between direct repeats of the proviral long terminal repeat. 
Since it does not form integrated arrays, evidence of line-
specific variation in the expression of a retrovirus suggests 
the existence of chromosomal position effects (34). The 
introduction into the mouse germ line of single copies of a 
retroviral provirus (e.g.. Moloney murine leukemia virus) 
leads in different lines to different patterns of expression of 
the viral RNA (20. 21). This has been attributed to chromo-
somal position effect (20). The ectopic expression of retro-
virus-borne cellular genes (35) may be a related phenome-
non. However, as pointed out by Soriano et al. (35), the high 
mutation rate of retroviruses. including Moloney murine 
leukemia virus (27, 31), makes it impossible to draw a firm 
conclusion on these grounds. A proof that chromosomal 
position effect, or indeed any effect other than mutational 
alteration, is operating in these cases would require a dem-
onstration that the viral genome is unchanged in at least 
some of the cited instances. In one case (Mov-3), the 
proviral genome was recovered from the infected line, 
together with flanking sequences, and microinjected into the 
cytoplasm of mouse embryos (18). A single mouse that had 
integrated the provirus into its genome was recovered and 
analyzed. Viral sequences were expressed at a high level in 
skeletal muscle, an ectopic tissue with respect to normal 
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Moloney murine leukemia virus expression. This experiment 
has crucial weaknesses, however, as a demonstration of 
chromosomal position effect, principally because only a 
single mouse (integration event) was studied. The route by 
which the microinjected provirus became integrated into the 
genome of the embryo is unclear, but the flanking chromo-
somal sequences are known to have been removed in some 
way. If integration involved transcription from the proviral 
genome, followed by reverse transcription and integration 
by the normal retroviral route, then it is possible that the 
properties of the virus were altered by point mutation, 
frameshift, or deletion (27). If it was integrated by illegiti-
mate recombination between the incoming provirus (with 
flanking sequences) and chromosomal DNA, the loss of 
flanking sequences shows that DNA rearrangement has 
occurred, and this could have extended to the viral long 
terminal repeat. We conclude that while effects of chromo-
somal position may modulate the expression of retroviral 
proviruses, this explanation has the status of a hypothesis at 
this time. 
In the few well-studied cases of foreign genes that are 
expressionally inactive in some but not all transgenic animal 
or cell lines, the foreign DNA was hypermethylated. The 
HSV 1K gene which spawned expressionally inactive vari-
ants while resident in L cells was hypermethylated in most 
cases (4). Similarly, the murine line-specific inactive Mov 
proviruses studied by Jähner and Jaenisch (21) become 
hypermethylated during early development and are later 
selectively demethylated in a line- and tissue-specific man-
ner. As pointed out above, expression of the line 64 foreign 
hybrid genes cannot be uniformly and irreversibly inacti-
vated by methylation, since these genes are expressed in the 
liver and testis. However, it is possible that there is tissue-
specific hypermethylation (or failure of demethylation) in the 
preputial glands of this strain. This possibility is now under 
investigation. 
Causes of chromosomal position effect have been indi-
cated or identified in some special cases. None of these 
findings exclude hYpermethylation,s a concomitant of inac-
tivation. The poiHil selection possible in cell transfection 
experiments has allowed the identification of chromosomal 
enhancers in the region of hyperactive foreign genes (2. 16). 
Similarly, cell lines transfected with retroviruses have been 
used to study chromosomal position effects. In one study, a 
transcriptionally active provirus was found to have been 
integrated at a chromosomal site which, in uninfected cells, 
was within a DNase-sensitive region of the chromatin (10). 
In another, an enhancer sequence that activated the proviral 
LTR was found close to the site of integration of a provirus 
that was unexpectedly active in an EC cell line (38). These 
examples relate to gene activation, as do the tissue-specific 
DNase-hypersensitive sites which activate the transcription 
of globin and other genes (13. 14. 28). The causes of 
tissue-specific inactivation, like that observed in line 64, 
must be of a different nature. 
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The Herpes Simplex Virus Type 1 Thymidine Kinase Is Expressed 
in the Testes of Transgenic Mice under the Control of a 
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We reported previously that the herpes simplex virus type I (HSV-1) thymidine kinase reporter gene (tk) was 
expressed in the testes of transgenic mice when coupled to the promoter of a liver-specific mouse major urinary 
protein (MUP) gene. Here we show that HSV-I 1k is also expressed in the testis when coupled to a MUP 
pseudogene promoter, to a truncated MUP promoter that is not active in the liver, and to the promoter of the 
bovine thyroglobulin gene. Furthermore. LISV-I 1k itself was expressed in the testis, although its normal 
expression had been disabled by removing an upstream regulator of transcription. In every case, the same 
multiple transcripts were observed, with their 5' ends located downstream of the normal HSV-1 1k translation 
initiation codon. We conclude that the transcription of HSV-I 1k in the testis is directed by a cryptic TATA 
box-independent promoter located in the coding region of the gene. The longest HSV-1 thymidine kinase (TK) 
polypeptides synthesized in the testis were shorter than full-length TK and probably result from translational 
initiation at Met 46 and Met"', the second and third ATG codons of the 1k reading frame. Male mice of most 
transgenic lines were sterile, and the severity of the lesion in spermatogenesis was directly related to the level 
of TK expression. In the most highly, expressing lines, sperm counts were low and morphologically defective 
sperm were common. In other sterile lines, TK was expressed at a lower level and sperm counts were normal 
but sperm motility was greatly reduced. Lines with the lowest levels of HSV- I TK expression were fertile. 
HSV-1 TK was expressed in germ line cells, mainly in the haploid spermatids. However, low-level HSV-1 TK 
activity was found in the testis before the first germ cells entered meiosis, showing that if expression is confined 
to the germ cells, it also occurs in spermatogonia. 
The coding region of the herpes simplex type 1 (HSV-1) 
virus thymidine kinase gene (tk) has been used extensively 
as a reporter sequence in cell transfection (30. 45) and was 
one of the first reporters used in work with transgenic 
animals (8. 43. 44). More recently it was adopted as a 
component of a system for destroying (ablating) specific cell 
types in transgenic animals (4, 5. 22). The basis of the 
procedure is to place HSV-1 tk under the control of a 
tissue-specific promoter and introduce the compound gene 
into the mouse genome. HSV-1 thymidine kinase (TK) is 
expressed in target tissues when the promoter becomes 
active. At this time, target cells may be killed by adminis-
tering an antiherpetic agent to the transgenic mouse. Several 
potentially useful antiherpetic agents are available, the most 
effective of which seems to be Ganciclovir (9-11,3-dihy-
droxy -2-propoxy(methyl)l -guanine [DHPGJ). The agent is 
phosphorylated quite efficiently by HSV-1 TK, and the 
phosphorylated DHPG derivatives are lethal to the cell. 
DHPG is phosphorylated very inefficiently by cellular nude-
oside kinases, and this explains its lack of toxic effects on 
nonexpressing tissues and nontransgenic animals. 
In addition to an agent which is nontoxic to nonexpressing 
cells, the ideal ablation system would employ an enzyme 
which has no deleterious effect in the absence of the agent. 
The apparent lack of deleterious effects of HSV-1 TK (4) is 
* Corresponding author.  
quite surprising in view of its nonphysiological mode of 
action: unlike the major cellular enzyme, it phosphorylates 
cytidine as well as thymidine (11. 26). and it also phospho-
rylates pyrimidine nucleotides (10. 41). We reported previ-
ously that in combination with a mouse major urinary 
protein (MUP) gene promoter sequence. HSV-1 tk was 
expressed in the testis and caused male sterility (1). We have 
now coupled HSV-1 tk to other promoters and find that it is 
invariably expressed in the testis. The severity of the defect 
in spermatogenesis correlates positively with the level of TK 
expression. 
MATERIALS AND METHODS 
Plasmid constructs and transgenic mice. The different hy -
brid genes with animal promoters and the HSV-1 1k coding 
region are described elsewhere (1. 2, 44a, 44h). All contain 
the same 1,759-hp fragment of HSV-1 tk between a Bglll site 
in the 5' noncoding region and a BstEIL site 430 bp down-
stream of the polyadenylation signal (Fig. 1). The Bg/Il site 
was joined to each cellular promoter at a site in the 5' 
noncoding region of the transcription unit and in each case 
the bacterial supF gene was attached beyond the BstEIl site 
as described previously (1). The 1.887-bp EcoRl-BstElI 
fragment of HSV-1 ik (Fig. 1) was excised from plasmid 
pTK1 (46). DNA fragments for microinjection were prepared 
as described. i'ransgenic mice were identified by polymerase 
chain reaction of tail-cut DNA. 
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FIG. 1. (A) Diagram of the HSV-1 ik gene. DS  and DS2 are the transcriptional control regions (38): M', M 4 '. and M°° are the first three 
ATG codons of the reading frame. The testis transcription initiation sites (TESTIS SITES) are described in the text. The fragment used as 
a reporter sequence with cellular promoters was always the same BgIII - to -BsiElt fragment, with the promoter attached at the BgIll site and 
the bacterial supE gene at the BsiEIl site. Both sites were eliminated during construction. (B) The MUP BSÔ- ik-supF gene. The reporter 
sequence is attached to the HSV tk gene at the Bglll site, which was first blunted with DNA polymerase I. P1 and P2 are polylinkers at the 
junctions with plasmid vector DNA. 
RNA analysis. Testis RNA was prepared and Northern 
(RNA) blot analysis was performed as described previously 
(1). The probes used were (i) pTK1. which could react with 
up to 1.256 nucleotides of full-length transcript (BgIII site to 
polyadenylation site). (ii) probe A (Fig. 1). an 841 - hp PstI 
fragment of pTK1. and (iii) probe B. RNA transcribed from 
a 419-hp EeoRI-EcoRV fragment of HSV - 1 tk (-80 to +339) 
cloned in pT7-2(U.S. Biochemicals). Primer extension anal-
ysis was carried out as described previously (16), using as 
primer a 5'-end-labelled (32) 23-nucleotide oligonucleotide 
complementary to the region from +369 to +347 of HSV-1 
1k. RNase protection assays were carried out as described 
previously (28) with use of probe C (Fig. 1). RNA tran-
scribed from a 450-hp Asp700I-EcoRV fragment of BS6- ik-
siipF (-142 to +348) cloned in pBluescript II SK+ (Strata-
gene Ltd.). Approximately 5 x 10 dpm of antisense probe 
was hybridized overnight at 45°C with 5 p.g of total testis 
RNA. Digestion was with 40 p.g of RNase A and 650 U of 
RNase T 1 per ml for 30 min at 37°C. 
Protein and enzyme analysis. Tissue extracts were pre-
pared and HSV TK assays were performed as described 
previously (1). Where indicated, the protease inhibitors 
3.4-dichloroisocumarin (DCI) or tosyl phenyl chloroketone 
(TPC) and p-hydroxymercurihenzoate (PHMB) were added 
at the time of homogenization. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis was carried out with 12% 
separating and 4% stacking gels. Proteins were transferred to 
nitrocellulose (0.2-p.m pore size : Schleicher & Schuell), and 
Western immunoblots were carried out as described previ-
ously (27). using a 1/250 dilution of rabbit anti-HSV-1 TK 
serum (provided by W. P. Summers) as the primary antibody 
and biotinylated goat anti-rabbit immunoglohulin G (Amer-
sham) as the secondary antibody. Filters were treated with 
streptavidin-alkaline phosphatase conjugate (1/1000 dilution: 
Amersham) for 45 min at room temperature and developed  
with 7 mM 5-bromo-4-chloro-3-indolyl phosphate and 6 mM 
nitroblue tetrazoliurn in 0.1 M Tris-HCI, pH 9.5, at room 
temperature for about 20 mm. 
Immunostaining of testis sections. Deeply anesthetized 
mice were perfused with 2% paraformaldehyde. and tissues 
were postfixed with modified Bouin fixative, dehydrated in 
graded alcohols, and embedded in paraffin wax. Dewaxed 
4-p.m sections were treated with 1% H.O. in methanol to 
block endogenous peroxidase, treated with 1 mM EDTA-
0.05% Tween 20 in phosphate-buffered saline for 10 mm. 
flooded with 2% egg albumen, and incubated overnight at 
4°C after addition of rabbit anti-H SV-1 TK serum. Peroxi-
dase-conjugated goat anti-rabbit immunoglobulin G was 
added for 90 nun, and slides were developed with 3.3'-
diaminobenzidine. 
RESULTS 
Expression of HSV-1 1k in the testis in conjunction with 
active and inactive tissue-specific promoters. We previously 
described a construct (BSÔ - tk - supF) in which the expression 
of HSV-1 tk was directed by a MUP gene promoter (1). This 
gene was expressed consistently in the livers and preputial 
glands of transgenic mice (four of five transgenic lines in 
each case). It was also expressed very consistently in the 
testis (five of five transgenic lines), and males of all five 
transgenic lines were sterile. We next made a comparative 
study of a number of other constructs in which the same 
HSV-1 tk reporter sequence was coupled to different pro-
moters (Fig. 1). Two of these contained defective MUP 
promoters: 13S2-tk-.rupF contained a fragment of a MUP 
pseudogene homologous to the BS6 promoter. and 
BS6Sau2 - tk -supF contained only the proximal part (to m.1 - 
cleotide —314) of the BS6 promoter. Another. TG-ik-supF. 
contained a 3.05-kb promoter fragment of the bovine thyro- 
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TABLE 1. Expression of HSV-1 TK in tissues of lines of transgenic mice carrying constructs with different 
promoters linked to the HSV-1 ik reporter 
TK activity pmoliminlmg of protein) 
Construct Fertility" iz Testis Liver Preputial gland 
Mean ± SE' Range' Mean ± SE Range Mean ± SE Range 
BS6-ik-supF S 5 84.0 ± 20.7 31-140 4.39 ± 2.04 0.05-12.7 27.4 ± 13.3 0.0443 
BS6-1k-.sipF (TR) S 4 195 ± 40.8 68-286 5.86 ± 3.68 0.62-18.5 70.9 ± 37.6 14.4-200 
F 2 2.52 1.77-3.26 
BS2-1k-supF S 3 60.7 ± 9.2 47-83 0.47 ± .005 0.46-0.48 0.01 ± 0.01 0.(-4)04 
BS6Sau2-tk-supF S 6 60.6 ± 10.9 17.4-91 0.09 ± 0.03 0.01-0.16 3.66 ± 1.29 0.0-7.8 
F 1 2.0 0.06 1.53 
TG-tk-supF S 3 54.5 ± 9.0 40.4-73.3 0.01 0.35' 
S. sterile males; F, fertile males. 
Number of transgenic lines studied. 
Mean of line means. 
" Range of line means. 
Mean of two lines. Values typically observed in extracts from nonlransgenic mice are shown in Table 3 
globulin (TG) gene (13). BS6-1k-,supF (TR) contains two 
copies of 13S6-tk-supF, each lacking a short 5 region and 
separated by a 500-hp fragment of mouse DNA, which were 
integrated at a single chromosomal site in a line of transgenic 
mice (2. 27a). The complete tandem dimer together with 
flanking DNA sequences was recovered from two bacterio-
phage lambda clones and reintroduced into the mouse ge-
nome (2). These constructs displayed different patterns of 
tissue-specific expression (Table 1). In addition. TG-tk-SupF 
was expressed in the thyroid gland (44a). 
Expression in the testis was remarkably consistent: the 
male offspring of every transgenic G 11 female expressed 
HSV-1 TK in the testis. Furthermore, most of the lines were 
male sterile, and sterility was invariably associated with a 
higher level of expression in the testis. Altogether. 21 
transgcnic lines representing five constructs expressed 
HSV-1 TK at a high level and were male sterile, while three 
transgenic lines expressed the enzyme at a low level and 
were fertile. When the expression of each construct was 
averaged over all transgenic lines for which data were 
available, the level of expression of the reporter gene in the 
testis was nearly the same in most cases. The single excep-
tion was 13S6-tk-.supF (TR), which had a level of expression 
roughly twice that of the other lines. This may relate to the 
fact that BS6-ik-supf (TR) was microinjected as a tandem 
dimer (see above). The relatively uniform expression of 
HSV-1 1k when coupled with a variety of promoters suggests 
that expression in the testis is a function of the tk sequence, 
which was the same in all cases. 
Some lines of each series were extensively screened for 
expression in other tissues. Low-level expression of MUP 
promoter constructs was very occasionally found in the 
lachrymal gland. Other tissues were negative. Although all 
of the constructs carried the bacterial .cupF gene, this wa 
not the cause of their expression in the testis: a construct 
identical to BSÔ-rk-supF but without the siipF gene was 
expressed in the testis at similar levels (1). The data thus 
confirm our conclusion (1) that sterility correlates with 
expression of HSV-1 TK in the testis, not with expression in 
the liver (constructs 13S6Sau2-tk-supF and TG-tk-supF) or in 
the preputial gland (constructs BS2-ik-supF and TG-tk-
siipF). 
Truncated forms of HSV-1 1k RNA and HSV-1 TI( protein 
are expressed in testes of transgenic mice. We reported 
previously that two main size classes of HSV-1 1k-specific 
RNA were present in testes of transgenic mice carrying 
13S6-tk-supF ( 1). A 900-bp transcript, first observed by 
Roberts and Axel (39), was not labelled by an antisense 
probe (Fig. 2A and C. lane 1) and must therefore be a reverse 
transcript, possibly related to a reverse transcript previously 
observed in cells infected with HSV-1 (18. 25). Line L78 
carries a full-length copy and a second truncated copy of the 
5' end of the BSfi-tk-supF gene (2). L78 uniquely has a third 
short (500-hp) testis transcript (Fig. 2A. lane 1) which was 
labelled by a probe directed against the 5' part of the HSV-1 
1 	2 	3 	4 
am 
i 
FIG, 2. Mapping 01 HS\ -1 iA-peciti RNA in extracts of line 78 
testis. Identical RNA transfers were probed with a full-length 
HSV-1 tk double-stranded DNA probe (A). a 5' double-stranded 
DNA probe (B). and a 5' single-stranded antisense RNA probe (C). 
Lanes contain RNA samples as follows: 1. line 78 testis: 2. BHK 
cells stably transformed with a plasmid with an active BS6-zk gene; 
and 3. nontransgenic testis. Lane 4. runoff RNA size markers. 1.830. 
1.320, 957. and 444 nucleotides long. 
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tk gene (Fig. 213). We interpret the 500-bp transcript which is 
peculiar to L78 as being from the second truncated copy of 
the gene. A 1,200-hp transcript is the predominant transcript 
in testis from all transgenic lines examined. It is the on[ 
transcript that can act as template for the synthesis of active 
TK but is shorter than the 1.350-hp transcript expected if 
transcription was initiated at the cap site of the BS6 gene. 
Primer extension (not shown) and nuclease protection 
experiments were carried out to determine the effective cap 
site of the 1,200-hp transcript. Lines L40, L46. and L78 (all 
carrying BS6-rk-supF) were used in different experiments. 
Apart from the additional short transcript present in L78 
RNA, these lines showed the same band pattern in Northern 
blots. In liver RNA, the 5' ends of transcripts mapped in 
approximately equal amounts to two sites, one within 1 
nucleotide of the predicted MUP gene cap site (-1) and a 
second site 73 nucleotides downstream (Fig. 3, lane 3. 
markers B and D). In testis RNA, no transcripts originated at 
the MUP gene cap site. At least six different 5' ends mapped 
to sites between about +130 and ±205, the most prominent 
being at about +150 and +160 (Table 2 and Fig. 3. lane (. 
markers E to I). All of these sites lie between the normal 
initiation codon of HSV-1 ik (M 1 : Fig. 1) and the second 
methionine codon (M 46 : Fig. 1). The same 5' ends were 
observed in experiments with testis RNA from transgenic 
mice carrying BS6-Sau2-ik-siipF and TG-zk-supF (Fig. 3. 
lanes 10 and 12). 
In L46. the BSfi-tk hybrid gene was highly expressed in 
both the testis and the male preputial glands. We examined 
the pattern of anti-TK antibody-reactive polypeptides in 
extracts of these two tissues. Several polypeptides present in 
a standard preputial gland extract reacted with anti-TK 
antiserum (Fig. 4. lane 3). The most prominent was a 
proteolytic product, since it was absent when the extracts 
were prepared in the presence of protease inhibitors (Fig. 4. 
lanes 4 to 6). In the presence of protease inhibitors (19), the 
most prominent component was the full-length M-43,000 
(43K) HSV-1 TK. A similar amount of a 37K polypeptide 
and a smaller amount of a 39K polypeptide were also 
present. These polypeptides are present in cells infected 
with HSV-1 (31). The truncated forms are due to initiation of 
translation at two internal ATG codons corresponding to 
M46 and M60 . They were produced in increased amounts 
when M 1 was deleted (20) or if a stop codon was introduced 
between M' and M 46 (19, 23), and at least one of them has 
TK activity (12. 19). The origin of an additional 35K poly-
peptide is not known, but it is also observed in extracts of 
HSV-1-infected cells and may result from initiation at the 
fourth ATG codon of the reading frame, M ° . Overall, the 
pattern of polypeptide expression in the preputial gland was 
similar to that observed in HSV-1-infected cells (Fig. 4. lanes 
1 and 6). 
The testis pattern was unaffected by the addition of 
protease inhibitors, indicating that testis extracts do not 
proteolyze HSV-1 TK (Fig. 4. lanes 7 to 10). The predomi-
nant components were the 39K and 37K polypeptides. 
consistent with the initiation of transcription between ATG' 
and ATG 2 . In most cases full-length (43K) HSV-1 'UK was 
not observed, but in some experiments a very small amount 
of antigenically reactive protein migrated with the appropri-
ate mobility. This may represent the translation of a small 
amount of the 43K protein from rare transcripts initiated 
upstream of ATG'. Testis RNA from lines carrying MUP 
gene constructs contains a small amount of transcript which 
may originate within the MUP promoter sequence upstream 








FIG. 3. Mapping of 5' ends of HSV-1 th-specific RNA in livers 
and testes of transgenic mice. The RNA riboprobe was transcribed 
from a fragment of BS6-th-supF which overlaps the MUP gene cap 
site (see Materials and Methods). Lanes'. 1 and 7, tRNA controls: 2. 
RNA from nontransgenic liver; 3, RNA from line 78 (BS6-rk-.supF) 
liver: 4, undigested probe: 5, sequencing ladder: 8. RNA from 
nontransgenic testis: 6 and 9 to 12. RNA from transgenic testis from 
line 78 (lane 6). line 40 (BSÔ-tk-supF) (lane 9). line S87 (BS6SUu2-
tk-supF) (lane 10). line TK16 (HSV-1 IkIJS2-) (lane 11). and line 
TG66 (TG-lk-supF) (lane 12). Note that the 3' end of the riboprobe 
is not complementary to the region around the cap sites of con-
structs HSV-1 tkDS2- and TG-ils-supf: the furthest 5' position of 
these constructs that could be mapped with this probe is shown as 
marker C. 
Similarly. the RNA from TG-t/-supF mice shows a pro-
tected hand at the point at which homology between probe 
and target ends, presumably derived from transcripts origi-
nating upstream of the junction (Fig. 3. lane 12, marker C). 
These longer transcripts, which are present in very small 
amounts relative to the shorter transcripts, may account for 
the production of small amounts of full-length HSV TK. 
Since the testes of transgenic mice carrying different 
HSV-1 ik constructs contained the same truncated RNA 
transcripts, it was expected that they would also contain the 
same HSv-1 'rK polypeptides. This was found to be the 
case. 'Testis extracts from five different transgenic lines 
which carry the BSÔ-tk-supF hybrid gene (lines L40. L46, 
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TABLE 2. Transcription initiation sites in liver and testis of 
line L78 transgenic mice" 
Transcription initiation Sites as determined by: 
Tissue 
Primer extension 	 Nuclease protection 
Liver 	 —1 
+73 
+129 	 +133 
+144 +153 
Testis 	 +159 	 +160 
+169 +168 
+208 	 +203 
Methionine initiation codons are as follows: M'. +79; M 46 . + 214; M, 
+256. 
1234567 
--. . . 39 
. 37 
FIG. 5. HSV-1 TK-specific polypeptides in testis extracts from 
different lines of transgenic mice. The positions of the 39K and 37K 
polypeptides are marked. Lanes contain testis extracts as follows: 1, 
nontransgenic control: 2. line 64 (BS6-lk-supF); 3, line 78 (BS6-1k-
supF); 4, line 46 (BSÔ-tk-supF): 5. line TK16 (HSV-1 ikDS2—); 6, 
line TG66 (TG-lk-supF): 7. line S87 (BS6Sau2-tk-supF). 
L58, L64. and L78) and from lines carrying the different 
constructs listed in Table 1 exhibited the same pattern of 
truncated HSV-1 TK polypeptides (Fig. 5). 
Expression of a promotorless HSV-I 1k gene in testes of 
transgenic mice. The identical patterns of aberrant transcrip-
tion in the testes of transgenic mice carrying HSV-1 rk with 
different tissue-specific promoters suggested that the cellular 
promoters are not involved in the initiation of transcription 
in the testis. To test this possibility, an 1.887-bp EcoRl-
BstEII fragment (-79 to +1808) of the HSV-1 ik gene (Fig. 
1) was excised and introduced into the mouse genome by 
microinjection. This fragment (HSV-1 tkDS2—) terminates 
at the same 3' site in the HSV-1 genome as the HSV-1 tk 
fragment used in the constructs listed in Table 1. At the 5' 
end it carries the HSV tk TATA box, but it lacks the more 
distal of two upstream control elements which are both 
required for full expression of the gene in frog oocytes and 
HSV-1-infected cells (14, 34). Removal of the distal element 
by deleting the 5' end of the gene down to position —85 
reduces expression in frog oocytes by approximately 20-fold 
(33). 
HSV-1 TK expression was measured in four G 0 transgenic 
1 2 3 4 5 6 7 8 9 10 11 12 
Li 
I 	 43 -39
r 
S 	 V 
1`I0 4. Ellect of pite 	inhitutois on I IS\ -1 1 K polypeptides 
in extracts of transgenic preputial glands and testes. Each lane was 
loaded with 50 p.g of protein. Proteins were transferred to a filter and 
developed with anti-HSV-1 TK antibody as described in Materials 
and Methods. The positions of the 43K, 39K, and 37K polypeptides 
are marked. Lanes: 1 and 12, HSV-1-infected cells; 2 to 6, preputial 
gland extracts from a nontransgenic control mouse (lane 2), and 
from line 40 mice (HSV-1 tk-cupF construct) (lanes 3 to 6), without 
added protease inhibitor (lane 3), with 20 mM DCI (lane 4), with 10 
mM TPC plus 10 mM PHMB (lane 5), and with 20 mM TPC plus 20 
mM PHMB (lane 6): 7 to 11, testis extracts from a nontransgenic 
control mouse (lane 11), and from line 40 mice (lanes 7 to 10) with 20 
mM TPC plus 20 mM PHMB (lane 7), with 10 mM TPC plus 10 mM 
PHMB (lane 8). with 20 mM DCI (lane 9), and without added 
protease inhibitor (lane 10). 
males carrying the HSV-1 tkDS2— fragment and in male 
transgenic offspring of a G ( female (founder of line TK16). 
Three of the G 0 males and the line TK16 males expressed 
HSV-1 TK at moderate to high levels in the testis (Table 3). 
Expression in other tissues was sporadic and, other than in 
the brain and lachrymal glands of TK16 males, at very low 
levels. Two of the expressing males were fertile nontrans-
mitting, like many G 1 males carrying ik constructs (1). Such 
males are probably mosaics with nontransgenic precursor 
cells in their germ line (see below). The third expressing G 0 
male and line TK16 males were sterile (Table 3). In nuclease 
protection experiments, testis RNA from line TK16 showed 
the same pattern of 5' ends within the HSV ik coding region 
as did testis RNA from mice carrying the promoter con-
structs (Fig. 3, lane 11). Furthermore, line TK16 testis 
contained the same shorter HSV TK polypeptides that were 
observed in the testis of those mice (Fig. 5. lane 5). These 
results argue convincingly that the expression of HSV-1 TK 
in the testes of transgenic mice is not due to the various 
tissue-specific promoters when these are present. Instead, it 
appears to be due to a cryptic promoter within the HSV-1 ik 
reporter gene, located downstream of the TATA box-con-
taining promoter which is utilized during HSV infection. 
Sites of HSV-J TK expression in the testis. To determine 
whether HSV-1 TK is expressed in spermatogenic cells or in 
ancillary cells, sections of testis from mature male transgenic 
mice were immunostained with anti-TK antiserum as the 
primary antibody. The sections consistently showed expres-
sion in the postmeiotic haploid spermatids (Fig. 6). No 
evidence was obtained of expression at earlier stages of 
spermatozoan development or in Sertoli cells, and staining 
was observed only rarely and sporadically outside the tu-
bules. 
Developmental onset of HSV-I TK expression. During post-
natal development in the male mouse, some germ cells in all 
of the testicular tubules begin to advance toward the first 
meiosis at about the same time (35). The first spermatocytes 
in meiotic prophase are observed between 8 and 10 days 
after birth. Between days 10 and 12, the most advanced cells 
observed are in mid-pachytene: at 15 to 17 days, 30% of 
tubules contain cells in late pachytene; and at 22 to 24 days, 
spermatids are observed for the first time in about 35% of 
tubules. Thus, by assaying the testis at different times during 
the first 3 weeks of life, an indication can be obtained of the 
developmental stage at which a gene product is first formed. 
At 7 days after birth, when the testis first becomes large 
enough to permit the assay, the specific HSV-1 TK activity 
(units per milligram of testis protein) was significant (Fig. 7). 
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TABLE 3. TK activities in tissues of transgenic mice carrying the promoter-truncated HSV-1 tkDS2- fragment 
1K activity (pmol/min/mg of protein) 
Tissue Nontransgenic G, transgenic males Line TK16 
control TKIO, fertile" TK22. fertile 	TK39. sterile TK40. fertile" 
male, sterile 
Testis 0.11 23.15 0.16 	 37.75 4.25 97.23 
Liver 0.06 0.46 0.0() 0.04 0.00 0.07 
Preputial gland 0.16 0.00 0.(X) 	 0.00 0.00 0.28 
Kidney 0.08 0.27 0.20 0.00 000 0.08 
Brain 0.20 ND# ND 	 0.35 0.07 2.99 
Muscle 0.00 ND ND 0.00 0.08 00) 
Lachrymal gland 0.07 ND ND 	 0.03 0.00 8.01 
Submaxillary gland 0.03 ND ND 0.00 0.00 1.02 
Fertile nontransmitting 
" ND. not determined. 
The lack of HSV-1 TK immunostaining in ancillary cells of 
mature testis suggests that this TK activity is present in the 
spermatogonia. However the possibility that HSV-1 TK is 
expressed in ancillary cells in immature testis has not been 
excluded. Between 10 and 20 days after birth, a higher level 
of HSV-1 TK was present, possibly due to a continuing 
increase in the proportion of the testis made up of sper-
matogonia and spermatocytes (35). At about 21 days, the 
time at which the first haploid spermatids appear, a more 
abrupt increase in HSV-1 TK activity occurred. This finding 
suggests that there may be renewed expression in the round 
spermatids. a stage at which de novo synthesis of spermio- 
genesis-specific proteins is frequently observed (17. 21, 36, 
40). 
Effects of HSV-1 TK expression on spermatogenesis. In 
lines which expressed HSV-1 TK at a low level, the male 
mice were fertile. One of seven BS2-tk-siipF lines and two of 
six BS6-tk-supF(TR) lines had relatively low levels of HSV-1 
TK expression and were male fertile, and males transmitted 
the foreign gene to their progeny (Table 1). This finding 
suggests that sterility ensues only above a threshold level of 
HSV TK (7). However, the highest level of expression 
among the male-fertile lines was five times less than the 
lowest level among male-sterile lines (3.3 versus 17.4 U/mg). 
Ak 
, 	 D 
Fit. ' 	I 	 Hft. 	Iii!IIi,Ic 	ii .uiti-HSV-1 TK serum. (A) Nontransgenic testis; (B) transgenic testis 
from line l666 (TG-th-supF); (C and D) transgcnic testis front line 78 BS6-tk-szipF). Magnifications: A. B, and C. x70; D. x280. 
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FIG. 7. Time course of HSV-1 TK expression in testis during sexual maturation. Testes of pups from crosses of line 40 and line 46 females 
with nontransgenic males were assayed as described prior to determining their transgenic status. Ordinate. HSV-1 TK activity, expressed as 
picomoles ofTMP synthesized per minute per milligram of protein. P.P., after birth. The bars show the average HSV-1 TK activity for cases 
in which more than one pup was measured. The numbers of transgenic L40 (U) and L46 () and nontransgenic L40 () and L46 91) pups 
are shown above the bars. The times at which meiotic figures [leptotene of first meiosis. L(MI)] and haploid meiotic products (spermatids. 
H) are first observed are indicated. These are the stages to which the most advanced tubules have progressed at that time. 
This large discontinuity raises the possibility that there are 
two modes of expression of HSV-1 ik in the testis, for 
example two independent mechanisms of transcriptional 
activation or possibly expression in two different cell lin-
eages. If so, it is possible that only one of the two modes is 
active in the male-fertile lines while the other causes steril-
ity. 
Although the levels of testis expression due to different 
constructs were similar when averaged over several lines, 
different lines carrying the same construct exhibited substan-
tial differences. Three transgenic lines carrying the BS6-tk-
supF gene were therefore examined. Line L78 mice have an 
intermediate level of expression in the testis (62 U/mg of 
protein). In L78, development of the spermatozoa appeared 
normal (Fig. 6). The sperm counts of L78 mice were also 
normal, but the motility of the spermatozoa was reduced and 
furthermore faded very rapidly in vitro. 
In lines L40 and L46, which have a high level of HSV TK 
expression in the testis (140 U/mg of testis protein), testis 
weight was lower than in nontransgenic controls and the 
sperm content of the epididymides was lower by a factor of 
25 to 500 (Table 4). Very few sperm were found in the vas 
deferentia of these animals and those observed had very 
abnormal morphology and were nonmotile (Fig. 8). Thus the 
severity of the spermatogenic lesion is greater when the 
expression level of HSV.1 TK in the testis is higher. 
Sterility of G0 transgenic males. In the lines that express 
moderate levels of I-ISV-i TK and produce normal numbers 
of nonmotile sperm, the heterozygous male offspring of 
transgenic females were sterile although half of the sperm 
should not carry the foreign gene. This outcome could be 
expected if the lesion which results in sperm incapacitation 
occurs prior to meiosis. However, the cells descended by 
mitosis and meiosis from each committed spermatogonium 
remain together as a syncytium with cytoplasmic bridges 
between the cells (6). Transfer of HSV TK across the bridges 
could he expected to lead to complete sterility of heterozy-
gous males even if the lesion due to HSV-1 TK expression 
occurred only in the haploid spermatids (7). 
Two classes of G 11 transgenic males were obtained with 
each of the constructs listed in Table 1. Taken together. 47% 
of the transgenic G 11 males were sterile, while 53 17c were 
fertile but did not transmit the foreign gene to any of their 
offspring. The sterile transgcnic males are taken to be 
descended from injected embryos in which at least one 
insertional event occurred prior to DNA replication at the 
one-cell stage, leading to a uniformly heterozygous individ-
ual G1> pup, comparable to the heterozygous male offspring 
of transgenic females. The fertile nontransmitting males are 
taken to be germ line mosaics, in which integration of foreign 
DNA occurred at some time after the first round of DNA 
synthesis. The transgenic cells of such individuals are het- 
TABLE 4. Defects of spermiogenesis in severely affected sterile mice 
Line L40 	 Line 46 Determination 	 Controls  
Mouse 1 	 Mouse 2 	 Mouse 1 	 Mouse 2 
Sperm weight (mg) 	 91. 95 
Epididymal sperm 2-3 x 10' 
Contents of vas deferens 	 Numerous sperm 
80 normal 
Motility normal 
HSV-1 TK activity" (line 
mean ± SE) 
From Al-Shawi et at. (1).  
72 	 74 	 80 	 63 
10 1 5 x 103 	 los s x io 
Very few sperm 
None with normal morphology 
Nonmotile 
140 ± 6.7 	 139 ± 17.6 
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FIG. 5. Noi mdl mimd delLlic pei naRt. I hc Ljntcnts of the 
vas deferens of nontransgenic (A) and line 40(B) mice were stained 
with eosin. The bar represents 10 p.m. 
erozygous and, by analogy with the heterozygous male 
offspring of transgenic females, are assumed to generate only 
defective spermatozoa. The nontransgenic germ cells pre-
sumably develop separate syncytia which generate compe-
tent spermatozoa. 
DISCUSSION 
HSV-I 1k contains a cryptic promoter which directs its 
expression to the testis. The observations described lead to 
the conclusion that the HSV-1 ik gene contains a cryptic 
promoter, independent of its own TATA box, which is 
particularly active in postnleiotic spermiogenic cells. The 
putative cryptic promoter, assumed to he located upstream 
of the sites of transcription initiation, possesses properties 
associated with promoters of housekeeping genes. Thus, 
transcription is initiated at several quite widely dispersed 
sites, and these are located within a region with a high G±C 
content which contains no discernible TATA box but resem-
bles an HTF (Hpall tiny fragment) island (3) in containing 
many potential methylation sites. However it is clearly not a 
true housekeeping promoter since it is consistently ex-
pressed at a detectable level only in the testis. The location 
of this promoter sequence is presently being investigated. 
In an interesting parallel. vigorous TATA box-indepen-
dent transcription of the metallothionein 1 gene is initiated at 
several sites between —134 and —28 in spermatocytes and 
spermatids (15). This observation and those reported here. 
together with at least one other example (42), suggest that 
the transcriptional activation of cryptic promoters which 
share properties with housekeeping promoters may be a 
property of postmeiotic male germ cells. 
In the testes of mice carrying a metallothionein promoter-
3-interferon—tk construct. Iwakura et al. (24) observed mi-
nority transcripts (about 20%) which hybridized with both  
n-interferon and tk probes, while about 80% of the tran-
scripts reacted only with the ik probe and closely resembled 
the testis ik transcripts that we observed (Fig. 2). The cryptic 
tk promoter evidently did not abrogate (or abrogate com-
pletely) the activity of the upstream metallothionein pro-
moter, which was itself active in the testis. In contrast, our 
MUP and TG constructs produce minute amounts, if any, of 
full-length mRNA. presumably because these tissue-specific 
promoters are inactive in the testis. 
Synthesis of truncated FISV-1 TK polypeptides in the testis. 
In HSV-1-infected cells, the synthesis of HSV TK is nor -
mally initiated not only at the first ATG codon but also, at 
much lower frequencies, at the second and third ATG 
codons (19. 31), possibly because both the first and second 
ATG codons lie within consensus sequences which are 
inefficient translational initiators (19). The pattern of HSV 
TK synthesis in the preputial glands of MUP-tk transgenic 
mice closely resembled that observed in HSV-1-infected 
cells. 
In cells infected with HSV-1 carrying a deletion that 
removes the first ATG codon of the tk reading frame, the 
second and third ATG codons are utilized more efficiently 
(19). The truncated HSV-1 tk RNA molecules synthesized in 
the testis lack the first ATG codon, and to this extent they 
are equivalent to the mRNA synthesized from the deletion 
mutant. Accordingly, the most abundant HSV-1 TK poly-
peptide in the testis comigrates with the most abundant TK 
polypeptide (37K) present in cells infected with the deletion 
mutant (19). Translation of the 37K polypeptide is presumed 
to be initiated at M' ° , the third methionine of the reading 
frame, which lies within the strongest translational initiation 
consensus of the first three ATG codons. Mr.O  lies within a 
region of the enzyme shown by site-directed mutagenesis to 
be the ATP-binding pocket (29). Consequently. the enzy-
matic activity of the 37K protein is likely to he less than that 
of full-length rK and the level of TK expression in the testis 
may be considerably higher than indicated by enzyme as-
says. Supporting this view, the level of HSV-1 tk mRNA in 
testis RNA is disproportionately high relative to that in 
preputial gland RNA in comparison with the ratio of TK 
activities in the two tissues (1). 
TK expression in the testis causes sterility. We previously 
concluded that male sterility in mice carrying an HSV-1 tk 
reporter gene was due to a high level of ectopic HSV-1 TK 
expression in the testis (1), and this was recently confirmed 
(7). The results presented here strengthen our previous 
conclusion. While the truncated HSV-1 tkI),S2— gene caused 
male sterility (Table 3), transgenic mice carrying the HSV-1 
ik gene with the promoter region intact were male fertile (7). 
Thus, the property of causing sterility seems to he neutral-
ized by the HSV-1 1k promoter. In these fertile mice. the 
onset of TK expression was at it later stage in sperm 
development and the level of enzyme activity attained was 
lower than in sterile mice with similar levels of HSV-1 ik 
mRNA (7). This finding suggests that the effect of the HSV-1 
ik promoter was to postpone expression of the gene to a later 
stage in spermatocyte development when protein synthesis 
is less vigorous. Since transgenic mice which exhibit a low 
level of TK expression in the testis are fertile (Table 1), the 
fertility of the mice that carry the HSV-1 tk gene with its 
promoter intact may be due simply to reduced enzyme 
activity. 
The ectopic expression of HSV-1 tk in the testis has in the 
past led to erroneous conclusions being drawn. In one case, 
male sterility in mice transgenic for a cosmid containing the 
major histocompatihility complex class II E gene was at 
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first attributed to the expression of E,,d  (37). However the 
cosmid also carried an HSV-1 tk gene, and sterility was later 
found to be due to the expression of this gratuitous compo-
nent of the construct (7). In another case, a metal lothionein-
13-interferon-tk foreign gene caused male sterility, which was 
attributed to the expression of 13-interferon (24). HSV-1 TK 
activity at levels similar to those we have observed was 
detected in the testes of the transgenic mice, and it was not 
convincingly demonstrated that 13-interferon rather than 
HSV-1 TK was the cause of sterility. 
Impaired fertility has been reported in transgenic mice 
carrying HSV ik directed by the immunoglohulin gene 
promoter and enhancer (22). Although it is unlikely that 
testis expression of HSV tk influenced the ablation of the 
lymphocytes by DHPG or of the somatotrophs of mice 
carrying a growth hormone promoter-HSV ik reporter gene 
(5), it is clearly an undesirable potential complication in 
experimental animals. 
Causes of male sterility. Our data indicate that sterility in 
mice with an intermediate level of TK expression may be 
due to expression in the postmeiotic spermatids. Since 
mammalian sperm do not undergo postmeiotic mitosis, this 
would exclude effects involving the synthesis of DNA, such 
as hypermutation. The nonmotile sperm produced by these 
sterile mice are present in normal numbers and are mainly 
normal in appearance, suggesting that their lack of motility 
may he due to an impoverished energy source. HSV-1 TK is 
an aggressively promiscuous nucleoside kinase. is only 
poorly susceptible to end-product inhibition, and vigorously 
phosphorylates mononucleotides as well as nucleosides (10, 
41). Extracts of transgenic testis show elevated levels of 
both nucleoside kinase and nucleotide kinase activity (34a). 
Normal mouse sperm remain motile for several hours in the 
absence of an exogenous energy source, suggesting that they 
possess a sizable energy store (9). Thus, the lack of sperm 
motility may derive from a failure of energy storage due to 
ATP depletion during maturation. 
The gross morphological defects and almost complete 
failure of sperm maturation that are observed in mice with 
higher levels of testis HSV-1 TK activity are likely to have a 
more radical cause. Possibly the low-level TK activity 
present prior to the first meioses. and tentatively attributed 
to expression in premeiotic germ cells, interferes with DNA 
synthesis or some other vital cellular function in lines with 
higher levels of expression but not in lines with intermediate 
expression levels. 
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